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Abstract	
Schizophrenia	 is	 highly	 heritable,	 indicating	 that	 a	 large	 proportion	 of	 one’s	
susceptibility	to	developing	the	disorder	is	attributable	to	genetics.	Recent	large-scale	
genomic	 studies	 have	 revealed	 that	 genetic	 variants	 in	 patients	 with	 schizophrenia	
affect	genes	 involved	 in	synaptic	plasticity	processes,	which	are	required	for	 learning	
and	memory,	including	genes	encoding	protein	complexes	associated	with	the	NMDA	
receptor	 and	 the	 postsynaptic	 density.	 Further	 evidence	 suggests	 that	 associative	
learning	may	be	particularly	affected,	although	it	is	unclear	which	components	of	this	
cognitive	process	are	implicated	in	schizophrenia.		
The	 present	 studies	 investigated	 the	 relationship	 between	 particular	 phases	 of	
associative	 learning,	 represented	 by	 the	 consolidation,	 retrieval	 and	 extinction	 of	
contextual	 fear	 memory	 in	 rats,	 with	 genetic	 variants,	 psychoactive	 drugs	 and	
postsynaptic	 density	 proteins	 associated	 with	 schizophrenia.	 I	 tested	 associative	
learning-related	 gene	 expression	 datasets	 for	 enrichment	 in	 genetic	 copy	 number	
variants	from	a	large	cohort	of	patients	with	schizophrenia	and	demonstrated	that	only	
genes	associated	with	extinction	learning	are	enriched	in	patient	variants	(Chapter	3).	I	
report	 that	 fear	 extinction	 in	 rats	 was	 impaired	 by	 administration	 of	 the	 NMDA	
antagonist	 and	 psychotomimetic,	 ketamine	 (Chapter	 4).	 The	 expression	 of	 activity-
induced,	postsynaptic	density	products	of	the	Homer1	gene,	which	has	been	linked	to	
psychiatric	 disease,	 was	 differentially	 regulated	 in	 specific	 hippocampal	 subregions	
following	extinction	learning	(Chapter	5),	and	the	effect	of	a	partial	knockdown	of	these	
genes	during	different	phases	of	associative	learning	was	investigated	(Chapter	6).	
These	 results	 build	 on	 clinical	 studies	 linking	 abnormalities	 in	 associative	 and,	
specifically,	extinction	learning	with	schizophrenia	and	support	the	notion	that	genetic	
variants	associated	with	the	disorder	impact	particular	cognitive	domains.	My	findings	
are	consistent	with	the	theory	that	altered	inhibitory-type	learning	processes	contribute	
to	the	manifestation	of	schizophrenia.	
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Chapter	1: Literature	Review	
1.1 Schizophrenia	–	current	status	
1.1.1 Introduction	
With	a	prevalence	of	up	to	1%	(McGrath	et	al.,	2008;	van	Os	and	Kapur,	2009),	a	10-20	
years	reduction	of	life	expectancy	(Chesney	et	al.,	2014),	an	80-90%	unemployment	rate	
(Marwaha	and	Johnson,	2004)	and	an	enormous	cost	to	society	(around	£12	billion	per	
year	 in	 England	 alone;	 Andrew	 et	 al.,	 2012),	 schizophrenia	 is	 a	 severely	 disabling	
psychiatric	disorder	to	both	the	affected	individuals	and	society.	It	therefore	warrants	
the	 tremendous	 research	 effort	 which	 endeavours	 to	 understand	 the	 disorder	 and	
improve	 therapeutics.	 However,	 despite	 more	 than	 60	 years	 of	 research	 since	 the	
serendipitous	advent	of	the	first	antipsychotic	drugs	(Charpentier	et	al.,	1952;	Laborit	et	
al.,	1952;	Seeman	et	al.,	1976),	medication	for	schizophrenia	has	improved	very	little.	
The	most	 frequently	used	class	of	antipsychotics	still	have	the	same	pharmacological	
target	(dopamine	receptor	D2),	are	effective	in	only	a	subset	of	patients	(Leucht	et	al.,	
2013),	treat	only	some	of	the	symptoms	and	induce	a	number	of	side-effects	(Leucht	et	
al.,	2012).	It	has	been	only	in	the	past	decade	that	advances	in	our	understanding	of	the	
disease	have	accelerated,	largely	due	to	large-scale	genomics	projects.		
Schizophrenia	 is	 typically	 characterised	 by	 three	 clusters	 of	 symptoms:	 positive	
symptoms	 (e.g.	 delusions	 and	 hallucinations),	 negative	 symptoms	 (e.g.	 social	
withdrawal	 and	 impaired	 motivation)	 and	 cognitive	 symptoms	 (e.g.	 attention	 and	
working	memory	deficits).	Psychotic	symptoms	usually	first	manifest	at	late	adolescence	
or	early	adulthood,	although	many	patients	display	 social	 and	cognitive	 impairments	
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long	before	the	onset	of	schizophrenia	(Lewandowski	et	al.,	2011).	However,	there	are	
at	present	no	tests	or	known	biomarkers	to	facilitate	a	definitive	diagnosis,	and	since	
schizophrenia	 shares	many	of	 its	 symptoms	with	other	psychiatric	disorders,	 such	as	
bipolar	disorder,	major	depressive	disorder,	autism	spectrum	disorder	and	intellectual	
disability,	clinical	differential	diagnoses	rely	on	the	use	of	disease	classification	criteria	
such	 as	 those	 defined	 in	 the	 Diagnostic	 and	 Statistical	 Manual	 of	 Mental	 Disorders	
(American	Psychiatric	Association,	2013).	Whilst	this	permits	consistency	in	diagnoses	
across	clinics	globally,	the	segregation	of	psychiatric	disorders	 into	distinct	categories	
does	not	necessarily	reflect	their	overlapping	genetics	and	pathophysiology	(Craddock	
and	Owen,	2010).		
1.1.2 Pathophysiology	and	pathogenesis	
Whilst	 no	 specific	 anatomical	 abnormalities	 are	 common	 to	 all	 patients	 with	
schizophrenia	(Linden,	2012),	some	structural	and	functional	differences	are	recurrently	
observed.	One	of	the	most	consistently	reported	findings	is	a	reduction	of	grey	matter,	
which	 is	 linked	 to	 an	 enlargement	 of	 the	 ventricles	 and	 worsens	 as	 the	 disease	
progresses	(Vita	et	al.,	2012;	Haijma	et	al.,	2013).	Another	consistent	finding	is	altered	
hippocampal	 volume	 and	 function	 (Tamminga	 et	 al.,	 2010).	 The	 hippocampus,	
particularly	 its	 cornu	 ammonis	 (CA)	 subregions,	 is	 responsible	 for	 several	 cognitive	
functions	that	are	impaired	in	schizophrenia,	including	episodic,	working	and	associative	
memory	 (Ranganath	 et	 al.,	 2004,	 2008;	 Diwadkar	 et	 al.,	 2008a;	 Hall	 et	 al.,	 2009).	
Structural	alterations	in	the	hippocampus	are	accompanied	by	molecular	changes.	In	the	
CA1	 hippocampal	 subregion	 of	 patients,	 a	 recent	 study	 found	 reduced	 postsynaptic	
density	 (PSD)95-complex	 proteins,	 reduced	 metabotropic	 glutamate	 receptors	 and	
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altered	Homer1	 scaffold	 proteins	 in	 the	CA1	hippocampal	 subregion	 (Matosin	 et	 al.,	
2016),	all	of	which	are	components	of	synapses.		
Indeed,	synaptic	systems	have	been	further	 implicated	in	schizophrenia	 in	relation	to	
dopaminergic	and	glutamatergic	neurotransmission.	A	substantial	body	of	evidence,	led	
by	 the	 fact	 that	 current	 antipsychotics	 block	 dopamine	 D2	 receptors,	 implicates	
abnormalities	in	dopamine	signalling	in	the	pathogenesis	of	schizophrenia	(Baumeister	
and	Francis,	2002).	However,	two	predominant	sources	of	evidence	account	for	a	shift	
in	the	focus	of	research	and	potential	therapeutics	from	the	dopamine	system	to	the	
glutamatergic	 system.	 Firstly,	 antagonists	 of	 the	 N-methyl-ᴅ-aspartate	 (NMDA)	
glutamate	 receptor,	 including	 phencyclidine	 and	 ketamine,	 induce	 schizophrenia-like	
symptoms	 in	 health	 humans	 and	 worsen	 those	 of	 patients	 (Javitt	 and	 Zukin,	 1991;	
Krystal	et	al.,	1994;	Newcomer	et	al.,	1999).	Secondly,	there	is	a	convergence	of	genetic	
evidence	upon	NMDA	receptor	signalling	in	schizophrenia,	discussed	later.	Importantly,	
this	evidence	does	not	negate	the	role	of	dopamine	in	schizophrenia	and	the	afflicted	
circuitry	likely	involves	the	interaction	of	both	systems.		
The	age-dependent	onset,	at	late	adolescence	or	early	adulthood,	is	a	contrast	to	many	
other	 psychiatric	 disorders	 with	 childhood	 onset,	 and	 strongly	 suggests	 that	
schizophrenia	 has	 a	 neurodevelopmental	 aetiology.	 Consistent	 with	 this	 notion	 are	
multiple	branches	of	research	implicating	the	disruption	of	neuronal	maturation	during	
critical	developmental	periods	in	schizophrenia	(Fatemi	and	Folsom,	2009;	Jaaro-Peled	
et	al.,	2009).	Indeed,	a	period	of	synaptic	overproduction	and	elimination	accompanies	
the	 periadolescent	 period,	 which	 is	 thought	 to	 be	 sensitive	 to	 environmental	 and	
intrinsic	insult	(Andersen,	2003;	Cannon	et	al.,	2003).	Specific	disruptions	to	neuronal	
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development	 observed	 in	 schizophrenia	 include	 γ-aminobutyric	 acid	 (GABA)	
interneuron	maturation	 (Beasley	 and	 Reynolds,	 1997;	 Lewis	 et	 al.,	 2005;	 Tseng	 and	
O&apos;Donnell,	2007),	maturation	of	mesocortical	dopaminergic	projections	(Akil	et	
al.,	1999,	2000),	pruning	of	glutamate	synapses	(Keshavan	et	al.,	1994;	Boksa,	2012)	and	
myelination	(Hakak	et	al.,	2001;	Tkachev	et	al.,	2003).		
The	incidence	of	schizophrenia	can	vary	region-by-region	across	the	globe	(McGrath	et	
al.,	2008).	Hence,	the	exposure	to	environmental	risk	factors	varies	with	demographics.	
Studies	of	environmental	risk	strengthen	the	view	that	neurodevelopment	represents	
an	important	period	in	the	pathogenesis	of	psychiatric	disease	(Cannon	et	al.,	2003;	van	
Loo	and	Martens,	2007).	These	studies	have	found	relationships	between	schizophrenia	
and	 environmental	 insults	 such	 as	 maternal	 stress	 (Khashan	 et	 al.,	 2008),	 infection	
(Khandaker	et	al.,	2012)	or	inflammation	(Knuesel	et	al.,	2014),	postnatal	stress	(Dvir	et	
al.,	 2011),	 childhood	 adversity	 (Varese	 et	 al.,	 2012)	 and	 exposure	 to	 psychoactive	
substances	 (Malone	 et	 al.,	 2010).	 It	 is	 notable	 that	 inflammatory	 and	other	 immune	
processes	during	development	represent	a	recurrent	finding	and	important	branch	of	
epidemiological	 and	 clinical	 studies	 in	 schizophrenia	 (Benros	 et	 al.,	 2012;	 Smyth	 and	
Lawrie,	 2013).	 It	 is	 the	 interaction	 between	 environmental	 risk	 factors	 and	 an	
individual’s	genetic	predisposition	that	ultimately	cause	schizophrenia	to	manifest	(van	
Os	et	al.,	2008;	Karl	and	Arnold,	2014).		
1.1.3 Genetics	
Heritability	 estimates	 for	 schizophrenia	 range	 from	 65-80%	 (Sullivan	 et	 al.,	 2003;	
Lichtenstein	 et	 al.,	 2009).	 This	 genetic	 contribution	 to	 the	 disorder	 does	 not	 form	 a	
Mendelian	pattern	of	inheritance,	but	is	instead	derived	from	variants	in	a	large	number	
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of	genomic	regions	(Purcell	et	al.,	2009;	Lee	et	al.,	2012;	Ripke	et	al.,	2013,	2014).	Despite	
this	complexity,	an	increasing	number	of	genetic	risk	variants	are	being	identified	from	
the	 substantial	 progress	made	 recently	 in	 large-scale	 collaborative	 genomic	 studies.	
Some	 of	 the	 associated	 genetic	 loci	 are	 common	 single	 nucleotide	 polymorphisms	
(SNPs),	 individually	 contributing	 only	 a	 small	 amount	 of	 risk,	 whilst	 others	 are	 rare	
variants	 in	 the	 form	 of	 copy	 number	 variants	 (CNVs),	 single	 nucleotide	 variants,	
insertions	or	deletions,	which	may	contribute	a	much	greater	amount	of	risk	(Stefansson	
et	al.,	2008;	Fromer	et	al.,	2014;	Purcell	et	al.,	2014;	Rees	et	al.,	2014b;	Ripke	et	al.,	
2014).	 Figure	 1.1	 illustrates	 the	 relationship	 between	 frequency	 and	 penetrance	 of	
genetic	risk	variants,	due	to	selection	pressure.	 	
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Figure	1.1	The	inverse	relationship	between	allele	frequency	and	effect	size	in	genetic	diseases.	Variants	
with	small	effect	sizes	may	become	common	in	a	population	because	of	weak	selection	pressure.	Variants	
with	larger	effect	sizes	will	therefore	be	rare	in	the	population,	and	often	de	novo.	Rare	variants	with	small	
effect	size	are	difficult	to	detect	due	to	lack	of	statistical	power.	From	(Manolio	et	al.,	2009),	adapted	from	
(McCarthy	et	al.,	2008).	
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1.1.3.1 Common	variants	
It	 is	 estimated	 that	 over	 8000	 SNPs	 contribute	 to	 schizophrenia	 (Ripke	 et	 al.,	 2013).	
Together,	 they	 may	 contribute	 more	 than	 50%	 of	 overall	 risk	 (Ripke	 et	 al.,	 2013),	
although	each	one	typically	has	an	odds	ratio	for	the	development	of	schizophrenia	of	
around	 1.10	 (Ripke	 et	 al.,	 2011,	 2013,	 2014).	 In	 order	 to	 obtain	 sufficient	 statistical	
power	 to	 reveal	 some	 of	 these	 SNPs,	 a	 Psychiatric	 Genomics	 Consortium	 generated	
meta-analyses	of	genetic	data	from	large	numbers	of	patients	and	control	subjects.	In	
the	most	recent	of	these	analyses,	involving	data	from	approximately	37,000	cases	and	
113,000	controls,	108	separate	loci	were	associated	with	schizophrenia	with	sufficient	
statistical	 significance	 to	 surpass	 the	 genome-wide	 multiple	 comparisons	 involved	
(Ripke	et	al.,	2014).		
The	next	step	–	linking	these	SNPs	to	individual	genes	–	is	not	straight	forward.	Most	
SNPs	 have	 the	 potential	 to	 affect	 multiple	 genes,	 creating	 uncertainty	 as	 to	 which	
functional	product	mediates	the	risk	encoded	by	a	SNP.	Many	of	the	associated	SNPs	
are	within	non-coding	regions	of	DNA	and	several	appear	to	affect	non-protein-coding	
genes	 (Maurano	 et	 al.,	 2012;	 Ripke	 et	 al.,	 2014).	 Instead,	 it	 is	 likely	 that	 a	 large	
proportion	of	these	variants	affect	gene	expression	timing	or	location	(Kleinman	et	al.,	
2011).	Furthermore,	SNPs	attributed	to	risk	for	schizophrenia	may	also	contribute	risk	
for	 other	 psychiatric	 disorders.	 Such	 pleiotropy	 exists	 between	 schizophrenia	 and	
bipolar	disorder,	major	depressive	disorders,	autism	spectrum	disorder	and	attention-
deficit	 hyperactivity	 disorder	 (Lee	 et	 al.,	 2013).	 Despite	 these	 limitations,	 biological	
insights	into	genetic	risk	from	common	variants	is	emerging	(Ripke	et	al.,	2014).		
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1.1.3.2 Rare	variants	
Studies	of	rare	variants	have	identified	an	increased	burden	of	CNVs,	either	deletions	or	
duplications,	 in	 patients	with	 schizophrenia	 compared	 to	 controls	 (Stefansson	 et	 al.,	
2008;	Malhotra	and	Sebat,	2012).	CNVs	are	thought	to	contribute	around	a	tenth	of	the	
heritability	attributed	to	common	SNPs	(Purcell	et	al.,	2014).	So	far,	11	recurrent	CNVs	
have	 been	 linked	 to	 schizophrenia	 (Rees	 et	 al.,	 2014a,	 2014b),	 which	 each	 confer	 a	
relatively	high	risk	to	the	disorder	(Kirov	et	al.,	2014).	Odds	ratios	for	these	CNVs	range	
from	around	2	to	60	(Rees	et	al.,	2014b,	2015).	Like	SNPs,	CNVs	are	often	difficult	to	map	
to	specific	genes,	since	many	overlap	with	multiple	genes	and	others	are	within	non-
coding	regions	(Rees	et	al.,	2014a).	Schizophrenia-associated	CNVs	also	confer	risk	for	
other	 disorders,	 including	 intellectual	 disability,	 autism	 and	 generalized	 epilepsy	
(Malhotra	and	Sebat,	2012;	Kirov	et	al.,	2014).	In	addition,	the	occurrence	of	de	novo	
CNVs	 through	 new	 mutations,	 as	 well	 as	 other	 varieties	 of	 rare	 variant,	 i.e.	 single	
nucleotide	variants	and	 indels	 (point	mutations),	also	play	a	role	 in	conferring	risk	to	
schizophrenia	(Kirov	et	al.,	2012;	Fromer	et	al.,	2014;	Purcell	et	al.,	2014).		
1.1.3.3 Missing	heritability	
Indeed,	many	more	 common	 and	 rare	 genetic	 variants	 in	 addition	 to	 those	 already	
discovered	contribute	risk	to	schizophrenia	and	will	 require	 further	studies,	 including	
analyses	with	 larger	sample	sizes,	 in	order	to	 identify	them.	However,	even	taking	all	
those	variants	yet	 to	be	 identified	 into	account,	 their	 respective	contributions	 to	 the	
disorder	do	not	completely	account	for	the	total	heritability	of	schizophrenia	(Manolio	
et	al.,	2009;	Lee	et	al.,	2011).	At	least	some	of	this	“missing	heritability”	may	derive	from	
multiplicative,	rather	than	additive,	effects	of	multiple	genetic	variants	within	the	same	
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individual	(epistasis;	Mackay,	2014).	 In	support	of	this,	epistatic	 interactions	between	
schizophrenia	candidate	genes	have	been	observed	in	clinical	experiments	(Nicodemus	
et	al.,	2007,	2010a,	2010b,	2014).	A	further	component	of	heritability	may	come	from	
interactions	between	genetic	variants	and	environmental	 input	via	epigenetic	 factors	
(Millan,	2013),	whereby	 inherited	non-genetic	mediators	of	gene	expression,	 such	as	
histone	 modifications	 and	 DNA	 methylation,	 alter	 sensitivity	 to	 environmental	 risk	
factors,	increasing	susceptibility	to	disease	progression	(Dempster	et	al.,	2013).		 	
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1.2 Risk	variants	to	biological	pathways	
1.2.1 Introduction	
Genetic	 discoveries	 do	 not	 in	 themselves	 equate	 to	 drug	 targets,	 particularly	 for	
polygenic	disorders	such	as	schizophrenia.	Even	though	some	variants	may	be	mapped	
accurately	to	affected	genes,	many	genes	have	unknown,	or	partially	known,	functions	
and	their	gene	product	may	not	be	possible	to	target	with	drugs	(Plenge	et	al.,	2013).	In	
order	to	use	genetic	findings	to	better	understand	the	pathophysiology	of	schizophrenia	
and	 related	 complex	 disorders,	 it	 is	 important	 to	 find	 common	molecular	 pathways	
affected	by	many	genetic	variants	conferring	susceptibility.	Here,	I	present	the	evidence	
implicating	 specific	 biological	 pathways	 in	 schizophrenia	 from	 previous	 studies	 and	
compare	the	pathways	implicated	through	common	and	rare	variants.	I	also	address	the	
variety	of	methods	used	to	approach	pathway	analyses	of	polygenetic	data.	
1.2.2 Glutamate	synapses	
As	alluded	to	previously,	caution	must	be	taken	when	attempting	to	link	genetic	variants	
to	specific	genes.	In	the	case	of	CNVs,	this	is	due	to	the	fact	that	they	may	span	several	
genes.	In	order	to	circumvent	this	issue,	studies	of	biological	pathways	represented	in	
patient	CNVs	use	a	hypothesis-based	systems	approach,	whereby	gene	sets	are	tested	
for	statistical	overrepresentation	in	case	variants.	This	gene	set	enrichment	analysis	has	
been	used	 in	analyses	of	CNVs	from	large	cohorts	of	patients	with	schizophrenia	and	
healthy	 controls.	 Kirov	 et	 al	 (2012)	 found	 an	 enrichment	 of	 genes	 in	 the	 NMDA	
glutamate	receptor	complex	in	patient	inherited	and	de	novo	CNVs,	corroborating	pre-
existing	NMDA	hypofunction	hypotheses	(Olney	and	Farber,	1995;	Kantrowitz	and	Javitt,	
2010)	and	candidate	gene	studies	(Moghaddam,	2003;	Harrison	and	Weinberger,	2005).	
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This	finding	accompanied	an	overall	enrichment	of	genes	encoding	components	of	the	
postsynaptic	density,	together	lending	support	to	the	notion	that	excitatory	glutamate	
synapses	are	involved	in	schizophrenia’s	aetiology	(Kirov	et	al.,	2012;	Pocklington	et	al.,	
2014).		
Further	 synaptic	 components	 have	 been	 linked	 to	 schizophrenia	 through	 gene	 set	
enrichment	analyses	in	rare	variants.	These	include	interactors	of	the	activity-regulated	
cytoskeletal-associated	protein	(ARC),	which	have	been	implicated	through	CNVs	(Kirov	
et	al.,	2012;	Pocklington	et	al.,	2015)	and	point	mutations	(Fromer	et	al.,	2014;	Purcell	
et	al.,	 2014).	Arc	 is	an	 immediate-early	gene	which	 is	 rapidly	activated	 through	 local	
translation	at	the	synapse	and	has	an	essential	role	in	learning	and	memory	(Plath	et	al.,	
2006).	 Studies	 of	 point	 mutations,	 through	 exome	 sequencing,	 again	 found	 an	
enrichment	 of	 the	 NMDA	 receptor	 complex,	 as	 well	 as	 the	 related	 PSD-95	 protein	
complex	(Fromer	et	al.,	2014;	Purcell	et	al.,	2014).		
A	 role	 for	 synaptic	 components	 in	 schizophrenia	 is	 further	 corroborated	by	genome-
wide	significant	common	variants.	SNPs	associated	with	the	disorder	 lie	within	genes	
encoding	 a	 subunit	 of	 the	 NMDA	 receptor	 (GRIN2A),	 a	 subunit	 of	 the	 α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic	 acid	 (AMPA)	 glutamate	 receptor	 (GRIA1),	 the	
glutamate	metabotropic	receptor	3	(GRM3)	and	an	enzyme	responsible	for	synthesizing	
the	intrinsic	NMDA	agonist,	D-serine,	serine	racemase	(SRR)	(Ripke	et	al.,	2014),	all	of	
which	are	involved	in	glutamate	receptor	signalling.		
It	is	important	to	note	that,	as	well	as	glutamate	signalling,	components	of	the	dopamine	
system	have	also	been	implicated	through	genetic	association	studies,	albeit	to	a	lesser	
extent.	Perhaps	the	most	interesting	of	these	is	the	association	with	schizophrenia	of	
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common	 variants	 within	 the	 DRD2	 gene	 (Ripke	 et	 al.,	 2014),	 which	 encodes	 the	
dopamine	receptor	targeted	by	current	antipsychotic	medicine.	An	enzyme	responsible	
for	 metabolising	 dopamine,	 Catechol-O-methyltransferase,	 is	 associated	 with	
schizophrenia	through	the	overlap	of	its	gene,	COMT,	with	a	recurrent	CNV	located	at	
22q11.	However,	since	COMT	is	not	the	only	gene	affected	by	this	CNV,	it	is	not	clear	
that	 it	 is	 the	deletion	of	 this	 gene	 that	 confers	 risk	 to	 the	disorder	 (Liu	 et	 al.,	 2002;	
Bassett	and	Chow,	2008).		
1.2.3 Synaptic	plasticity	and	calcium	signalling	
The	 emerging	 picture	 from	 studies	 of	 the	 biological	 pathways	 represented	 by	
schizophrenia-associated	 genetic	 variants	 is	 an	 enrichment	 of	 overlapping	molecular	
systems,	not	all	situated	within	the	postsynaptic	cleft,	yet	which	are	collectively	involved	
in	 synaptic	 plasticity	 processes	 (Hall	 et	 al.,	 2015;	 Figure	 1.2).	 One	 of	 the	 most	
consistently	reported	gene	set	enrichments	in	rare	variants	is	that	of	targets	of	fragile	X	
mental	retardation	protein	(FMRP).	This	group	of	genes	are	enriched	in	rare	disruptive	
and	 de	 novo	 point	 mutations	 (Fromer	 et	 al.,	 2014;	 Purcell	 et	 al.,	 2014)	 and	 CNVs	
(Szatkiewicz	et	al.,	2014a;	Pocklington	et	al.,	2015).	FMRP	regulates	the	translation	of	
specific	mRNAs,	 including	ARC	 (Darnell	 et	 al.,	 2011;	 Fernandez	et	 al.,	 2013),	 through	
interactions	with	 its	binding	partner	CYFIP1,	associated	with	schizophrenia	 through	a	
CNV	 located	 at	 15q11.2	 (Napoli	 et	 al.,	 2008;	 Stefansson	 et	 al.,	 2008).	 Through	 the	
regulation	 of	 translation,	 CYFIP1	 and	 FMRP	 are	 thought	 to	 be	 critical	 mediators	 of	
synaptic	 plasticity	 processes,	 specifically	 the	 regulation	 of	 dendritic	 complexity	 and	
spine	 morphology	 (Pathania	 et	 al.,	 2014).	 These	 same	 processes	 are	 additionally	
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regulated	by	actin	filament	complexes,	which	are	enriched	in	schizophrenia-associated	
point	mutations	(Fromer	et	al.,	2014).		
A	further	group	of	proteins	central	to	synaptic	plasticity	and	implicated	in	schizophrenia	
through	 genetic	 variants	 is	 voltage-gated	 calcium	 channels.	 Genes	 coding	 for	 these	
proteins	are	enriched	in	case	point	mutations	(Purcell	et	al.,	2014),	and	schizophrenia-
associated	SNPs	exist	within	genes	CACNA1C	 and	CACNB2	 (Ripke	et	 al.,	 2013,	2014),	
encoding	the	subunit	of	CaV1.2	and	CaV1.3,	respectively.	Along	with	NMDA	receptors,	
voltage-gated	 calcium	 channels	mediate	 calcium	 signalling	 cascades	 required	 for	 the	
activation	of	transcription	factors	and	the	modification	of	synaptic	excitability	(West	et	
al.,	2001;	Moosmang	et	al.,	2005),	and	have	been	shown	to	be	central	to	learning	and	
memory	(Moosmang	et	al.,	2005;	White	et	al.,	2008;	Heck	et	al.,	2014).		 	
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Figure	 1.2	 The	 convergence	 of	 synaptic	 pathways	 implicated	 in	 schizophrenia.	 Protein	 complexes,	
including	the	NMDA	 receptor	complex,	actin	filament	complex,	Arc	 interactors,	voltage	gated	calcium	
channels	 and	 targets	 of	 FMRP/CYFIP1	 are	 associated	 with	 schizophrenia	 through	 genetic	 variants.	
Abbreviations:	 α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic	 acid	 (AMPA),	 activity-regulated	
cytoskeletal	 protein	 (ARC),	 N-methyl-ᴅ-aspartate	 receptor	 (NMDAR),	 voltage-gated	 calcium	 channel	
(VGCC).	From	Hall	et	al.,	2015.	
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1.2.4 Excitatory	and	inhibitory	signalling	complexes	
A	recent	study	by	Pocklington	et	al	 (2015)	 replicated	and	extended	previous	 findings	
linking	 excitatory	 glutamatergic	 signalling	 to	 CNVs	 from	 patients	with	 schizophrenia,	
whilst	 providing	 novel	 evidence	 implicating	 inhibitory	 GABAergic	 systems	 in	
schizophrenia	(Pocklington	et	al.,	2015).	The	study	demonstrated	that	genes	coding	for	
components	of	GABAA	 receptor	complexes	are	enriched	 in	patient	CNVs,	building	on	
previous	hypotheses	of	GABAergic	signalling	deficits	and	the	involvement	of	inhibitory	
interneurons	 in	 schizophrenia	 (Lewis	 et	 al.,	 2005,	 2012;	 Gonzalez-Burgos	 and	 Lewis,	
2012).	Since	alterations	in	the	ratio	of	excitation	to	inhibition	have	been	proposed	to	
underlie	schizophrenia	phenotypes	(Kehrer	et	al.,	2008),	these	results	lend	support	to	
the	notion	that	disruption	of	either	glutamatergic	or	GABAergic	signalling	could	create	
an	imbalanced	state,	vulnerable	to	the	development	of	psychosis.		
1.2.5 Conclusions	
The	advent	of	large	collaborative	clinical	studies,	genome-wide	association	studies	and	
sequencing	 brought	 with	 it	 high-powered	 evidence	 supporting	 the	 involvement	 of	
specific	genetic	variants	 in	schizophrenia.	Multiple	pathway	analyses	with	 these	data	
revealed	 a	 striking	 convergence	 of	 common	 and	 rare	 variants	 on	 genes	 involved	 in	
synaptic	 plasticity	 processes.	 These	 studies	 provide	 valuable	 guidance	 to	 future	
experiments	 aiming	 to	 further	 our	 understanding	 of	 the	 biological	 mechanisms	
underlying	schizophrenia.	However,	“synaptic	plasticity”	is	not	specific	enough	to	advise	
therapeutic	design.	One	of	the	limitations	affecting	these	pathway	analyses	is	the	gap	in	
understanding	 of	 gene	 function	 and	 hence	 the	 incompleteness	 of	 gene	 ontology	
databases.	This	also	creates	bias	in	the	analyses,	due	to	the	overrepresentation	of	those	
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biological	pathways	on	which	more	research	has	been	focused.	Gene	expression	studies	
that	capture	gene	sets	associated	with	particular	functionality	of	a	tissue	may	yield	more	
specific	 biological	 information	 in	 gene	 set	 enrichment	 analyses	of	 disease-associated	
variants.		
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1.3 Associative	learning	and	schizophrenia	
1.3.1 Introduction	
Synaptic	plasticity	is	widely	believed	to	underlie	learning,	memory	and	the	development	
of	neural	 circuits	 (Abbott	 and	Nelson,	2000;	Martin	et	 al.,	 2000;	Neves	et	 al.,	 2008).	
However,	 the	 convergence	of	 genetic	 findings	 on	 synaptic	 plasticity	 processes	 is	 not	
mirrored	 by	 universal	 memory	 deficits	 in	 schizophrenia.	 Instead,	 patients	 display	
impairments	in	specific	facets	of	learning	and	memory	(Stone	et	al.,	1998;	Rushe	et	al.,	
1999;	 Diwadkar	 et	 al.,	 2008a),	 which	 implies	 that	 the	 genetic	 component	 of	
schizophrenia	susceptibility	must	 impact	on	more	specific	biological	mechanisms	and	
perhaps	on	particular	cognitive	processes.		
Based	on	the	pre-existing	convergence	of	patient	CNVs	on	genes	 involved	in	synaptic	
plasticity,	Pocklington	et	al	(2015)	investigated	the	enrichment	of	more	specific	genes	
sets,	 all	 relating	 to	 aspects	 of	 plasticity,	 learning	 and	 memory,	 in	 schizophrenia-
associated	 CNVs.	 Among	 the	 gene	 sets	 statistically	 associated	 with	 case	 deletions,	
duplications	or	both	combined,	were	those	relating	to	“learning/memory/conditioning”,	
“contextual	 conditioning	behaviour”,	 “cued	 conditioning	behaviour”	 and	 “associative	
learning”	(Pocklington	et	al.,	2015).	These	intriguing	findings	highlight	a	specific	memory	
system	–	association	formation	–	as	impacted	on	by	CNVs	in	schizophrenia.	They	also	
strengthen	existing	hypotheses	concerning	dysfunctions	of	associative	 learning	 in	the	
manifestation	of	 schizophrenia	phenotypes	 (Miller,	1976;	Bazin	and	Perruchet,	1996;	
Friston,	1998;	Diwadkar	et	al.,	2008a;	Hall	et	al.,	2009).		
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1.3.2 Neural	circuitry	for	aversive	conditioning	to	a	context	
Since	associating	environmental	stimuli	with	safety	or	danger	is	a	key	functionality	for	
the	 survival	 of	 all	 mammals,	 it	 is	 understandable	 that	 the	 circuitry	 responsible	 is	
common	among	many	species	(Pearce	and	Bouton,	2001;	Fanselow	and	Poulos,	2005).	
Studies	of	classical	Pavlovian	conditioning	(Pavlov,	1927)	in	rodents	have	contributed	to	
a	thorough	understanding	of	the	systems	involved	in	associative	learning	(Mackintosh,	
1983).	One	of	the	best	understood	systems	is	that	of	aversive	learning,	typically	studied	
through	fear	conditioning	(Maren,	2001).	In	this	paradigm,	an	innately	neutral	stimulus,	
such	as	a	cue	or	context	is	presented	to	a	rodent	simultaneously	to,	or	with	constant	
temporal	separation	from,	the	presentation	of	an	unconditioned	shock	stimulus.	Their	
pairing	 leads	 to	 the	 previously	 neutral	 stimulus	 becoming	 an	 aversively	 conditioned	
stimulus,	so	that	the	presentation	of	the	cue	or	context	alone	elicits	a	fear	response	akin	
to	that	exhibited	following	the	unconditioned	stimulus.		
The	central	hub	for	fear	conditioning	is	the	amygdala	(LeDoux	et	al.,	1991;	Phelps	and	
LeDoux,	 2005).	 Through	 projections	 from	 the	 thalamus,	 hippocampus	 and	 cortical	
regions,	and	projections	to	the	hypothalamus,	periaqueductal	grey	and	other	brainstem	
regions,	the	amygdala	mediates	the	expression	of	conditioned	fear	responses	to	learned	
conditioned	stimuli	(Applegate	et	al.,	1982;	LeDoux	et	al.,	1991;	Pitkänen	et	al.,	1997).	
Whilst	simple	auditory	conditioned	stimuli	are	processed	via	direct	projections	from	the	
medial	geniculate	nucleus	of	the	thalamus	to	the	amygdala,	more	complex	conditioned	
stimulus	information,	such	as	context	cues,	reach	the	amygdala	after	processing	by	the	
entorhinal	cortex	and	hippocampus	(LeDoux	et	al.,	1991;	Maren	and	Fanselow,	1995;	
Fanselow	and	Poulos,	2005;	Hugues	and	Garcia,	2007).	Hence,	the	hippocampus	is	able	
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to	gate	complex	contextual	 fear	 learning	and	fear	responses	(Radulovic	and	Tronson,	
2010).		
At	the	molecular	level,	both	glutamatergic	and	dopaminergic	systems	are	required	for	
the	 acquisition	 of	 aversive	 conditioning.	 Blockade	 of	 NMDA	 glutamate	 receptors	 in	
lateral	and	basal	nuclei	of	the	amygdala	prevents	fear	conditioning	(Fendt,	2001;	Bauer	
et	al.,	2002;	Fanselow	and	Poulos,	2005).	Furthermore,	hippocampal	NMDA	receptor-
mediated	 plasticity	 has	 been	 shown	 to	 be	 necessary	 for	 the	 generation	 of	 context	
representations	during	conditioning	to	a	context	(Cravens	et	al.,	2006).	The	interactions	
of	these	processes	with	dopamine	signalling	are	additionally	involved	in	the	acquisition	
of	 conditioned	 associations.	 Mesolimbic	 dopamine	 neurons	 fire	 in	 response	 to	 the	
presentation	of	an	unconditioned	stimulus,	yet	following	conditioning,	fire	in	response	
to	 the	 conditioned	 stimulus	 (Grace,	 1991).	 This	 activity	 serves	 to	 mediate	 NMDA	
receptor-dependent	 synaptic	plasticity	 in	 the	hippocampus	and	cortex	 (O’Carroll	 and	
Morris,	2004;	Calabresi	et	al.,	2007)	and	to	provide	feedback	in	the	form	of	prediction	
error,	valence	or	salience	(Berridge	and	Robinson,	1998;	Waelti	et	al.,	2001;	Kapur	et	al.,	
2005;	Cooper	and	Knutson,	2008).		
1.3.3 Associative	learning	in	psychopathology	
From	 a	 psychological	 perspective,	 new	 associative	 learning	 in	 healthy	 individuals	 is	
mediated	by	an	interaction	between	experience	and	belief	(Corlett	et	al.,	2009;	Fletcher	
and	Frith,	2009).	Experiences	that	do	not	challenge	a	belief	system	become	predictable	
and	 can	 be	 ignored,	 yet	 experiences	 that	 contradict	 a	 belief	 induce	 new	 learning.	
Prediction	 error	 is	 a	 model	 used	 to	 explain	 the	 process	 through	 which	 these	
unpredictable	 events	 induce	 new	 learning,	 and	was	 derived	 from	 Bayesian	machine	
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learning	 approaches	 to	 the	 study	 of	 learning	 (Fletcher	 and	 Frith,	 2009).	 It	 has	 been	
proposed	that	the	instability	of	this	system	could	lead	to	the	persistence	of	delusional	
beliefs,	 despite	 the	existence	of	 conflicting	evidence,	 in	 schizophrenia	 (Corlett	 et	 al.,	
2009;	Fletcher	and	Frith,	2009).		
Deficits	 in	multiple	aspects	of	 associative	 learning	have	been	 recurrently	 reported	 in	
schizophrenia	 (Diwadkar	 et	 al.,	 2008a).	 Firstly,	 patients	 exhibit	 impairments	 in	
contextual	 processing	 (Maren	 et	 al.,	 2013),	 demonstrated	 through	 tests	 of	 AX-
continuous	 performance	 (Cohen	 et	 al.,	 1999;	 Barch	 et	 al.,	 2003),	 which	may	 reflect	
hippocampal	and	medial	prefrontal	cortex	abnormalities	in	the	disorder	(Taylor	et	al.,	
2012).	 Secondly,	 deficits	 in	 the	 classical	 conditioning	 of	 associations	 have	 been	
observed,	typically	in	test	of	eyelid	conditional	discrimination	(Sears	et	al.,	2000;	Hofer	
et	 al.,	 2001;	Marenco	 et	 al.,	 2003).	 Thirdly,	 patients	 with	 acute	 schizophrenia	 show	
evidence	 of	 impaired	 signalling	 of	 prediction	 error	 when	 existing	 associations	 are	
challenged	(Baruch	et	al.,	1988;	Jones	et	al.,	1992;	Serra	et	al.,	2001).	Fourthly,	learning	
of	aversive	stimuli	is	consistently	reported	to	be	abnormal	in	the	disorder	(Kosmidis	et	
al.,	1999;	Jensen	et	al.,	2008;	Linnman	et	al.,	2013).		
1.3.4 Inhibitory	learning	of	associations	
A	 further	 component	 of	 associative	 learning	 frequently	 linked	 to	 the	 persistence	 of	
psychotic	 and	 cognitive	 symptoms	 in	 schizophrenia	 is	 the	 inhibitory	 learning	 of	
associations	(Baruch	et	al.,	1988;	Swerdlow	et	al.,	1996;	Rascle	et	al.,	2001;	Serra	et	al.,	
2001;	Holt	 et	 al.,	 2009,	 2012).	 Three	 types	 of	 inhibitory	 learning	 are	 relevant	 in	 this	
regard.	Firstly,	latent	inhibition	is	the	process	by	which	prolonged	or	repeated	exposure	
to	 a	 neutral	 stimulus	 prior	 to	 its	 pairing	 with	 an	 unconditioned	 stimulus,	 inhibits	
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conditioning	 to	 the	neutral	 stimulus	 (Escobar	et	 al.,	 2002).	 Secondly,	 Kamin	blocking	
describes	the	prevention	of	conditioning	to	a	neutral	stimulus	due	to	its	pairing	with	an	
unconditioned	 stimulus	 in	 conjunction	 with	 a	 further	 stimulus	 previously	 associated	
with	the	unconditioned	stimulus	(Padlubnaya	et	al.,	2006).	Finally,	extinction	learning	
occurs	 when	 a	 previously	 conditioned	 stimulus	 is	 presented	 repeatedly	 or	 for	 an	
extended	period	of	time	in	the	absence	of	the	unconditioned	stimulus,	resulting	in	the	
reduction	of	memory-associated	behavioural	responses	(Quirk	and	Mueller,	2008).		
Deficits	in	each	of	these	types	of	inhibitory	learning	have	been	reported	in	schizophrenia	
(latent	inhibition:	Baruch	et	al.,	1988;	Swerdlow	et	al.,	1996;	Serra	et	al.,	2001;	Corlett,	
2012;	blocking:	Jones	et	al.,	1992;	Serra	et	al.,	2001;	extinction:	Holt	et	al.,	2009,	2012).	
Focusing	 on	 complex	 contextual	 associations,	 substantial	 evidence	 suggests	 that	 the	
hippocampus	 is	 responsible	 for	 the	 context-dependent	 gating	 of	 inhibitory	 fear	
extinction	 (Corcoran	 et	 al.,	 2005;	Maren	 and	 Hobin,	 2007;	 Zelikowsky	 et	 al.,	 2012),	
through	 indirect	 projections	 to	 inhibitory	 intercalated	 neurons	 of	 the	 amygdala	 via	
medial	prefrontal	cortex	(Likhtik	et	al.,	2008;	Maren,	2011;	Sotres-Bayon	et	al.,	2012).	It	
has	 been	 proposed	 that	 abnormalities	 in	 the	 functional	 connectivity	within	 this	 fear	
extinction	 circuit	 form	 the	 neurobiological	 basis	 for	 impaired	 extinction	 learning	 in	
adolescence	 (Neumann	 et	 al.,	 2008;	 Pattwell	 et	 al.,	 2012),	 which	 has	 important	
implications	for	the	development	of	schizophrenia	in	early	adulthood.		
1.3.5 Conclusions	
The	 enrichment	 of	 associative	 learning-related	 genes	 in	 CNVs	 from	 patients	 with	
schizophrenia	is	complimentary	to	the	convergence	of	schizophrenia-associated	genetic	
variants	on	synaptic	pathways	in	that	it	provides	a	hint	of	particular	cognitive	processes	
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affected	by	schizophrenia-associated	variants.	It	is	also	consistent	with	behavioural	and	
physiological	correlates	of	associative	learning	deficits	in	schizophrenia.	However,	since	
associative	 learning	 is	 comprised	 of	 multiple	 components,	 including	 inhibitory	
processes,	it	is	unclear	which	specific	aspects	of	associative	learning	are	implicated	in	
schizophrenia	through	genetic	variants.	 	
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1.4 Homer	family	activity-induced	proteins	
1.4.1 Introduction	
As	 detailed	 above,	 there	 is	 a	 substantial	 convergence	 of	 schizophrenia-associated	
genetic	variants	on	genes	involved	in	synaptic	plasticity	(Hall	et	al.,	2015).	A	considerable	
component	of	this	is	attributable	to	genes	encoding	parts	of	the	postsynaptic	density	
(PSD)	 (Kirov	 et	 al.,	 2012;	 Pocklington	 et	 al.,	 2014).	 The	 PSD	 is	 an	 architecture	 of	
specialised	 proteins	 responsible	 for	 mediating	 the	 response	 to	 converging	 synaptic	
input.	Rearrangement	of	PSD	proteins,	as	a	consequence	of	changes	to	the	pattern	of	
neurotransmission,	leads	to	alterations	in	synaptic	strength,	required	for	learning	and	
memory	(Kennedy	et	al.,	2005;	Moutin	et	al.,	2012;	Murakoshi	and	Yasuda,	2012).	Hence	
the	 study	 of	 PSD	 protein	 dynamics	 represents	 a	 fundamental	 route	 towards	
understanding	 synaptic	plasticity	 and	may	be	 central	 to	discerning	 the	aetiologies	of	
psychiatric	disorders	such	as	schizophrenia	(Grant,	2012).	
Homer	 proteins	 are	 key	 components	 of	 the	 PSD	 and	 form	 functional	 links	 between	
receptors,	 ion	 channels	 and	 scaffolding	 proteins	 (Brakeman	 et	 al.,	 1997;	 Xiao	 et	 al.,	
1998).	 They	 share	 an	 N-terminal	 ligand-binding	 domain,	 which	 interacts	 with	 the	
proline-rich	 sequences	 displayed	 by	 PSD	 proteins	 involved	 in	 regulating	 synaptic	
architecture,	 intracellular	 calcium	 signalling	 and	 neuronal	 development.	Whilst	most	
transcription	variants	of	the	Homer	family	are	constitutively	expressed	in	mammals,	two	
truncated	forms	of	Homer1,	Homer1a	and	Ania-3,	are	activity-induced	immediate	early	
genes	 (IEGs)	 (Fagni	 et	 al.,	 2002).	 These	 isoforms	 possess	 a	 common	 enabled/VASP	
homology	1	 (EVH1)	domain	but	 lack	a	 coiled-coil	domain	 that	permits	 longer	Homer	
proteins	 to	 oligomerise	 with	 one	 another	 (Hayashi	 et	 al.,	 2009).	 As	 a	 consequence,	
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Homer1a	and	Ania-3	bind	as	dominant	negative	 regulators,	allowing	 them	to	disrupt	
interactions	 between	 long	 Homers	 and	 their	 effector	 proteins	 (Xiao	 et	 al.,	 1998;	
Kammermeier	and	Worley,	2007).		
The	expression	of	Homer	IEGs	appears	to	represent	a	powerful	modulator	of	synaptic	
plasticity.	 The	 literature	 surrounding	 Homer1	 IEGs	 indicates	 that	 their	 precise	
temporospatial	 expression	 and	 recruitment	 to	 active	 synapses	 is	 essential	 for	 the	
regulation	of	PSD	protein	complexes	and	calcium	signalling	in	dendritic	spines	and	may	
therefore	 be	 important	 for	 learning	 and	memory	 (Worley	 et	 al.,	 2007;	Okada	 et	 al.,	
2009a;	Hu	et	al.,	2010).	Here,	potential	mechanisms	through	which	Homer1	IEGs	may	
mediate	synaptic	plasticity	are	discussed.	Since	most	research	to	date	has	focused	on	
either	Homer1a	only	or	short	Homer1	isoforms	as	a	collective,	any	distinct	functions	of	
Homer1a	and	Ania-3	remain	somewhat	hidden.	Thus	the	majority	of	the	content	in	this	
section	addresses	Homer1a	function.	
1.4.2 Implications	for	Neurological	Disease	
Homer1	 IEGs	 are	 rapidly	 induced	 following	 neuronal	 activity	 in	 limbo-corticostriatal	
circuits	 responsible	 for	 mediating	 cognitive	 and	 emotional	 functions	 (Tekin	 and	
Cummings,	 2002).	 Single	 nucleotide	 polymorphisms	 in	 the	 Homer1	 gene	 have	 been	
associated	 with	 schizophrenia	 (Norton	 et	 al.,	 2003;	 Spellmann	 et	 al.,	 2011),	 autism	
(Kelleher	 et	 al.,	 2012),	 major	 depression	 (Rietschel	 et	 al.,	 2010a),	 suicide	 attempt	
(Strauss	et	al.,	2012;	Rao	et	al.,	2016),	cocaine	dependence	(Dahl	et	al.,	2005)	and	opiate	
abuse	(Jacobs	et	al.,	2013).	These	genetic	associations	are	not	conclusive,	however,	and	
replication	is	needed	to	confirm	their	validity.	Further	evidence	suggests	that	Homer1a	
may	additionally	be	involved	in	the	pathology	of	neuropathic	pain	(Tappe	et	al.,	2006;	
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Roselli	 et	 al.,	 2009;	 Tappe-Theodor	 et	 al.,	 2011;	Obara	 et	 al.,	 2013)	 and	Alzheimer’s	
disease	(Dickey	et	al.,	2003;	Yamamoto	et	al.,	2011).	Here,	I	provide	an	overview	of	the	
evidence	implicating	short	Homer1	proteins	in	autism	and	schizophrenia.	
Perhaps	 the	 strongest	 evidence	 for	 the	 involvement	 of	 Homer	 IEGs	 in	 neurological	
disease	 is	 from	studies	of	 their	 association	with	Fragile	X	mental	 retardation	protein	
(FMRP).	The	absence	of	expression	of	FMRP	(coded	by	the	FMR1	gene)	 is	a	common	
single-gene	cause	of	autism	and	targets	of	FMRP	are	enriched	in	rare	genetic	variants	
from	patients	with	 schizophrenia	 (Fromer	et	 al.,	 2014;	 Pocklington	et	 al.,	 2015).	 The	
bindings	partner	of	FMRP,	CYFIP1,	is	also	implicated	in	schizophrenia	(Stefansson	et	al.,	
2008).	 FMRP	 is	 a	 negative	 regulator	 of	 group	 I	 mGluR-dependent	 protein	 synthesis	
(Weiler	et	al.,	2004)	and	mice	lacking	Fmr1	show	enhanced	long-term	depression	(Huber	
et	al.,	2002).	It	was	demonstrated	that	mGluR5-mediated	translation	initiation	and	long-
term	depression	are	dependent	on	mGluR5-long	Homer	interactions	(Ronesi	and	Huber,	
2008;	Ronesi	et	al.,	2012),	which	are	diminished	in	Fmr1	knockout	mice	(Giuffrida	et	al.,	
2005).	Moreover,	Homer1	protein	is	decreased	in	post-mortem	cerebellar	vermis	and	
superior	frontal	cortex	of	autistic	patients	(Fatemi	et	al.,	2013).	Instead,	mGluR5	is	more	
associated	with	Homer1a	in	mice	lacking	Fmr1	(Giuffrida	et	al.,	2005;	Ronesi	et	al.,	2012).	
Ronesi	and	colleagues	generated	an	Fmr1	/	Homer1a	(and	Ania-3)	double	knockout	in	
an	attempt	 to	 rescue	mGluR5	 function.	The	additional	deletion	of	Homer1a	 restored	
mGluR5-long	Homer	interactions,	stabilized	translation	rates	and	reversed	behavioural	
phenotypes.	 The	 abnormal	 translational	 control	 of	 specific	 FMRP	 target	 mRNAs	 or	
altered	mGluR-mediated	long-term	depression	in	Fmr1	knockout	mice	were	not	rescued	
by	Homer1a	deletion,	however	 (Ronesi	et	al.,	2012).	These	observations	 imply	that	a	
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higher	 ratio	 of	 short	 /	 long	 Homer	 proteins	 interacting	 with	 mGluR5	 might	 be	
responsible	 for	 disrupting	 mGluR5-mediated	 signalling	 in	 fragile	 X	 syndrome,	
contributing	 to	 the	 disorder.	 Therefore,	 the	 therapeutic	 action	 provided	 by	mGluR5	
antagonists	in	fragile	X	syndrome	(Pop	et	al.,	2014)	may	be	due	to	inhibition	of	Homer1a	
/	mGluR5-mediated	events.		
MGluR5	 signalling	 complexes	are	also	a	potential	 target	 for	 therapy	 in	 schizophrenia	
(Matosin	and	Newell,	2013).	Critically,	Homer1a	and	Ania-3	induction	is	manipulated	by	
environmental	 stimuli	 that	 impact	 on	 the	 manifestation	 of	 psychosis	 (reviewed	 in	
Szumlinski	 and	 Kippin,	 2008).	 For	 example,	 acute	 cocaine	 administration	 in	 rodents	
induces	 a	 pronounced	 elevation	 of	 Homer1a	 expression	 in	 the	 striatum,	 prefrontal	
cortex	 and	 ventral	 tegmental	 area	 (Brakeman	 et	 al.,	 1997;	 Zhang	 et	 al.,	 2007;	
Ghasemzadeh	 et	 al.,	 2009).	 This	 response	 is	 necessary	 for	 the	 regulation	 of	 cocaine	
sensitivity	 (Szumlinski	 et	 al.,	 2004;	 Lominac	 et	 al.,	 2005).	 Psychotomimetic	 NMDA	
antagonists	 and,	 interestingly,	 antipsychotics	 also	 modulate	 Homer1a	 and	 Ania-3	
expression	(De	Bartolomeis	et	al.,	2002,	2013;	Polese	et	al.,	2002;	Ambesi-Impiombato	
et	al.,	2007;	Iasevoli	et	al.,	2007,	2009;	Dell’Aversano	et	al.,	2009).	Furthermore,	recent	
evidence	showed	that	the	ratio	of	short	to	 long	Homer1	protein	may	be	abnormal	 in	
patients	 with	 schizophrenia.	 In	 analyses	 of	 protein	 expression	 in	 post-mortem	
hippocampus,	Matosin	 et	 al	 (2016)	 showed	 that	 there	was	 increased	 Homer1a,	 but	
decreased	long	isoforms	Homer1b/c,	in	the	CA1	region	of	patients	compared	to	controls	
(Matosin	et	al.,	2016).	This	 is	 consistent	with	an	earlier	 report	of	decreased	Homer1	
protein	 in	 the	 hippocampus	 and	 prefrontal	 cortex	 of	 patients	 with	 schizophrenia	
(Engmann	 et	 al.,	 2011).	 Finally,	 Homer1	 knockout	 mice	 display	 several	 behavioural	
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phenotypes	 consistent	 with	 schizophrenia,	 including	 impaired	 pre-pulse	 inhibition,	
increased	 anxiety	 and	 enhanced	 locomotion	 in	 response	 to	 MK-801	 or	
methamphetamine	(Szumlinski	et	al.,	2005),	together	implying	that	an	imbalance	of	the	
competitive	 short	 /	 long	 Homer1	 isoforms	 could	 contribute	 to	 the	 expression	 of	
schizophrenic	symptoms	in	humans.	
1.4.3 Protein	Structure	and	Interactions	
Homer	 proteins	 contain	 a	 highly	 conserved	 enabled	 /	 vasodilator-stimulated	
phosphoprotein	(ena	/	VASP)	homology	1	(EVH1)-like	domain	(Irie	et	al.,	2002;	Shiraishi-
Yamaguchi	and	Furuichi,	2007),	which	maintains	much	sequence	homology	with	other	
VASP	proteins	responsible	for	regulating	cytoskeletal	dynamics	(Reinhard	et	al.,	2001).	
A	neighbouring	proline	motif	is	specific	to	the	Homer1	subfamily	(Shiraishi-Yamaguchi	
and	Furuichi,	2007).	Through	the	EVH1	domain,	Homer	proteins	interact	with	proline-
rich	sequences	of	a	range	of	targets	including	group	I	metabotropic	glutamate	receptors	
(mGluR1	 and	mGluR5),	 inositol	 1,4,5-triphosphate	 (IP3)	 receptors,	 Shank	 scaffolding	
proteins,	ryanodine	receptors,	transient	receptor	potential	canonical	channels,	voltage-
gated	calcium	channels	and	dynamin	3	(Tu	et	al.,	1998,	1999;	Xiao	et	al.,	1998;	Beneken	
et	al.,	2000;	Feng	et	al.,	2002;	Gray	et	al.,	2003;	Yuan	et	al.,	2003;	Olson	et	al.,	2005;	
Hayashi	et	al.,	2009).	Long	Homer	isoforms	(Homer1b-h,	Homer2a	and	b,	Homer3a	and	
b),	 which	 form	multimers	 through	 their	 (low	 homology)	 carboxy-terminal	 coiled-coil	
domains,	 mediate	 functional	 links	 between	 these	 PSD	 proteins,	 facilitating	 signal	
transduction	(Kato	et	al.,	1998a;	Xiao	et	al.,	1998;	Hayashi	et	al.,	2006).		
Expression	 of	 shorter	 Homer1	 isoforms	 is	 introduced	 through	 alternative	 splicing.	
Premature	 termination	of	 transcription	downstream	of	exon	5	 creates	 the	 truncated	
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Homer1a	and	Ania-3	proteins	(Figure	1.3;	Brakeman	et	al.,	1997;	Soloviev	et	al.,	2000;	
Bottai	 et	 al.,	 2002).	 The	 fifth	 intron	 of	 the	Homer1	 gene	 comprises	 sections	 of	DNA	
specific	 to	 the	 transcription	of	Homer1a	or	Ania-3	mRNA	 (Bottai	 et	 al.,	 2002).	 These	
isoforms	therefore	lack	a	coiled-coil	domain,	the	absence	of	which	prevents	Homer1a	
and	 Ania-3	 from	 forming	 homo-	 or	 hetero-oligomers.	 Hence,	 since	 their	 discovery	
(Brakeman	et	al.,	1997;	Berke	et	al.,	1998),	it	has	been	supposed	that	Homer1a	and	Ania-
3	act	as	dominant	negative	regulators	of	long	Homer	function,	uncoupling	them	from	
effector	 proteins	 through	 competition	 for	 the	 proline-rich	 sequence	 of	 the	 target	
protein	(Fagni	et	al.,	2002;	Irie	et	al.,	2002).	Indeed,	expression	of	Homer1a	blocks	the	
binding	of	 long	Homers	 to	 group	 I	mGluR	and	disrupts	 long	Homer-mGluR-mediated	
functions	(Tu	et	al.,	1998;	Xiao	et	al.,	1998;	Kammermeier	et	al.,	2000).		
Short	Homers	are	synthesised	in	the	soma	before	vesicular	transportation	to	dendrites	
(Brakeman	et	al.,	1997;	Okada	et	al.,	2009a),	which	is	dependent	upon	interactions	with	
Group	I	mGluRs	(Ango	et	al.,	2000;	Okada	et	al.,	2009a).	This	is	indicated	by	the	dendritic	
colocalisation	of	Homer1a	and	mGluR5	following	depolarisation,	whilst	a	mutant	form	
of	the	mGluR5	receptor	that	cannot	bind	Homer1a	does	not	relocate	from	the	soma	to	
dendrites	(Ango	et	al.,	2000).	Long	Homer1	isoforms	are	also	transported	with	group	I	
mGluRs	 to	 dendrites	 (Roche	 et	 al.,	 1999;	 Ango	 et	 al.,	 2000),	 yet,	 in	 the	 absence	 of	
Homer1a,	retain	the	receptor	complex	within	endoplasmic	reticulum,	inhibiting	mGluR5	
surface	expression	(Roche	et	al.,	1999;	Ango	et	al.,	2000,	2002;	Coutinho	et	al.,	2001).	
The	induction	of	Homer1a	through	neuronal	excitation	then	interrupts	the	endoplasmic	
retention	of	mGluR5,	permitting	their	trafficking	to	the	membrane	(Ango	et	al.,	2002).	
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Hence,	long	Homers	keep	a	pool	of	group	I	mGluRs	at	the	endoplasmic	reticulum	until	
released	by	activity-induced	short	Homers	(Figure	1.4).		 	
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Figure	 1.3	 Primary	 structure	 of	 Homer1a,	 Ania-3	 and	 Homer1b	 proteins.	 The	 amino-terminal	 EVH1	
domain	 (blue)	 is	 conserved	across	all	Homer	proteins	and	permits	their	 interaction	with	proline-rich	
sequences	of	target	proteins.	The	proline	motif	(green;	Ser-Pro-Leu-Thr-Pro)	is	specific	to	the	Homer1	
subfamily.	At	the	carboxy-terminal	region,	long	Homer	isoforms,	including	Homer1b,	contain	a	coiled-
coil	domain	(cyan)	required	for	dimerization.	Short	Homers,	Homer1a	and	Ania-3,	 lack	the	coiled-coil	
domain	and	are	therefore	unable	to	form	dimers.			
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Figure	 1.4	 Cotransport	 of	 group	 I	 mGluRs	 and	 Homer	 proteins	 from	 the	 soma	 to	 the	 endoplasmic	
reticulum	and	cell	membrane.	(1)	Transcription	of	short	Homers	is	regulated	by	myocyte	enhancer	factor-
2	(MEF2)	transcription	factors.	The	protein	is	synthesised	in	the	soma.	(2)	Short	Homers	bind	to	group	I	
mGluRs	on	transport	vesicles	and,	together,	they	are	transported	in	dendrites	to	synaptic	sites.	(3)	Whilst	
long	 Homers	 retain	 clusters	 of	 mGluRs	 at	 the	 endoplasmic	 reticulum,	 short	 Homers	 reverse	 the	
intracellular	retention	of	mGluRs,	(4)	permitting	their	trafficking	to	the	cell	membrane.	
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1.4.4 Homer1	IEG	induction	and	regulation	
Neuronal	 activity-induced	 expression	 of	 short	 Homer1	 mRNA	 has	 been	 observed	
throughout	brain	structures	known	to	be	involved	in	learning	and	memory,	including	the	
cerebral	cortex,	hippocampal	CA1,	CA2,	CA3	and	dentate	gyrus,	striatum,	and	amygdala	
(Brakeman	et	al.,	1997;	Sun	et	al.,	1998;	Xiao	et	al.,	1998;	De	Bartolomeis	et	al.,	2002;	
Polese	 et	 al.,	 2002;	 Vazdarjanova	 et	 al.,	 2002;	 Ary	 et	 al.,	 2007;	 Zhang	 et	 al.,	 2007;	
Montes-Rodríguez	et	al.,	2013).	The	induction	of	Homer1a	has	been	investigated	in	vitro	
through	 neuronal	 depolarization	 with	 ionotropic	 glutamate	 receptor	 agonists,	 N-
methyl-D-aspartate	 (NMDA),	 kainate	 and	 potassium	 channel	 blockers	 (Ango	 et	 al.,	
2000),	application	of	brain-derived	neurotrophic	factor	(BDNF)	(Mahan	et	al.,	2012),	the	
use	 of	 a	magnesium-free	 artificial	 cerebrospinal	 fluid	medium	 (Okada	 et	 al.,	 2009a),	
gonadotropin-releasing	 hormone	 (Wang	 et	 al.,	 2014),	 traumatic	 injury	 (Huang	 et	 al.,	
2005;	 Luo	 et	 al.,	 2014),	 and	 evoking	 epileptiform	 activity	 with	 bicuculline	 and	 4-
aminopyridine	 (Li	 et	 al.,	 2012).	 Induction	 in	 vivo	 has	 been	 reported	 following	
electroconvulsive	shock	(Brakeman	et	al.,	1997;	Kato	et	al.,	1997;	Xiao	et	al.,	1998;	Bottai	
et	al.,	2002),	long	term	potentiation	(Kato	et	al.,	1997,	1998a),	exposure	to	psychoactive	
drugs	 such	 as	 cocaine	 (Brakeman	 et	 al.,	 1997;	 Zhang	 et	 al.,	 2007),	 lysergic	 acid	
diethylamide	(LSD)	(Nichols	and	Sanders-Bush,	2002;	Nichols	et	al.,	2003)	and	ketamine	
(Iasevoli	 et	 al.,	 2007;	 De	 Bartolomeis	 et	 al.,	 2013),	 direct	 dopamine	 D1	 receptor	
stimulation	 (Berke	et	 al.,	 1998),	 typical	 and	atypical	 antipsychotic	 administration	 (De	
Bartolomeis	et	al.,	2002;	Polese	et	al.,	2002;	Fatemi	et	al.,	2006;	Ambesi-Impiombato	et	
al.,	2007),	associative	learning	(Mahan	et	al.,	2012),	instrumental	learning	(Hernandez	
et	al.,	2006),	exploration	of	a	novel	environment	(Vazdarjanova	et	al.,	2002;	Marrone	et	
al.,	2008),	visual	experience	(Brakeman	et	al.,	1997),	environmental	stressors	(Igaz	et	al.,	
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2004;	 Ary	 et	 al.,	 2007)	 and	 neuropathic	 pain	 (Ma	 et	 al.,	 2009).	 Importantly,	 it	 is	
exclusively	the	short,	 IEG	isoforms	of	the	Homer1	gene	that	are	 induced	under	these	
conditions,	whilst	the	expression	of	the	longer	isoforms	typically	remains	unchanged.		
As	alluded	to	previously,	neuronal	activation	induces	a	switch	in	the	transcription	of	the	
Homer1	gene	 to	 the	preferential	expression	of	 short	 isoforms.	This	 switch	 is	 created	
through	 an	 activity-dependent	 change	 in	 the	 polyadenylation	 site	 usage,	 altering	
transcription	 termination,	 and	 is	 controlled	 by	 myocyte	 enhancer	 factor	 2	 (MEF2)	
transcription	 factors	 (Bottai	 et	 al.,	 2002;	 Flavell	 and	 Greenberg,	 2008;	 Flavell	 et	 al.,	
2008).	With	an	aim	to	gain	insight	into	the	transcriptional	machinery	of	Homer1a	that	
may	regulate	synaptic	plasticity	during	memory	consolidation,	Mahan	and	colleagues	
(2012)	examined	the	epigenetic	modulation	of	the	Homer1a	gene	during	BDNF-induced	
plasticity	in	vitro	and	in	vivo.	BDNF	prompted	an	upregulation	of	Homer1a	in	primary	
amygdala	and	hippocampal	cultures	that	was	dependent	upon	MEK	and	ERK	signalling.	
Around	 the	 Homer1	 promoter	 region,	 they	 observed	 an	 increase	 in	 histone	 H3	
acetylation,	a	marker	of	enhanced	gene	 transcription,	or	a	decrease	 in	histone	H3K9	
methylation,	a	transcriptional	repressive	marker.	When	mice	underwent	Pavlovian	fear	
conditioning,	 the	 consolidation	 of	 which	 involves	 BDNF	 signalling	 (Lee	 et	 al.,	 2004;	
Rattiner	 et	 al.,	 2004;	 Barnes	 and	 Thomas,	 2008),	 the	 same	 Homer1	 epigenetic	
modifications	 that	 were	 seen	 in	 vitro	 were	 found	 in	 the	 mouse	 hippocampal	 and	
amygdalar	 extracts	 (Mahan	 et	 al.,	 2012).	 This	 work	 demonstrates	 one	 possible	
mechanism	 through	 which	 activity-induced	 Homer1	 transcripts	 may	 be	 generated	
during	 processes	 of	 learning	 and	memory	 or	 developmental	 synaptic	 maturation	 to	
bring	about	the	necessary	plastic	changes	at	the	synapse.	
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A	few	developmental	studies	have	shown	that	Homer1a	is	regulated	with	postnatal	age.	
Given	its	functional	location	at	the	glutamate	PSD,	its	interactions	with	NMDA	receptor	
complexes,	the	critical	role	of	glutamate	synapses	in	the	developmental	refinement	of	
neuronal	connections	(Komuro	and	Rakic,	1993;	Behar	et	al.,	1999;	Ikonomidou	et	al.,	
1999;	Matsugami	et	al.,	2006;	Zhang	et	al.,	2013)	and	the	developmental	impairments	
caused	by	disrupting	glutamate	receptor	complexes	(Fredriksson	et	al.,	2004;	Clifton	et	
al.,	2013),	Homer1a	is	 in	a	prime	position	to	impinge	on	synaptogenesis	and	synaptic	
pruning	 mechanisms	 during	 brain	 maturation.	 Postnatal	 forebrain	 expression	 of	
Homer1a	 increases	 from	birth,	 peaking	 between	 3-5	weeks	 (Brakeman	 et	 al.,	 1997).	
Montes-Rodríguez	et	al	(2013)	demonstrated	that	Homer1a	is	induced	differentially	by	
neuronal	 activity	 through	 early	 mammalian	 postnatal	 development.	 Maximal	
electroconvulsive	 shock	 treatment	 in	 rats	 only	 increased	 hippocampal	 Homer1a	
expression	 after	 the	 first	 postnatal	 week,	 indicating	 that	 Homer-related	 activity	
dependent	synaptic	plasticity	is	absent	at	this	early	stage	of	synaptogenesis	(Montes-
Rodríguez	et	al.,	2013).	The	number	of	activity-induced	Homer1a	positive	cells	rapidly	
increased	 during	 the	 second	 postnatal	 week,	 reaching	 adult	 levels	 by	 P9,	 although	
hippocampal	activity-induced	Homer1a	intra-nuclear	foci	intensity,	representing	mRNA	
quantity,	peaked	after	3	weeks,	in	parallel	with	synaptic	maturation,	hinting	towards	a	
role	of	the	protein	in	the	refinement	of	neuronal	circuits	(Yoshihara	et	al.,	2009;	Montes-
Rodríguez	et	al.,	2013).	Furthermore,	the	balance	of	short	to	long	Homer1	isoforms	is	an	
important	 regulator	 of	 axonal	 pathfinding	 in	 developing	 neurons	 (Foa	 et	 al.,	 2001).	
Unsurprisingly,	disruption	of	Homer1a	expression	causes	developmental	impairments.	
These	include	deficits	in	motor	coordination,	learning,	memory	and	sensorimotor	gating	
(Szumlinski	et	al.,	2005;	Tappe	and	Kuner,	2006;	Jaubert	et	al.,	2007).	
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1.4.5 Regulation	of	mGluR-NMDA	Complexes		
At	the	PSD,	short	Homer1	proteins	act	to	interrupt	the	scaffolds	created	by	long	Homer1	
isoforms	(Kato	et	al.,	1998a;	Xiao	et	al.,	1998;	Hayashi	et	al.,	2006).	Overexpression	of	
Homer1a	 in	 cultured	 hippocampal	 neurons,	 or	 induction	 of	 Homer1a	 expression	 by	
BDNF,	prompts	a	reduction	in	long	Homer1c	clusters,	without	decreasing	the	amount	of	
protein	(Inoue	et	al.,	2004).	Clusters	of	F-actin	and	PSD-95	are	similarly	reduced,	through	
disruption	of	their	association	with	Shank	protein	(Sala	et	al.,	2003;	Inoue	et	al.,	2004;	
Hayashi	et	al.,	2009),	and	dendritic	spine	size	is	decreased	(Sala	et	al.,	2003).	Homer1a	
therefore	appears	to	redistribute	functional	synaptic	architecture	constructed	by	long	
Homer1	proteins,	in	response	to	neuronal	activity,	to	bring	about	modifications	in	PSD	
scaffolds	and	spine	morphogenesis,	indicative	of	synaptic	plasticity	(Bosch	et	al.,	2014;	
Tønnesen	et	al.,	2014).		
The	interaction	between	Homer	and	group	I	mGluRs	(mGluR1	and	mGluR5)	has	been	a	
particular	 focus	 of	 functional	 research	 into	 Homer	 proteins,	 because	 of	 the	 role	 of	
Homer	as	an	intermediary	between	mGluRs	and	their	effector	proteins,	 including	the	
NMDA	receptor	(Tu	et	al.,	1998;	Bertaso	et	al.,	2010;	Sylantyev	et	al.,	2013).	Reciprocal	
signal	 transduction	 between	 group	 I	 mGluRs	 and	 NMDA	 receptors	 permits	 the	
regulation	of	NMDA-evoked	currents	by	mGluR	activation	(Fitzjohn	et	al.,	1996;	Awad	et	
al.,	 2000;	 Bertaso	 et	 al.,	 2010;	 Sylantyev	 et	 al.,	 2013),	 which	 is	 required	 for	 certain	
NMDA-dependent	processes	(Jia	et	al.,	1998;	Rodrigues	et	al.,	2002).	The	directionality	
of	NMDA	modulation	by	group	I	mGluRs	varies	between	studies.	Whilst	some	studies	
report	 that	 group	 I	mGluR	 activation	 augments	NMDA	activity	 (Fitzjohn	 et	 al.,	 1996;	
Awad	 et	 al.,	 2000;	 Sylantyev	 et	 al.,	 2013),	 others	 report	 inhibition	 (Yu	 et	 al.,	 1997;	
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Bertaso	et	al.,	2010;	Moutin	et	al.,	2012).	The	emerging	explanation	for	these	opposing	
outcomes	is	that	it	depends	upon	the	relative	involvement	of	long	and	short	Homer1	
proteins.		
NMDA	 receptors	 are	 located	 within	 the	 PSD,	 whereas	 group	 I	 mGluRs	 are	 typically	
located	at	extrasynaptic	and	perisynaptic	regions	(Baude	et	al.,	1993;	Lujan	et	al.,	1996)	
and	do	not	colocalize	with	NMDA	receptors	(Moutin	et	al.,	2012).	Instead,	interactions	
between	 the	 two	 glutamate	 receptors	 are	mediated	by	 a	Homer-Shank-GKAP-PSD95	
scaffold	(Naisbitt	et	al.,	1999;	Tu	et	al.,	1999).	It	has	been	suggested	that	mGluRs	use	
this	 long	 Homer-containing	 scaffold	 to	 facilitate	 NMDA	 activity,	 supported	 by	 the	
observation	that	the	potentiation	of	NMDA	receptor	currents	by	group	I	mGluR	agonists	
is	 blocked	 by	 postsynaptic	 transfection	 of	 Homer1a	 (Sylantyev	 et	 al.,	 2013).	 Other	
studies	 have	 similarly	 demonstrated	 a	 Homer1a-dependent	 inhibition	 of	 NMDA	
receptor	activity,	whilst	showing	that	it	is	calcium-independent	(Bertaso	et	al.,	2010)	and	
requires	the	integrity	of	the	EVH1	domain	of	Homer1a	(Sala	et	al.,	2003),	highlighting	
further	the	functional	importance	of	mGluR-Homer	interactions.		
This	model	does	not	yet	fully	explain	how	group	I	mGluRs	could	promote	the	inhibition	
of	 NMDA	 currents	 in	 the	 presence	 of	 Homer1a,	 as	 reported	 by	 some	 studies	 using	
sustained	stimulation	paradigms	(Bertaso	et	al.,	2010;	Moutin	et	al.,	2012).	MGluR1a-
mediated	 Homer1a-dependent	 inhibition	 of	 NMDA	 receptors	 gives	 rise	 to	 the	 co-
immunoprecipitation	 of	 Gβ-protein	 with	 NMDA	 NR1	 subunits	 and	 is	 attenuated	 by	
disrupting	G-proteins	(Bertaso	et	al.,	2010).	Moreover,	these	results	could	be	imitated	
by	transfecting	neurons	with	Shank3	mutants	that	are	unable	to	bind	Homer	complexes,	
but	not	by	mutants	unable	to	bind	the	GKAP-PSD95	complex	(Bertaso	et	al.,	2010).	These	
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data	 indicate	 that	 Homer1a	 may	 release	 group	 I	 mGluRs	 from	 their	 perisynaptic	
attachment	to	the	scaffolding	complex,	permitting	their	translocation	into	the	PSD	and	
physical	inhibition	of	NMDA	receptors	via	Gβγ	subunits.	This	notion	is	supported	by	a	
recent	 bioluminescence	 resonance	 energy	 transfer	 (BRET)	 study	 of	 cultured	
hippocampal	 neurons,	 which	 imaged	 spine-specific	 protein-protein	 interactions	
between	mGluR5a	and	NMDA	receptors	only	in	the	presence	of	Homer1a,	prompting	an	
inhibition	of	NMDA	currents	(Moutin	et	al.,	2012).		
Hence,	 group	 I	mGluRs	 regulate	NMDA	 receptor	 activity.	Whether	 that	 regulation	 is	
facilitatory	or	inhibitory	is	determined	by	the	mutually	exclusive	interaction	with	long	or	
short	Homer	proteins,	respectively.	Homer1a-induced	scaffold	remodelling	represents	
a	switch	for	mGluR	function	upon	synaptic	stimulation	that	could	be	important	for	the	
initiation	of	plasticity	processes	such	as	long-term	potentiation	or	long-term	depression.	
1.4.6 Calcium	Homeostasis	
The	majority	of	the	proteins	that	Homer	is	known	to	interact	with	are	involved	in	calcium	
homeostasis,	including	mGluRs,	IP3	receptors,	TRPC	channels,	ryanodine	receptors	and	
L-type	 voltage	 dependent	 calcium	 channels.	 Elevation	 in	 intracellular	 calcium	 in	
dendritic	spines	modifies	neuronal	excitability,	initiates	signalling	cascades	and	recruits	
new	membrane	proteins,	ultimately	adjusting	synaptic	strength	(Berridge,	1998;	Yang	
et	al.,	1999;	Yeckel	et	al.,	1999).		
It	has	 long	been	 recognised	 that	group	 I	mGluRs	 regulate	 the	activity	of	 the	 calcium	
releasing	 IP3	 receptors	 on	 intracellular	 endoplasmic	 reticulum	 stores	 via	Homer	 and	
Shank	protein	scaffolds	(Kawabata	et	al.,	1998;	Tu	et	al.,	1998;	Hwang	et	al.,	2005;	Sala	
et	al.,	2005).	In	neocortex	pyramidal	neurons,	intracellular	injection	of	Homer1a	dose-
	 	 Literature	Review		
	
38	
	
dependently	 enhances	 spike-induced	 calcium	 increases	 through	mGluR-IP3	 signalling	
(Yamamoto	et	al.,	2005).	The	same	is	not	achieved	by	injection	of	Homer1b/c.	However,	
the	maintenance	of	this	Homer1a-induced	calcium	augmentation	depends	instead	on	
elevated	 calcium	 influx	 through	 L-type	 voltage	 dependent	 calcium	 channels.	 It	 was	
demonstrated	that	Homer1a	lowers	the	threshold	for	calcium	spikes	by	facilitation	of	
the	currents	through	these	channels	(Yamamoto	et	al.,	2005).		
Indeed,	L-type	voltage	dependent	CaV1.2	and	CaV1.3	calcium	channel	subunits	possess	
Homer	binding	domains	on	their	carboxyl	termini	(Olson	et	al.,	2005;	Huang	et	al.,	2007).	
A	 study	 of	 excitation-contraction	 coupling,	 which	modelled	 calcium-induced	 calcium	
release	by	ryanodine	receptor	2	(RyR2)	and	CaV1.2	in	human	embryonic	kidney	(HEK)	
cells,	suggests	that	the	communication	between	CaV1.2	at	the	cell	surface	and	RyR2	on	
endoplasmic	 reticulum	 is	 mediated	 through	 the	 Homer-calcium	 channel	 interaction	
(Huang	 et	 al.,	 2007).	 Long	 Homer1b/c	 facilitates	 an	 interaction	 between	 RyR2	 and	
CaV1.2,	which	decreases	the	sensitivity	of	the	cell	to	membrane	depolarization-induced	
calcium	 elevations,	 whereas	 Homer1a	 disassembles	 the	 interaction,	 increasing	 the	
sensitivity	and	efficiency	of	calcium-induced	calcium	release	(Huang	et	al.,	2007;	Figure	
1.5).	 These	 observations	 corroborate	 closely	 with	 those	 from	 neocortex	 pyramidal	
neurons	(Yamamoto	et	al.,	2005),	both	illustrating	how	activity-induced	Homer	isoforms	
permit	a	rise	in	intracellular	calcium	concentration.		
The	link	between	ryanodine	receptors	and	L-type	voltage	gated	calcium	channels	is	not	
the	only	occurrence	of	Homer1	facilitating	the	signal	transduction	between	endoplasmic	
reticulum	and	cell	membrane	proteins	involved	in	calcium	homeostasis.	IP3	receptors	
communicate	with	transient	receptor	potential	canonical	(TRPC)	family	cation	channels	
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within	 a	 complex	 assembled	by	Homer.	 Similarly	 to	 the	 regulation	of	 L-type	 calcium	
channels,	the	disassembly	of	this	complex	increases	channel	activity	and	calcium	influx	
(Yuan	 et	 al.,	 2003).	 TRPC-Homer-IP3R	 disassembly	 is	 regulated	 by	 calcium	 store	
depletion	 and	 IP3-IP3R	 binding	 (Yuan	 et	 al.,	 2003,	 2012;	 Kim	 et	 al.,	 2006),	 although	
expression	 of	 Homer1a	 similarly	 causes	 complex	 dissociation	 by	 interrupting	 the	
coupling	 between	 long	 Homer	 isoforms	 and	 TRPC,	 permitting	 channel	 opening	 by	
stromal	 interacting	molecule	1	(STIM1;	Yuan	et	al.,	2003,	2012;	Dionisio	et	al.,	2015).	
Homer1a	 has	 also	 been	 reported	 to	 translocate	 TRPC	 complexes	 to	 the	membrane,	
where	they	are	spontaneously	active	(Kim	et	al.,	2006).		
These	 studies	 collectively	 demonstrate	 that	 activity-induced	 Homer	 proteins	
dynamically	regulate	the	communication	between	calcium	signalling	proteins	to	achieve	
the	 facilitation	 of	 calcium	 currents.	 Calcium	 elevations	 through	 NMDA	 and	 mGluR-
coupled	 signalling	 cascades	 are	 important	 components	 of	 spike-timing-dependent	
synaptic	plasticity	and	determinants	of	the	directionality	of	changes	in	synaptic	strength	
(Kampa	et	al.,	 2006;	Nevian	and	Sakmann,	2006).	 Therefore,	 the	 role	of	Homer1a	 in	
initiating	calcium	entry	is	highlighted	as	a	key	modulator	of	synaptic	plasticity.		 	
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Figure	1.5	The	regulation	of	postsynaptic	calcium	homeostasis	by	Homer	proteins.	Long	Homer	proteins	
(left)	 link	calcium-regulating	proteins	 into	complexes	by	forming	dimers	through	their	carboxy-terminal	
domains.	Activity-induced	short	Homer	proteins	(right)	act	as	dominant	negative	regulators	of	long	Homer	
complexes,	disrupting	the	links	between	synaptic	proteins	and	affecting	the	gating	of	calcium.	A	group	I	
mGluR-dependent	 potentiation	 of	 NMDA	 receptors	 is	 facilitated	 by	 a	 long	Homer-Shank-GKAP-PSD95	
scaffold,	 which	 is	 dismantled	 by	 short	 Homers.	 Short	 Homer	 proteins	 may	 also	 elicit	 the	 agonist-
independent	activation	of	group	 I	mGluRs.	TRPC	and	L-VDCC	channels	 form	complexes	with	 IP3Rs	and	
RyRs,	 respectively,	 through	 long	Homer	 dimers,	 which	 limits	 the	 influx	 of	 calcium.	 The	 induction	 and	
binding	of	 short	Homers	disrupts	 these	 complexes,	 increasing	 channel	activity	and	 calcium	 influx.	 ER,	
endoplasmic	 reticulum;	 GKAP,	 guanylate	 kinase-associated	 protein;	 IP3R,	 inositol	 1,4,5-triphosphate	
receptor;	 L-VDCC,	 L-type	 voltage-dependent	 calcium	 channel;	 mGluR1/5,	 metabotropic	 glutamate	
receptor	1/5;	NMDA,	N-methyl-D-aspartate;	PLC,	phospholipase	C;	PSD-95,	postsynaptic	density	protein	
95;	RyR,	ryanodine	receptor;	TRPC,	transient	receptor	potential	canonical	channel.	
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1.4.7 Functional	Plasticity	
I	 have	 discussed	 how	 activity-induced	 Homer	 protein	 is	 expressed	 during	 synaptic	
plasticity	 and	 interacts	 with	 other	 PSD	 components	 responsible	 for	 bringing	 about	
changes	 in	 synaptic	 strength;	 I	 now	 present	 the	 evidence	 that	 short	 Homers	 are	
themselves	 functionally	 involved	 in	 synaptic	plasticity.	This	work	 implicates	Homer1a	
and	Ania-3	in	the	local	regulation	of	synaptic	strength	and	the	global	scaling	of	synaptic	
excitability.	
Synaptic	strength	may	be	modified	by	the	trafficking	and	phosphorylation	of	AMPA-type	
glutamate	receptors	in	the	postsynaptic	membrane,	causing	an	adjustment	of	excitatory	
postsynaptic	currents	(Bredt	and	Nicoll,	2003;	Derkach	et	al.,	2007).	This	process	is	in	
part	 driven	 by	 group	 I	 mGluR	 activation	 (Snyder	 et	 al.,	 2001;	 Kelly	 et	 al.,	 2009).	
Overexpression	 of	 Homer1a	 in	 hippocampal	 neurons	 can	 globally	 decrease	 surface	
AMPA	receptors	 (Sala	et	al.,	2003;	Hu	et	al.,	2010;	Rozov	et	al.,	2012),	 reduce	GluA2	
subunit	tyrosine	phosphorylation	(Hu	et	al.,	2010)	and	block	the	maintenance	of	long-
term	potentiation	(Celikel	et	al.,	2007;	Rozov	et	al.,	2012).	These	effects	are	dependent	
on	group	I	mGluR	signalling,	yet	do	not	require	the	binding	of	glutamate	to	the	receptors	
(Hu	 et	 al.,	 2010).	 Indeed,	 Homer1a	 has	 been	 shown	 to	 activate	 group	 I	 mGluRs	
independently	of	glutamate	(Ango	et	al.,	2001;	Hu	et	al.,	2010).	Conversely,	knocking	
out	either	the	Homer1	gene	or	the	short	Homer1	isoforms	results	in	an	up-regulation	of	
postsynaptic	 AMPA	 receptors	 and	 currents	 (Hu	 et	 al.,	 2010;	 Rozov	 et	 al.,	 2012).	 In	
contrast,	one	study	reported	an	increase	in	synaptic	AMPA	receptors	following	Homer1a	
overexpression	 (Hennou	 et	 al.,	 2003),	which	may	 reflect	 differences	 in	 experimental	
protocols,	whilst	supporting	the	notion	that	scaffold	remodelling	can	lead	to	the	scaling	
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up	or	down	of	synapses,	depending	on	the	nature	of	the	stimulation.	Van	Keuren-Jensen	
and	Cline	(2006)	demonstrated	in	tadpole	optic	tectal	neurons	that	the	application	of	
group	 I	mGluR	agonists	 to	cells	with	a	 low	Homer1a/Homer1b	ratio	 increased	AMPA	
currents,	similarly	to	cells	that	had	been	removed	from	tadpoles	after	>12h	of	darkness.	
Conversely,	 either	 the	 exogenous	 expression	 of	 Homer1a,	 or	 Homer1a	 induction	
through	 visual	 stimulation	 for	 >4h,	 reversed	 the	 mGluR-mediated	 change	 in	 AMPA	
currents	 (Van	Keuren-Jensen	and	Cline,	2006).	These	studies	clearly	demonstrate	the	
involvement	of	Homer1a	in	AMPA	receptor	regulation,	whilst	indicating	a	specific	role	
of	the	protein	in	the	homeostatic	scaling	of	synaptic	strength.	
The	mechanism	through	which	Homers	regulate	mGluR-mediated	AMPA	plasticity	may	
involve	their	coupling	to	dynamin	3	in	endocytic	zones	(Gray	et	al.,	2003).	Long	Homers	
physically	 tether	 clathrin-positive	 endocytic	 zones	 near	 the	PSD	 through	 interactions	
with	Shank	and	dynamin	3,	 to	permit	 local	 cycling	and	 recapture	of	AMPA	receptors	
(Gray	 et	 al.,	 2003;	 Zhang	 et	 al.,	 2007).	 Disruption	 of	 this	 link	 by	 the	 expression	 of	
Homer1a	in	hippocampal	neurons	frees	the	endocytic	zones	from	the	PSD,	which	leads	
to	 a	 decrease	 in	 the	 number	 of	 postsynaptic	membrane	 AMPA	 receptors	 (Lu	 et	 al.,	
2007).	Therefore,	Homer1a	induction	can	remove	the	AMPA	cycling	capacity	of	dendritic	
spines,	regulating	synaptic	strengthening.		
The	long-term	maintenance	of	synaptic	strength	for	memory	consolidation	requires	de	
novo	 protein	 synthesis	 and	 scaffold	 remodelling	 over	 an	 extended	 period	 of	 time	
following	an	initial	synaptic	event	(Kandel,	2001;	Lee	et	al.,	2004).	One	of	the	intriguing	
aspects	of	Homer1a	function	is	its	expression	following	neuronal	activity,	which	occurs	
in	 conjunction	 with	 the	 expression	 of	 Arc,	 another	 IEG	 essential	 for	 memory	
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consolidation	 (Vazdarjanova	et	 al.,	 2002;	Plath	et	 al.,	 2006).	Both	are	 induced	 in	 the	
same	hippocampal	neurons	by	exploration	of	a	novel	environment	(Vazdarjanova	et	al.,	
2002;	Marrone	et	al.,	2008),	implying	that	their	coordinated	activity	may	be	necessary	
for	forming	a	memory	pertaining	to	that	environment.	Further	work	has	examined	the	
recruitment	of	Homer1a	to	active	synapses	in	order	to	select	spines	for	plasticity.	Okada	
and	 colleagues	 (2009)	 demonstrated	 that	 soma-derived	 Homer1a	 is	 recruited	 from	
dendrites	specifically	into	activated	spines.	This	only	occurred	if	NMDA	receptors	were	
stimulated	 and	 required	 extracellular	 calcium	 and	 the	 nitric	 oxide-protein	 kinase	 G	
signalling	pathway.	Trapping	of	Homer1a	into	spines	did	not,	however,	require	group	I	
mGluR	 activation	 (Okada	 et	 al.,	 2009a).	 The	 recruitment	 of	 Homer1a	may	 therefore	
represent	a	synaptic	tag	for	subsequent	spine	remodelling	and	the	targeting	of	de	novo	
plasticity-related	proteins.		
A	few	studies	have	evaluated	the	effect	of	manipulating	the	expression	of	short	Homer	
isoforms	 on	 learning	 and	memory.	 Overexpression	 of	 Homer1a	 in	 the	 hippocampus	
impairs	spatial	working	memory	and	spatial	reference	memory	(Klugmann	et	al.,	2005;	
Celikel	et	al.,	2007).	Short	form-specific	Homer1	knockout	mice	exhibit	a	deficit	in	cued	
and	contextual	fear	conditioning	(Inoue	et	al.,	2009a;	Mahan	et	al.,	2012).	These	mice	
have	 normal	 memory	 acquisition	 and	 short	 term	 memory	 of	 contextual	 fear,	 but	
impaired	 fear	 memory	 consolidation	 and	 memory	 retention,	 reminiscent	 of	 Arc	
knockout	mice	(Plath	et	al.,	2006),	another	IEG	critical	for	regulating	synaptic	plasticity.	
Interestingly,	 re-exposing	short	Homer1	knockout	mice	to	the	context,	and	therefore	
reactivating	the	fear	memory,	attenuated	the	conditioned	response,	indicating	a	deficit	
in	 reconsolidation	 or	 memory	 updating	 (Inoue	 et	 al.,	 2009a).	 These	 studies	 form	
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additional	corroboration	to	the	view	that	activity-induced	Homer	proteins	are	critical	for	
coordinating	plasticity	relevant	to	learning	and	memory.	It	should	be	noted	that,	since	
both	Homer1a	and	Ania-3	are	absent	 in	 these	knockout	models,	 delineation	of	 their	
respective	contributions	to	fear	memory	consolidation	is	lacking.	
1.4.8 Conclusions	
Homer1a	is	recruited	to	active	dendritic	spines	upon	stimulation	and	de	novo	Homer1a	
protein	is	synthesised	somatically	and	transported	to	the	PSD,	thereby	facilitating	short-	
and	 long-term	 scaffold	 remodelling	 for	 early	 and	 late	 phases	 of	 synaptic	 plasticity.	
Primarily,	 its	 function	 is	 the	 dominant	 negative	 disruption	 of	 functional	 synaptic	
architecture	constructed	by	long	Homer1	proteins,	which	can	result	in	a	switch	of	group	
I	mGluR	function,	receptor	translocation	or	the	accommodation	of	calcium	entry.	These	
findings	suggest	that	the	role	of	short	Homer	proteins	is	to	transiently	destabilise	the	
PSD	in	order	to	permit	scaling	of	the	most	currently	or	recently	active	synapses;	or	in	
other	words,	to	selectively	facilitate	the	plasticity	of	excitatory	synapses.	Disruption	of	
Homer1a	and	Ania-3	has	 implications	for	neurological	disease	and	their	manipulation	
may	represent	a	novel	therapeutic	approach.	
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1.5 Experimental	Plan	
Synaptic	plasticity	is	presented	here	as	a	critical	point	of	convergence	in	schizophrenia	
pathogenesis,	 particularly	 in	 relation	 to	 NMDA	 receptor	 and	 postsynaptic	 density	
protein	 complexes.	 It	 is	 noted	 that	 this	 may	 mediate	 specific	 deficits	 in	 associative	
learning	processes.	 In	 this	 thesis,	 I	 further	 the	 investigation	of	 the	role	of	associative	
learning	 in	 schizophrenia	 through	 studying	 the	 impact	 that	 genes	 and	 pathways	
conferring	 risk	 to	 the	disorder	 have	on	 the	 consolidation,	 retrieval	 and	 extinction	of	
contextual	fear	memory.	My	aims	were	as	follows.	
• Determine	whether	genes	associated	with	particular	components	of	associative	
learning	are	enriched	 in	the	genetic	variants	from	patients	with	schizophrenia	
and	related	disorders.	
• Explore	the	effect	of	the	NMDA	antagonist	and	psychotomimetic,	ketamine,	on	
the	consolidation	and	extinction	of	contextual	fear	memory.		
• Deduce	 the	 role	 of	 postsynaptic	 density	 Homer1	 proteins	 in	 associative	 fear	
learning	processes.	
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Chapter	2: General	Methodology	
This	chapter	describes	the	general	protocol	for	each	method	used	in	this	thesis.	Details	
of	 the	 specific	 methodology	 used	 in	 each	 experiment	 is	 given	 within	 its	 respective	
chapter.	
2.1 Copy	number	variant	enrichment	analysis	
Enrichment	 analyses	 are	 used	 to	 determine	 whether	 a	 gene	 set	 is	 overrepresented	
within	a	reference	gene	list,	compared	to	that	which	you	would	expect	by	chance.	They	
can	also	be	used	to	compare	the	relative	enrichment	of	a	gene	set	in	genetic	mutations	
from	 patients	 of	 a	 particular	 disease,	 relative	 to	 its	 enrichment	 in	 mutations	 from	
healthy	 controls.	 For	CNVs,	 this	 can	be	done	using	 a	 logistic	 regression	 analysis	 that	
regresses,	for	each	CNV,	case-control	status	of	the	patient	on	the	number	of	genes	from	
the	gene	set	that	the	CNV	overlaps	with.		
2.1.1 Logistic	regression	analysis	
Gene	sets	were	formatted	as	tab-delimited	text	files	containing	the	human	Entrez	ID	for	
each	gene.	CNV	lists	were	annotated	with	CNV	size,	deletion	or	duplication,	case-control	
status,	chip	type	(Affymetrix	chip	ID),	CNV	study	name,	number	of	genes	hit	by	the	CNV	
and	Entrez	gene	IDs.	Using	MATLAB	(R2015a)	or	R	(v	3.2.3),	the	number	of	genes	in	a	
gene	 set	 overlapped	 by	 each	 CNV	was	 counted.	 The	 logistic	 regression	 analysis	was	
performed	using	the	general	linear	model	(glm;	binomial)	function	in	R,	as	follows:	
!"#$-!&'()&*	#("(,#	~	.$'$	#$(	ℎ0(# + 234	#05$ + (&("*	.$'$#	0'	234 + #(,67+ !ℎ08	(78$		
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P-values	 outputted	 by	 this	 analysis	 were	 converted	 to	 − log=>(P-A"*,$)×#.'(Z-A"*,$).	
2.1.2 Permutation	correction	
In	order	 to	 remove	 the	effect	of	any	background	enrichment	 in	 the	gene	sets,	 some	
analyses	 were	 subjected	 to	 permutation	 correction.	 This	 adjusts	 the	 observed	
enrichment	P-value	 so	 that	 it	 is	 empirically	 determined	by	 a	 distribution	 of	P-values	
obtained	from	randomly	permuted	gene	sets.		
Using	 MATLAB,	 all	 genes	 (after	 any	 filtering	 processes	 specific	 to	 the	 study)	 were	
permuted	many	times	(e.g.	1000).	Following	each	permutation,	the	top	N	genes	were	
taken	as	a	random	gene	set,	where	N	is	the	size	of	the	gene	set	used	for	the	analysis	
being	 corrected.	 Each	 gene	 set	 was	 subjected	 to	 a	 logistic	 regression	 analysis	 as	
described	 above,	 producing	 a	 null	 distribution	 of	 P-values	 (or	 –log10(P-value)).	 An	
empirical	P-value	is	then	calculated	as	follows:	
E&)	7 = 7= …7H	.0A$'	I	
J = 	 5HKL=3 	Mℎ$)$	5 = 10 7K ≤ I			7K > I				
where	7	is	the	null	distributed	P-values	and	I	is	the	observed	P-value.	
2.2 Common	variant	enrichment	analysis	
The	enrichment	of	a	gene	set	 in	common	variants	 is	done	using	whole	genome	data	
analysis	 toolsets,	 such	as	PLINK	and	MAGMA.	Due	 to	 the	different	 statistical	models	
employed	by	each	approach,	they	may	yield	different	results	when	applied	to	the	same	
dataset.		
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2.2.1 PLINK	SNP	analysis	
Gene	sets	were	converted	to	genomic	locations	using	the	genome	build	37.3	sequence	
file	found	at	the	NCBI	FTP	site:	
(ftp://ftp.ncbi.nih.gov/genomes/MapView/Homo_sapiens/sequence/BUILD.37.3/initial
_release/seq_gene.md.gz).	
1000	Genomes	 reference	 files	 (http://www.1000genomes.org)	were	used	 for	 linkage	
disequilibrium	calculations.	Case-control	SNPs	were	mapped	 to	 the	gene	set	and	 the	
enrichment	 probability	 calculated	 using	 Plink’s	 “--set-screen”	 function.	 Each	 analysis	
yielded	P-values	from	two	levels	of	statistical	stringency.	P1	is	an	uncorrected	P-value	
and	P2	is	an	empirical	P-value	corrected	for	the	multiple	SNPs	within	the	set.	
2.2.2 MAGMA	SNP	analysis	
MAGMA	 (Multi-marker	 Analysis	 of	 GenoMic	 Annotation)	 uses	 a	 multiple	 regression	
model	and	performs	single	gene	analysis	in	conjunction	with	gene	set	analysis	for	added	
flexibility.		
Case-control	 SNP	data	was	annotated	with	gene	 location	using	NCBI	Build	37.3	gene	
locations	 obtained	 from	 (http://ctg.cncr.nl/software/magma/aux_files/NCBI37.3.zip).	
Then	a	gene-wide	analysis	was	performed,	using	the	1000	Genomes	reference	files	(as	
above)	for	linkage	disequilibrium	calculations.	Gene	set	analyses	were	performed	using	
the	 output	 from	 the	 gene-wide	 analysis.	 During	 this	 analysis,	 MAGMA	 executed	 a	
correction	for	false	discovery	rate	using	100,000	data	permutations.	
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2.3 The	ethical	use	of	animals	in	research	
All	experiments	were	conducted	in	accordance	with	the	United	Kingdom	1986	Animals	
(Scientific	 Procedures)	 Act	 (Project	 licenses	 PPL	 30/3135	 and	 PPL	 30/2236;	 Personal	
license	PIL	I16A5E86C).		
2.4 Contextual	fear	conditioning	behavioural	paradigms	
2.4.1 Subjects	
Subjects	were	adult	male	Lister	Hooded	rats	from	Charles	River	UK,	weighing	250-350	g	
(8-14	weeks	 old).	Upon	 arrival,	 rats	were	 housed	 in	 pairs	 in	 conventional	 cages	 in	 a	
holding	room	maintained	at	21°C	on	a	12h	reversed	 light/dark	cycle.	All	experiments	
were	conducted	during	the	dark	period.	Food	(chow)	and	water	were	freely	available	
and	the	cages	were	cleaned	weekly.	A	cardboard	tube	was	provided	as	environmental	
enrichment.	Rats	were	habituated	to	their	home	cages	for	at	least	5	days	prior	to	the	
experiment	start.	Tails	were	labelled	for	identification	using	a	permanent	marker	pen.	
The	handling	of	animals	from	each	experimental	group	was	ordered	pseudorandomly.		
2.4.2 Contextual	fear	conditioning,	recall	and	extinction	
The	protocol	described	here	is	a	well-established	paradigm	for	studying	associative	long-
term	memory	 in	 rodents	 (Lee	et	al.,	2004;	Barnes	and	Thomas,	2008),	 in	which	a	 rat	
learns	to	associate	a	novel	context	with	the	receipt	of	an	electric	footshock.	Rats	were	
transported	from	the	holding	room	to	the	behaviour	suite	 in	dark	transport	boxes	to	
avoid	 exposing	 the	 animals	 to	 the	 light	 during	 their	 dark	 period.	 Rats	 were	 placed	
individually	into	either	conditioning	context	A	or	B.	Conditioning	contexts	were	30.5	cm	
x	24.1	cm	x	29.2	cm	chambers	(Med	Associates,	UK)	with	19	floor	bars	raised	1.6	cm	
above	a	floor	tray,	all	contained	within	a	sound-attenuating	cubicle	55.9	cm	x	55.9	cm	x	
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35.6	cm.	During	conditioning	trials,	rats	received	a	2	second	0.5	mA	footshock	after	2	
min	context	exposure.	The	footshock	was	administered	through	the	floor	bars	and	was	
controlled	by	a	Med-PC	(version	IV)	Research	Control	and	Data	Acquisition	System	(Med	
Associates).	Rats	were	removed	from	the	context	1	min	after	footshock	and	transported	
back	to	their	home	cages.		
Recall	and	extinction	trials	were	conducted	at	the	same	time	of	day	as	the	conditioning	
trial.	Rats	were	transported	to	the	context	in	the	same	transport	boxes.	In	recall	trials,	
rats	were	returned	to	the	context	for	2	min.	In	extinction	trials,	rats	were	returned	to	
the	context	for	10	min.	Proof	of	concept	experiments	are	presented	in	sections	4.2-4.3.	
All	periods	of	context	exposure	were	recorded	on	video	(JSP	Electronics,	China),	using	
Numeriscope	software	(Viewpoint,	France),	for	behavioural	analysis.		
2.4.3 Quantification	of	freezing	response	
The	freezing	response	of	the	animals	was	used	as	a	metric	of	fear	memory	acquisition	
and	 recall.	 Files	 containing	 video	 recordings	 of	 context	 exposures	 were	 randomised	
programmatically	in	order	to	blind	the	experimenter	to	the	experimental	group	of	each	
subject,	 thereby	 minimising	 subjectivity	 during	 analyses.	 Freezing	 behaviour	 was	
defined	as	 the	 complete	 and	 sudden	 cessation	of	movement	 and	was	 recorded	as	 a	
binary	variable	every	10	sec	(freezing	/	not	freezing),	starting	from	the	time	at	which	the	
door	to	the	conditioning	context	was	closed.	Percent	freezing	therefore	represents	the	
proportion	of	samples	in	which	the	rat	was	observed	freezing.	
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2.5 In	situ	hybridization	
In	situ	hybridization	is	a	method	of	localising	and	quantifying	specific	mRNA	sequences	
in	fixed	tissue	sections	by	hybridising	with	labelled	strands	of	complementary	nucleotide	
sequences	(Figure	2.1).		
2.5.1 Brain	extraction,	coronal	sectioning	and	paraformaldehyde	fixation	
Rats	 were	 killed	 by	 CO2	 inhalation	 at	 the	 time	 point	 of	 interest.	 They	 were	 then	
immediately	decapitated	and	the	brain	was	extracted	and	snap	frozen	on	dry	ice	within	
10	min	of	death.	Brains	were	wrapped	in	Parafilm	(Sigma-Aldrich,	USA)	and	foil	before	
storage	at	-80°C	until	needed.		
Microscope	slides	used	for	mounting	coronal	brain	sections	were	prepared	by	baking	
overnight	at	180°C	and	allowing	to	cool	before	coating	in	poly-L	lysine	solution	(2%).	The	
slides	were	dried	and	stored	at	4°C	until	use.	A	custom	MATLAB	program	was	used	to	
design	the	arrangement	of	brain	sections	onto	a	 library	of	microscope	slides,	so	 that	
there	 was	 a	 maximum	 of	 6	 sections	 per	 slide,	 each	 from	 a	 different	 subject,	 with	
pseudorandom	subject	selection	and	without	position	bias	for	any	experimental	group.	
From	each	subject,	114	14	µm	coronal	sections	of	the	region	of	interest	were	cut	using	
a	cryostat	(Leica	Biosystems,	Germany)	and	mounted	on	a	series	of	glass	slides.	Slides	
were	then	racked	into	hollow	glass	slide	racks	for	fixing	and	storage.	
To	fix	the	brain	sections,	slides	were	bathed	in	4°C	4%	paraformaldehyde	/	phosphate	
buffer	 saline	 (PBS;	 1.3	 M	 NaCl,	 70	 mM	 disodium	 phosphate,	 30	 mM	 monosodium	
phosphate)	solution	for	5	min,	before	washing	in	PBS	(1	min)	and	70%	ethanol	(4	min).	
Slides	were	 then	stored	 in	95%	ethanol	at	4°C	until	use.	A	minimum	of	2	weeks	was	
allowed	for	before	performing	in	situ	hybridization	to	allow	for	delipidation.		
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2.5.2 Oligonucleotide	probe	design	
Single-stranded	 oligonucleotide	 probes	 were	 designed	 to	 target	 unique	 mRNA	
sequences.	 Due	 to	 the	 number	 of	 filtering	 steps	 required	 to	 identify	 a	 candidate	
oligonucleotide	probe,	a	tool	was	developed	 in	MATLAB	to	do	this	programmatically.	
Probes	were	designed	to	be	only	45	base-pairs	long	to	facilitate	penetration	into	cells.	
Optimisation	 steps	 included	 choosing	 probes	 with	 G/C:A/T	 ratios	 close	 to	 1	 and	
excluding	probes	containing	trains	of	the	same	nucleotide	 longer	than	3.	These	steps	
permit	consistency	in	hybridization	conditions	and	prevent	excessive	secondary	folding	
of	the	oligonucleotide.		
On	occasions	where	the	probe	is	being	designed	to	target	a	unique	isoform,	the	probes	
are	ranked	by	their	maximum	homology	with	the	other	isoforms	of	the	same	gene	to	
allow	identification	of	the	most	specific	oligonucleotide	probe.	
2.5.3 5’	end	35S	labelling	of	oligonucleotides	
Oligonucleotide	probes	(Sigma-Aldrich)	were	radiolabelled	with	35S	for	detection.	To	do	
this,	pure	oligonucleotides	were	dissolved	to	1	µg/µl	in	DEPC-treated	phosphate	buffer	
before	dilution	to	5	ng/µl	in	DEPC-treated	water.	This	was	added	to	the	radioisotope	in	
the	following	solution:	12.5%	recombinant	terminal	deoxynucleotidyl	transferase	(rTDT)	
enzyme	(Promega,	USA),	20.1%	5x	TDT	buffer	(Promega),	16.7%	5	ng/µl	oligonucleotide	
probe,	12.5%	35S-dATP	(87-day	half-life;	Perkin-Elmer).	The	solution	was	 incubated	at	
35°C	for	1	h	before	diluting	4.2X	in	DEPC-treated	water.	In	order	to	extract	the	labelled	
probe,	the	solution	was	spun	for	2	min	at	2000	rpm	on	a	spin	column	consisting	of	a	1	
ml	syringe	filled	with	Sephadex	G-25	(Sigma-Aldrich)	TNES	(0.14	mM	NaCl,	20	mM	Tris,	
General	Method	
	
53	
	
5	mM	EDTA,	0.1%	SDS)	slurry.	Dithiothreitol	(DTT;	Sigma-Aldrich)	was	added	to	3.8%	to	
terminate	the	reaction,	before	storage	at	-20°C	until	use.		
2.5.4 Hybridization	of	coronal	brain	sections	
The	specific	activity	of	 the	 labelled	oligonucleotide	probe	was	calculated	by	mixing	a	
sample	of	it	with	scintillation	fluid	at	a	ratio	of	1:1000	and	quantifying	the	disintegrations	
per	minute	 (dpm)	using	a	 liquid	scintillation	counter	 (Tri-Carb	2800	TR;	Perkin-Elmer,	
USA).	Coronal	brain	sections	representing	the	same	region	along	the	sagittal	plane	were	
selected.	Each	slide	of	coronal	brain	sections	was	covered	with	a	solution	containing	
R>>STUVW	XYWZK[KZ	\Z]K^K]_	YWT	`a	µl	oligonucleotide	probe,	100	µl	HYB	buffer	 (50%	deionised	
formamide,	20%	20X	saline-sodium	citrate	buffer,	5%	0.5	M	sodium	phosphate,	1%	0.1	
M	 sodium	 pyrophosphate,	 10%	 50X	 Denhardt’s	 solution,	 5%	 4	 mg/ml	 acid-alkali	
hydrolysed	salmon	sperm	DNA,	2%	5	mg/ml	polyadenylic	acid,	0.1%	120	mg/ml	heparin	
and	10%	dextran	sulphate)	and	2	µl	DTT.	Control	(non-specific)	slides	were	covered	in	
the	 same	 solution	 with	 the	 addition	 of	 R>>STUVW	XYWZK[KZ	\Z]K^K]_	YWT	`a ×4	 µl	 5	 ng/µl	
unlabelled	oligonucleotide	probe.	A	strip	of	Parafilm	(Sigma-Aldrich)	acted	as	a	coverslip	
on	each	slide,	before	incubation	in	a	humid	environment	overnight	at	42°C.	Slides	were	
bathed	 in	1X	saline-sodium	citrate	buffer	 (SSC)	at	 room	temperature	 to	 facilitate	 the	
removal	of	the	coverslips.	The	slides	then	underwent	washes	in	52°C	1X	SSC	(30	min),	
52°C	1X	SSC	(30	min),	room	temperature	0.1X	SSC	(1	min),	70%	ethanol	(1	min)	and	95%	
ethanol	(1	min).		
2.5.5 Imaging	and	quantification	of	gene	expression	
When	dry,	 labelled	 slides	were	 arranged	 in	 a	 radiographic	 cassette,	 along	with	 a	 14C	
standard	slide	for	calibration,	sealed	underneath	a	sheet	of	radiographic	film	(American	
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Radiolabeled	Chemicals,	USA).	The	duration	for	which	the	slides	were	left	against	the	
radiographic	 film	depended	on	 the	 intensity	 of	 the	 autoradiograph	 produced	 by	 the	
oligonucleotide	 probe	 (typical	 variation	 from	 3-30	 days)	 and	 preliminary	 tests	 were	
performed	to	optimize	this	duration.	The	film	was	developed	using	an	EXOMAX	x-ray	
processor	(PROTEC,	Germany)	and	scanned	to	produce	a	digital	greyscale	image	(Figure	
2.1).	
Autoradiographs	of	labelled	brain	sections	were	analysed	using	ImageJ	(NIH).	Analysis	
was	 performed	 blind	 to	 the	 respective	 experimental	 groups.	 Densitometry	 was	
calibrated	 using	 known	 radioactive	 quantities	 from	 the	 14C	 standards.	 Triplets	 of	
intensity	measurements	were	sampled	from	each	region	of	 interest,	per	hemisphere,	
per	section.	For	each	subject,	the	intensity	of	signal	within	a	brain	region,	representing	
the	quantity	of	mRNA	expressed,	was	calculated	as	follows.	
mRNA	expression	=	 #n + #o2 − '#	
where	Sa	and	Sb	are	the	densitometry	values	sampled	from	the	specific	signal	of	one	
brain	region	in	sections	A	and	B	of	a	subject	(Figure	2.1)	and	ns	is	the	densitometry	value	
acquired	 from	 the	 control	 (non-specific)	 section	 from	 the	 same	 subject.	 Expression	
values	 for	each	brain	 region	were	normalized	 to	 the	mean	expression	of	 the	 control	
group.		 	
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Figure	 2.1	 In	 situ	 hybridization	 autoradiograph	 from	 coronal	 rat	 brain	 sections	 hybridized	 with	
radiolabelled	oligonucleotides	specific	to	the	Homer1a	mRNA	sequence.	The	first	and	second	columns	are	
experimental	 repeats,	 showing	the	specific	binding	of	the	oligonucleotide	to	 its	complimentary	mRNA	
sequence	on	two	separate	slides	of	brain	sections.	Sections	in	the	third	column	have	been	hybridized	with	
an	excess	of	unlabelled	probe,	giving	the	background	signal,	which	is	deducted	from	the	specific	signal	
during	quantification.		
Specific	A	 Specific	B	
Non-specific	
(background)	
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2.6 Immunoblotting	
Immunoblotting	 was	 used	 to	 quantify	 proteins	 from	 hippocampal	 tissue	 samples	
obtained	from	behaving	rats.	
2.6.1 Tissue	homogenisation	and	sample	preparation	
2.6.1.1 Preparation	of	whole	hippocampal	homogenates	
Snap-frozen,	 micro-dissected	 hippocampi	 were	 stored	 at	 -80°C	 until	 preparation	 for	
immunoblotting.	 For	 the	 preparation	 of	 whole	 hippocampal	 fractions,	 30-100	 mg	
hippocampal	 tissue	 was	 homogenised	 with	 4°C	 10	 µl/mg	 radioimmunoprecipitation	
assay	 (RIPA)	 buffer	 (Thermo	 Fisher	 Scientific,	 USA)	 and	 protease	 inhibitors	 (Roche,	
Germany),	using	a	glass	3	ml	pestle	and	mortar	on	ice.	Homogenates	were	centrifuged	
at	1200g	for	20	min	at	room	temperature	to	pellet	and	remove	nuclei.	Samples	were	
stored	at	-80°C	until	use.	
2.6.1.2 Preparation	of	hippocampal	synaptosomes	
To	 prepare	 synaptosomal	 fractions	 of	 hippocampal	 tissue,	 30-100	 mg	 hippocampal	
tissue	was	homogenised	with	4°C	Synaptic	Protein	Extraction	Reagent	(Syn-PER;	Thermo	
Fisher,	USA)	 and	protease	 inhibitors	 (Roche,	Germany)	using	a	 glass	3	ml	pestle	 and	
mortar	on	ice.	Homogenates	were	centrifuged	at	1200g	for	10	min	at	4°C.	The	pellet	was	
discarded	and	the	supernatant	was	further	centrifuged	at	15000g	for	20	min	at	4°C.	The	
supernatant,	which	contains	the	cytosolic	fraction,	was	stored	for	reference.	The	pellet	
was	 re-suspended	 in	 1	 ml/g	 (original	 hippocampal	 tissue)	 Syn-PER	 with	 protease	
inhibitors,	and	re-homogenised,	before	storage	at	-80°C.		
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2.6.1.3 Global	protein	quantification	using	the	Bradford	or	BCA	assay	
Total	protein	concentration	of	samples	homogenised	in	Syn-PER	was	calculated	using	
the	Bradford	assay.	A	concentration	gradient	of	bovine	serum	albumin	(BSA;	Bio-Rad,	
USA)	was	used	to	create	a	standard	curve	for	reference.	Samples	were	diluted	10X	in	
Syn-PER	and	mixed	1:50	with	Bradford	reagent	(Bio-Rad)	in	a	cuvette.	Optical	density	
was	determined	at	595	nm.	
Since	 the	 Bradford	 assay	 is	 sensitive	 to	 buffers	 containing	 strong	 detergents,	 total	
protein	 concentration	 of	 samples	 homogenised	 in	 Radioimmunoprecipitation	 assay	
(RIPA)	 buffer	 was	 determined	 using	 the	 bicinchoninic	 acid	 (BCA)	 assay	 (Pierce	 BCA	
Protein	Assay	Kit;	Thermo	Fisher,	USA).	Samples	were	diluted	10X	in	RIPA,	before	being	
added	to	BCA	reagent	mix	1:20	and	incubated	at	37°C	for	30	min.	Following	incubation,	
samples	 were	 cooled	 rapidly	 to	 room	 temperature	 and	 the	 optical	 density	 was	
determined	at	562	nm.		
2.6.2 Western	blot	procedure	
To	 separate	 the	 proteins,	 samples	 were	 subjected	 to	 gel	 electrophoresis	 in	 an	
electrophoresis	chamber	(Bio-Rad).	Prior	to	loading	onto	the	gel,	samples	were	diluted	
to	equal	protein	concentrations	and	boiled	with	45%	Laemmli	sample	buffer	(Bio-Rad)	
and	5%	β-mercaptoethanol	 (Bio-Rad)	at	96°C	for	5	min.	Samples	containing	10-40	µg	
protein	 were	 loaded	 into	 each	 well	 of	 a	 12%	 precast	 polyacrylamide	 gel	 (Bio-Rad),	
bordered	by	5	µl	prestained	protein	standards	(Bio-Rad).	Electrophoresis	was	run	at	50V	
for	10	min,	followed	by	150V	for	40	min,	or	until	the	sample	has	traversed	the	gel.		
Proteins	were	transferred	to	a	nitrocellulose	membrane	 (Bio-Rad),	using	a	Trans-Blot	
Turbo	Transfer	System	(Bio-Rad).	Membranes	were	blocked	in	a	5%	milk	(Amersham	ECL	
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Prime,	GE	Healthcare,	UK)	and	Tris-buffered	saline	with	Tween	(TBST;	50	mM	Tris,	150	
mM	NaCl,	0.05%	Tween	20)	solution	for	1	h	at	room	temperature.	Primary	antibodies	
were	diluted	in	5%	milk	/	TBST	and	incubated	with	the	membrane	overnight	at	4°C.	The	
membrane	was	washed	three	times	in	TBST	for	5	min,	before	incubating	with	secondary	
fluorescent	 antibodies	 (LI-COR),	 diluted	 in	 5%	 milk	 /	 TBST,	 for	 1	 hour	 at	 room	
temperature.	The	membrane	was	washed	a	final	three	times	in	TBST	(twice)	and	TBS	
(once)	for	5	min	each.	Protein	bands	were	imaged	using	an	Odyssey	Clx	Infrared	Imaging	
System	(LI-COR).	
2.6.3 Quantification	of	protein	of	interest	
Typically,	each	membrane	was	probed	with	antibodies	targeting	the	protein	of	interest	
as	well	as	a	housekeeping	gene,	the	expression	of	which	is	known	to	be	unaffected	by	
the	experiment	manipulation,	for	normalisation	and	quality	control.	Western	blots	were	
analysed	 using	 Image	 Studio	 (LI-COR).	 Relative	 protein	 quantities	were	 calculated	 as	
follows.	
Protein	of	interest	in	sample	(arbitrary	unit)	=	 JK − 8oKwK − ℎoK 	
where	 each	 variable	 is	 a	 fluorescence	 intensity:	 P	 is	 protein	 of	 interest,	 H	 is	
housekeeping	gene,	pB	is	the	background	surrounding	the	protein	of	interest,	hB	is	the	
background	surrounding	the	housekeeping	gene	and	i	is	the	lane.		
2.7 Intracerebral	microinjection	of	substances	
2.7.1 Surgical	placement	of	indwelling	cannula	to	the	dorsal	hippocampus	
Rats	 were	 anaesthetised	 in	 an	 induction	 chamber	 using	 5%	 isoflurane	 (Abbott,	 UK),	
before	 the	 removal	of	 fur	on	 the	 top	of	 the	head	and	positioning	of	 the	animal	 in	a	
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stereotaxic	 frame	 (David	 Kopf,	 USA),	 where	 2-3%	 isoflurane	 was	 continuously	
administered	via	a	gaseous	mixture	of	oxygen	(0.8	L/min)	and	nitrogen	(0.4	L/min).	A	
midsagittal	 incision	was	made	 to	 expose	 the	 skull	 and	 two	holes	were	drilled	 at	 the	
following	 coordinates	 from	 Bregma:	 -3.5	 mm	 anterior-posterior,	 ±	 1.9	 mm	 medio-
lateral.	 A	 bilateral	 guide	 cannula	 (22	 gauge,	 3.8	 mm	 centre-to-centre,	 3	 mm	 below	
pedestal;	 Plastics	 One,	 UK)	 was	 implanted	 targeting	 the	 dorsal	 hippocampus	 and	
secured	with	screws	and	dental	acrylic	 (Kemdent,	UK).	A	dummy	stylet	(Plastics	One)	
was	 inserted	 into	 the	 cannula	 to	 prevent	 blockage.	 0.02	ml	 5	mg/ml	Metacam	was	
administered	subcutaneously	approximately	10	min	prior	to	the	end	of	surgery.	After	
surgery,	the	rat	was	placed	in	a	warm	(22°C)	recovery	chamber	for	30-60	min	and	given	
a	minimum	7	days	recovery	before	testing.		
2.7.2 Bilateral	hippocampal	infusion	
To	 administer	 substances	 via	 intracerebral	 microinjection,	 the	 dummy	 stylets	 were	
replaced	with	injector	stylets	(28	gauge,	4	mm;	Plastics	One)	attached	to	two	Hamilton	
syringes	 (Hamilton,	 Switzerland)	 by	 polyethylene	 tubing,	 fixed	 to	 a	 syringe	 pump	
(Harvard	Apparatus,	UK).	Substances	were	infused	at	1	µl/hemisphere	at	a	rate	of	0.5	
µl/min.	 A	 further	 2	min	was	 allowed	 after	 infusion	before	 removing	 the	 injectors	 to	
permit	sufficient	diffusion	of	the	solution	into	the	tissues.	
Each	subject	underwent	a	practice	infusion	session	using	sterile	PBS	at	least	3	days	prior	
to	testing,	in	order	to	habituate	the	animal	to	the	process.	
2.7.3 Histology	
Nissl	staining	was	performed	on	sections	of	brain	tissue	taken	from	rats	used	in	surgical	
procedures	to	verify	the	placement	of	cannulae	and	the	site	of	infusion.		
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14	µm	coronal	sections	were	cut	and	fixed	as	described	in	section	2.5.1.	Slides	were	then	
washed	as	follows:	distilled	water	(1	min),	0.1%	Thionin	(10	min),	distilled	water	(1	min),	
70%	ethanol	(1	min),	95%	ethanol	(1	min),	95%	ethanol	(1	min),	100%	ethanol	(1	min),	
100%	ethanol	(1	min).	Stained	sections	were	bathed	in	Histoclear	(National	Diagnostics,	
UK)	for	at	least	30	min,	before	being	dried	and	covered	with	DePeX	mounting	medium	
(BDH	Laboratory	Supplies,	UK)	and	a	glass	coverslip	(Agar	Scientific,	UK).		
Sections	were	imaged	using	a	Leica	DM2000LED	microscope	and	the	injection	site	was	
identified	 by	 finding	 the	 location	 of	 the	 most	 ventral	 point	 of	 the	 implant.	 Local	
inflammation	 and	 tissue	 damage	 was	 noted.	 Accurate	 bilateral	 dorsal	 hippocampal	
infusion	was	a	criterion	for	inclusion	of	a	subject’s	data	in	analysis.		
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Chapter	3: The	Enrichment	of	Learning-
Related	Genes	in	Genetic	Variants	from	
Patients	with	Schizophrenia	and	Related	
Disorders	
3.1 Introduction	
The	pathophysiology	of	 schizophrenia	 is	 unknown,	 yet	 its	 high	heritability	 implicates	
inherited	 genetic	 variants	 in	 its	 aetiology	 (Sullivan	 et	 al.,	 2003).	 A	 major	 branch	 of	
research	seeks	to	identify	genetic	variants	associated	with	the	disorder	through	large-
scale	 genomic	 studies.	 In	 recent	 years,	 this	 approach	 has	 progressively	 revealed	 a	
growing	list	of	common	variants,	rare	variants	and	structural	variants	that	increase	an	
individual’s	susceptibility	to	schizophrenia	(Stefansson	et	al.,	2008;	Stone	et	al.,	2008;	
Kirov	et	al.,	2012;	Ripke	et	al.,	2013,	2014,	Rees	et	al.,	2014a,	2014b;	Pocklington	et	al.,	
2015).	Each	genetic	variant	may	contribute	a	relatively	small	component	of	risk,	with	
rare	variants	typically	contributing	more	risk	than	common	variants,	but	collectively	they	
can	form	a	substantial	burden	that	accounts	for	a	large	proportion	of	risk	(Purcell	et	al.,	
2009;	Stefansson	et	al.,	2009).	Some	progress	has	been	made	in	subsequently	 linking	
these	genetic	variants	to	individual	genes	and	clustering	affected	genes	into	particular	
functional	pathways	(Hall	et	al.,	2015;	Kotlar	et	al.,	2015;	Owen	et	al.,	2016).	However,	
the	insight	from	these	analyses	is	limited	by	our	current	understanding	of	gene	function	
and	is	therefore	at	present	too	broad	to	be	of	sufficient	value	to	therapeutic	design.	
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It	is	notable	that	many	of	the	genetic	variants	linked	to	schizophrenia	also	increase	risk	
for	the	development	of	other	disorders.	For	example,	there	is	substantial	overlap	of	the	
risk	 conferred	 by	 schizophrenia-associated	 common	 variants	 to	 bipolar	 disorder	 and	
major	depressive	disorder,	and	by	schizophrenia-associated	rare	variants	to	intellectual	
disability	and	autism	spectrum	disorder	(Lee	et	al.,	2013;	Doherty	and	Owen,	2014).	This	
implies	that	there	 is	substantial	overlap	between	the	molecular	pathways	 involved	in	
the	 pathophysiology	 of	 these	 phenotypically-related	 disorders.	 However,	 the	 neural	
circuits	and	cognitive	domains	 that	are	consequently	 impaired	may	be	very	different	
(Millan	et	al.,	2012).		
3.1.1 A	convergence	of	susceptibility	genes	on	learning	pathways	
Despite	the	complex	genetics	of	schizophrenia,	pathway	analyses	across	studies	have	
found	 some	 points	 of	 convergence	 within	 the	 implicated	 genes.	 A	 predominant	
molecular	 convergence	 is	 that	 of	 synaptic	 proteins,	 particularly	 those	 of	 the	
postsynaptic	 density	 (Kirov	 et	 al.,	 2012;	 Fromer	 et	 al.,	 2014).	 Through	 analyses	 of	
inherited	and	de	novo	CNVs	from	patients	with	schizophrenia,	Kirov	et	al.	(2012)	found	
an	 enrichment	 of	 members	 of	 the	 NMDA	 receptor	 complex,	 PSD-95	 complex	 and	
activity-regulated	cytoskeleton-associated	protein	(ARC)	signalling	complex	(Kirov	et	al.,	
2012),	all	of	which	function	at	the	synapse.	Critically,	these	same	protein	complexes	are	
also	enriched	for	small	variants	observed	in	exome	sequencing	studies	(Fromer	et	al.,	
2014;	Purcell	et	al.,	2014).	A	further	group	of	genes,	those	targeted	by	fragile	X	mental	
retardation	protein	(FMRP),	were	also	implicated	through	exome	sequencing	(Fromer	et	
al.,	2014;	Purcell	et	al.,	2014)	and	through	the	 largest	common	variant	study	to	date	
(Ripke	et	al.,	2014).	FMRP	regulates	 the	translation	of	a	number	of	synaptic	proteins	
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(Fernandez	et	al.,	2013)	through	its	interactions	with	CYFIP1,	which	has	been	individually	
linked	to	schizophrenia	through	CNV	studies	(Stefansson	et	al.,	2008;	Kirov	et	al.,	2012).	
Common	 variant	 studies	 of	 the	 Psychiatric	 Genomics	 Consortium	 have	 revealed	
associations	with	schizophrenia	of	several	genes	coding	for	synaptic	proteins,	including	
clusters	 of	 genes	 coding	 for	 voltage-gated	 calcium	 channel	 subunits	 and	 glutamate	
receptor	subunits	(Ripke	et	al.,	2011,	2013,	2014).	
Beyond	the	structural	convergence	of	schizophrenia-associated	genes	at	the	synapse,	
further	 functional	 patterns	 have	 been	 noted	 amongst	 these	 genes.	 Many	 of	 the	
implicated	synaptic	proteins	are	key	regulators	of	synaptic	plasticity	(Hall	et	al.,	2015),	
both	of	excitatory	and	inhibitory	systems	(Pocklington	et	al.,	2015).	 	Pocklington	et	al	
(2015)	explored	 the	enrichment	of	134	gene	 sets	 in	patient	CNVs	 from	a	 large	 case-
control	cohort.	The	gene	sets	were	derived	from	functional	data,	mostly	curated	in	the	
Mouse	Genome	Informatics	(MGI)	Mammalian	Phenotype	database,	and	all	related	to	
aspects	of	brain	function	and	development.	As	well	as	replicating	previous	findings,	such	
as	the	overrepresentation	of	the	NMDA	receptor	and	PSD-95	complexes	in	patient	CNVs,	
they	also	show	that	genes	associated	with	particular	plasticity	processes,	including	long-
term	potentiation,	contextual	conditioning	and	associative	learning,	are	enriched	within	
CNVs	 from	 sufferers	 of	 schizophrenia	 (Pocklington	 et	 al.,	 2015).	 These	 findings	 are	
consistent	 with	 clinical	 studies	 showing	 deficits	 in	 associative-type	 learning	 in	
schizophrenia,	 which	 is	 thought	 to	 contribute	 to	 the	 manifestation	 of	 positive	 and	
cognitive	symptoms	(Serra	et	al.,	2001;	Corlett	et	al.,	2009;	Hall	et	al.,	2009).	However,	
there	are	multiple	components	to	associative	learning	(Barnes	et	al.,	2012;	Maren	et	al.,	
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2013),	 and	 it	 is	 thus	 far	 unclear	 which	 precise	 learning	 processes	 are	 affected	 by	
schizophrenia-associated	CNVs.	
3.1.2 Differential	 regulation	 of	 consolidation,	 retrieval	 and	 extinction	 of	 aversive	
memory	
Associative	 learning,	 and	 its	 constitutive	 components,	 has	 been	 studied	 in	 detail,	
particularly	in	relation	to	hippocampal	processing	of	contextual	fear	memory	(Barnes	et	
al.,	 2012;	Maren	et	 al.,	 2013;	 Scholz	 et	 al.,	 2016).	 Such	 studies	have	 shown	 that	 the	
consolidation,	 retrieval	 and	 extinction	 of	 contextual	 fear	memory	 are	 dependent	 on	
distinct	 patterns	 of	de	novo	gene	 expression,	 thereby	 recruiting	 different	 families	 of	
proteins	to	facilitate	the	particular	memory	process	(Duvarci	et	al.,	2008;	Mamiya	et	al.,	
2009;	 Barnes	 et	 al.,	 2012;	 Scholz	 et	 al.,	 2016).	 Like	memory	 consolidation,	memory	
extinction	 is	 an	 active	 form	 of	 new	 learning,	 which	 occurs	 upon	 the	 prolonged	 or	
repeated	exposure	to	a	conditioned	stimulus	in	the	absence	of	a	previously	associated	
unconditioned	stimulus,	and	results	in	dominance	over	the	former	associative	memory	
(Bouton,	 2004).	Using	microarrays	 to	quantify	 gene	expression	 in	CA1	 following	 fear	
memory	consolidation,	retrieval	and	extinction	in	rats,	Scholz	et	al.	(2016)	were	able	to	
create	 gene	 sets	 associated	 with	 each	 learning	 stage	 and	 explore	 their	 respective	
molecular	pathways.	This	data	therefore	provides	a	framework	for	further	investigating	
the	enrichment	of	associative	learning-related	genes	in	genetic	variants	from	patients	
with	psychiatric	disorders.	
Using	gene	sets	obtained	from	the	Scholz	et	al.	(2016)	study,	I	examined	the	hypothesis	
that	 genetic	 variants	 from	 patients	 with	 schizophrenia	 and	 related	 disorders	 are	
selectively	located	within	genes	related	to	specific	components	of	associative	learning.	
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Specifically,	 I	 used	 gene	 set	 enrichment	 analysis	 to	 investigate	 whether	 genes	
differentially	expressed	following	the	consolidation,	retrieval	or	extinction	of	contextual	
fear	are	enriched	in	CNVs	from	patients	with	schizophrenia,	autism,	intellectual	disability	
or	ADHD,	or	in	the	SNPs	from	patients	with	schizophrenia.	
3.2 The	enrichment	of	learning-related	genes	in	schizophrenia-
associated	CNVs	
3.2.1 Methods	
The	general	methodology	for	enrichment	analyses	and	contextual	fear	conditioning	can	
be	found	in	sections	2.1-2.4.	The	in	vivo	gene	expression	data	used	in	this	chapter	was	
generated	from	experiments	published	in	Barnes	et	al	(2012)	and	(Scholz	et	al.,	2016).	
Three	independent	expression	datasets	were	generated	representing	genes	regulated	
in	rat	CA1	associated	with	the	consolidation,	retrieval	and	extinction	of	contextual	fear	
memory.	 Section	 3.2.1.1,	 below,	 describes	 the	methods	 employed	 in	 these	 previous	
studies.		
3.2.1.1 The	generation	of	learning-related	gene	expression	data	–	previous	studies	
In	 brief,	 adult	 male	 Lister	 Hooded	 rats	 individually	 underwent	 contextual	 fear	
conditioning	(see	General	Methods	2.4).	In	the	consolidation	protocol,	awake	rats	(N	=	
8)	received	bilateral	microinfusions	of	either	brain-derived	neurotrophic	factor	(BDNF)	
antisense	 (5’-TCTTCCCCTTTTAATGGT-3’)	 or	 missense	 oligonucleotides	 (5’	 -
ATACTTTCTGTTCTTGCC-3’)	into	the	dorsal	hippocampus	(1	µl,	2	nmol/µl)	via	chronically	
implicated	 steel	 cannula,	 90	 min	 prior	 to	 the	 conditioning	 trial.	 The	 knockdown	 of	
hippocampal	 BDNF	 levels	 via	 antisense	 administration	 blocks	 the	 consolidation	 of	
contextual	fear	memory	(Lee	et	al.,	2004),	therefore	generating	a	control	group.	In	the	
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retrieval	protocol,	rats	were	replaced	into	the	same	context	48	hours	after	conditioning	
for	a	short	recall	trial	(2	min).	They	(N	=	8)	received	bilateral	microinfusions	via	chronic	
indwelling	 cannulae	 targeting	 the	dorsal	 hippocampus	of	 either	 Zif268	 antisense	 (5’-	
GGTAGTTGTCCATGGTGG-3’)	or	missense	oligonucleotides	(5’-GTGTTCGGTAGGGTGTCA-
3’;	1	µl,	2	nmol/µl),	90	min	prior	to	the	short	recall	trial.	Reducing	hippocampal	Zif268	
levels	 using	 antisense	 impairs	 the	 post-retrieval	 memory	 processes	 that	 serve	 to	
maintain	the	expression	of	contextual	fear	memory	(Lee	et	al.,	2004;	Trent	et	al.,	2015).	
To	 generate	 the	 extinction	 dataset,	 rats	 were	 pre-exposed	 to	 two	 different	 novel	
contexts	(Context	A	or	Context	B)	over	3	days	(10	min	/	day),	prior	to	conditioning	in	
either	Context	A	or	Context	B.	48	hours	later,	rats	underwent	a	long	recall	trial	(10	min)	
in	either	the	conditioned	context	(N	=	6)	or	the	unconditioned	context.	Those	placed	in	
the	conditioned	context	exhibit	a	progressively	decreased	freezing	response	over	the	
duration	of	the	long	recall	trial,	as,	in	the	absence	of	the	unconditioned	stimulus,	the	
association	 between	 the	 context	 and	 the	 footshock	 is	 extinguished,	 creating	 the	
extinction	group.	
All	rats	were	killed	by	CO2	inhalation	2	h	after	either	the	conditioning	or	recall	trials	and	
the	 dorsal	 CA1	 region	 of	 the	 hippocampus	 dissected	 and	 snap	 frozen	 prior	 to	 gene	
expression	analysis.	Microarray	analysis	was	performed	using	Affymetrix	Rat	Genome	
Array	 230.2	 (Thermo	 Fisher	 Scientific,	 US).	 Individual	 differential	 gene	 expression	
datasets	associated	with	the	consolidation,	retrieval	and	extinction	of	contextual	fear	
memory	were	generated	using	two	normalisation	methods:	Microarray	Suite	5	(MAS5)	
and	Robust	Multi-array	Average	(RMA).	These	normalisation	methods	each	yielded	a	P-
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value	per	probe	set,	representing	the	probability	of	differential	expression	compared	to	
the	respective	consolidation,	retrieval	and	extinction	control	groups.	
3.2.1.2 Extracting	consolidation-,	retrieval-	and	extinction-related	gene	sets	
The	 initial	 step	 in	 the	 analysis	 was	 to	 extract	 gene	 sets	 from	 the	 microarray	 data	
associated	with	contextual	fear	memory	consolidation,	retrieval	and	extinction.	Using	
Affymetrix	Rat	Genome	Array	230.2	resources,	probe	sets	that	did	not	target	a	unique	
coding	gene	were	filtered	from	the	dataset.	To	permit	comparison	with	human	mutation	
data,	rat	Entrez	gene	IDs	were	converted	to	human	homologs	through	the	HomoloGene	
ID	 index	 (Box	 3.1),	 obtained	 from	 the	Mouse	Genome	 Informatics	 (MGI)	 Vertebrate	
Homology	 table	 (http://www.informatics.jax.org/homology.shtml).	Genes	 that	do	not	
have	a	unique	human	homolog	according	to	this	database	were	thus	excluded.		
Genes	were	then	ranked	by	the	significance	of	 their	differential	expression.	For	each	
probe	set,	MAS5	and	RMA	P-values	were	combined	using	Fisher’s	method,	so	that	each	
probe	set	was	represented	by	a	single	P-value.	For	genes	targeted	by	more	than	one	
probe	set,	these	P-values	were	further	combined	using	Simes	P-value	correction	(Python	
3.5.1,	“StatsModels”	package),	thereby	giving	one	P-value	per	gene.	For	consolidation,	
retrieval	and	extinction,	genes	could	then	be	ranked	by	this	P-value,	with	smaller	values	
representing	a	stronger	association	with	the	particular	learning	phase.		
In	primary	analyses,	the	top	5%	learning-related	genes	(representing	607	genes	from	the	
consolidation,	retrieval	and	extinction	ranked	data	sets)	were	used	as	the	gene	set.	In	
subsequent	analyses,	gene	sets	were	generated	from	the	top	1,	2,	5,	10,	15,	20	and	25%	
of	learning-related	genes,	equating	to	121,	243,	607,	1214,	1822,	2429	and	3036	genes	
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respectively.	For	single	gene	analyses,	each	gene	from	the	top	5%	of	the	learning-related	
genes	was	considered	separate	sets.		 	
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	Box	3.1:	HomoloGene	ID	
Not	all	human	genes	are	present	 in	the	 rat	genome,	 just	as	not	all	 rat	genes	are	
present	in	the	human	genome.	For	those	that	do	have	corresponding	homologs,	the	
precise	sequence	of	the	gene	may	vary	and	therefore	its	function,	and	that	of	any	
proteins	it	codes	for,	could	differ.	Hence	when	converting	genes	across	species,	it	is	
crucial	that	controls	are	put	in	place	to	ensure	that	identified	homologs	are	likely	to	
be	functionally	identical.		
The	 HomoloGene	 ID	 is	 a	 numerical	 index	 for	 labelling	 genetic	 homologs	 across	
several	species	 (including	human,	 rat,	mouse,	chimpanzee,	rhesus	macaque,	dog,	
cattle	and	zebrafish),	created	by	the	National	Center	for	Biotechnology	Information	
(NCBI).	The	input	for	HomoloGene	comes	from	comparing	both	the	gene	sequence	
and	 protein	 structure,	 permitting	 the	 additional	 comparison	 of	 distance	metrics	
such	 as	 molecular	 distance	 and	 Ka/Ks	 ratio.	 An	 algorithm	 is	 applied	 that	 uses	
thresholds	of	bits	per	position	and	Ks	values	to	filter	out	unlikely	orthologs	and	group	
together	true	homologs.		
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3.2.1.3 Collating	patient	CNV	data	and	quality	control	
CNV	data	from	patients	with	schizophrenia	and	healthy	controls	were	compiled	from	
multiple	large-scale	studies,	to	reduce	any	bias	incurred	from	the	demographics	of	any	
one	cohort.	Data	 from	three	European	datasets	was	used:	 the	Molecular	genetics	of	
Schizophrenia	(MGS,	dbGAP	phs000167.v1.p1	and	phs000021.v3.p2),	the	International	
Schizophrenia	 Consortium	 (ISC)	 and	 a	 UK	 study	 of	 schizophrenic	 patients	 taking	
clozapine	(CLOZUK;	Stone	et	al.,	2008;	Levinson	et	al.,	2011;	Rees	et	al.,	2014;	Details	of	
genotyping:	Stone	et	al.,	2008;	Levinson	et	al.,	2011;	Rees	et	al.,	2014a;	Pocklington	et	
al.,	 2015).	 Control	 subjects	 for	 the	 CLOZUK	 cohort	 contains	 data	 obtained	 from	 The	
Genetic	 Architecture	 of	 Smoking	 and	 Smoking	 Cessation	 (dbGAP	 phs000404.v1.p1);	
Genetic	Epidemiology	of	Refractive	Error	in	the	KORA	Study	(dbGAP	phs000303.v1.p1);	
High-Density	SNP	Association	Analysis	of	Melanoma	(dbGAP	phs000187.v1.p1).	In	total,	
this	dataset	contains	CNVs	from	11917	schizophrenia	cases	and	16416	control	subjects.	
CNVs	from	patients	with	melanoma	were	obtained	from	a	Study	of	Melanoma	Risk	in	
Australia	and	the	United	Kingdom	(n	=	2416	following	QC).	6335	control	subjects	were	
obtained	 from	 The	 Genetic	 Epidemiology	 of	 COPD	 (COPDGene,	 dbGAP	
phs000179.v3.p2);	 A	 Genome-Wide	 Association	 Study	 of	 Fuchs'	 Endothelial	 Corneal	
Dystrophy	 (FECD,	dbGAP	phs000421.v1.p);	California	Pacific	Medical	Center	Research	
Breast	 Health	 Cohort	 (dbGAP	 phs000395.v1.p1);	 National	 Blood	 Donors	 Cohort	
(Wellcome	Trust	Case	Control	Consortium	2).		
Each	CNV	was	annotated	with	genes	using	the	corresponding	human	genome	reference	
assembly	(MGS:	Build	36,	ISC:	Build	35,	CLOZUK:	Build	37).	Only	protein	coding	genes	
were	 included	 in	 the	 annotation,	 as	 defined	 by	 the	 “Homosapiens_geneinfo.txt”	 file	
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within	the	genome	reference	assembly	files.	The	resulting	CNV	dataset	was	subjected	to	
quality	control.	This	involved	filtering	out	CNVs	smaller	than	100	kb,	covered	by	fewer	
than	15	probes	or	having	a	frequency	greater	than	1%.	These	steps	are	consistent	with	
recent	approaches	to	base	analyses	on	large,	rare	and	reliable	CNVs	(Szatkiewicz	et	al.,	
2014a;	Pocklington	et	al.,	2015).		
3.2.1.4 Logistic	regression	analysis	
Enrichment	analyses	were	performed	for	each	learning-related	gene	set,	comparing	the	
number	of	consolidation-,	retrieval-	and	extinction-related	genes	that	overlap	with	CNVs	
from	patients	or	healthy	 controls	 (Pocklington	et	al.,	 2015).	 This	was	done	using	 the	
following	logistic	regression	analysis:	
!"#$-!&'()&*	#("(,#	~	.$'$	#$(	ℎ0(# + 234	#05$ + (&("*	.$'$#	0'	234 + #(,67+ !ℎ08	(78$		
where	“case-control	status”	is	a	binary	variable	that	can	be	either	0	(control)	or	1	(case),	
“gene	set	hits”	 is	the	number	of	times	a	CNV	overlaps	a	gene	from	the	gene	set	and	
“CNV	size”	(base	pairs),	“total	genes	in	CNV”,	“study”	(i.e.	CLOZUK,	MGS	or	ISC)	and	“chip	
type”	(Affymetrix	chip	ID)	are	covariates.		
P-values	obtained	from	primary	analyses	(top	5%	learning-related	genes)	were	adjusted	
by	Bonferroni	correction	for	multiple	testing.	P-values	from	secondary	analyses	(top	1-
25%)	were	adjusted	by	permutation	correction.	P-values	from	single-gene	analyses	were	
uncorrected.	
3.2.1.5 Permutation	Correction	
Null	distributions	of	P-values	 for	each	gene	set	size	were	generated	by	permuting	all	
genes	2000	times,	each	time	taking	the	top	1,	2,	5,	10,	15,	20	and	25%	(giving	a	total	of	
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14000	 randomised	 gene	 sets)	 and	 analysing	 these	 gene	 sets	 by	 logistic	 regression	
analysis.	Empirical	enrichment	P-values	were	calculated	from	these	null	distributions	by	
finding	the	proportion	of	P-values	within	the	null	distribution	greater	than	the	observed	
P-value	(General	Methods	2.1.2).		
3.2.2 Results	
The	 consolidation,	 retrieval	 and	 extinction	 of	 contextual	 fear	 memory	 induced	 the	
expression	of	distinct	groups	of	genes,	with	only	chance	levels	of	overlap	between	the	
top	5%	of	each	learning	condition	in	Fisher’s	exact	test	(consolidation	vs	retrieval	P=0.85,	
consolidation	vs	extinction	P=0.39,	retrieval	vs	extinction	P=0.29;	Figure	3.1).	Top	5%	
gene	 sets	 encompassed	 genes	 with	 differential	 expression	 P-values	 <	 0.012	
(consolidation),	P	<	0.021	(retrieval)	and	P	<	0.032	(extinction).	
In	 primary	 logistic	 regression	 analyses,	 using	 a	 gene	 set	 comprised	 of	 the	 top	 5%	
learning-related	genes,	there	was	a	marked	enrichment	of	extinction-related	genes	in	
patient	CNVs	(P	=	3.9	×	10-4;	Bonferroni	corrected),	but	not	consolidation-	or	retrieval-
related	genes	(consolidation:	P	=	0.31;	retrieval:	P	=	0.23;	Bonferroni	corrected;	Figure	
3.2).		
The	 enrichment	 of	 extinction-related	 genes	 was	 observed	 in	 duplication	 CNVs	 and	
deletion	CNVs	separately.	The	top	5%	extinction-related	genes	were	enriched	in	both	
CNV	types	(deletions:	P	=	0.0034,	duplications:	P	=	0.042,	Bonferroni	corrected;	Figure	
3.1b	and	c).	No	enrichment	of	the	top	5%	consolidation-	or	retrieval-related	genes	was	
observed	in	deletions	or	duplications.		
By	 expanding	 the	 analysis	 over	 a	 range	 of	 gene	 set	 sizes	 (top	 1-25%),	 the	 statistical	
association	of	the	learning-related	gene	set	with	case	CNVs	increased	with	the	size	of	
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the	gene	set	(Figure	3.3a-c).	Plotting	the	enrichment	of	randomly	permuted	gene	sets	
of	the	same	sizes	confirmed	that	the	strength	of	the	enrichment	was	proportional	to	
gene	set	size	(Figure	3.3d).	This	may	be	due	to	a	background	enrichment	from	all	genes	
convertible	from	rat	to	human	homologs.	Hence,	the	permuted	gene	sets	were	used	to	
correct	the	observed	enrichment	P-values.	Following	permutation	correction,	only	the	
top	 1%,	 2%	 and	 5%	 extinction-related	 genes	 yielded	 a	 significant	 enrichment	 in	
schizophrenia-associated	 CNVs	 (Figure	 3.3g),	 whilst	 all	 sizes	 of	 consolidation-	 and	
retrieval-related	gene	sets	showed	no	enrichment	(Figure	3.3e	and	f).		
Since	this	CNV	dataset	is	made	up	of	CNVs	from	three	separate	studies	(MGS,	ISC	and	
CLOZUK),	 the	 existence	 of	 this	 finding	 in	 each	 independent	 cohort	was	 investigated.	
Interestingly,	 the	 same	 enrichment	 of	 extinction-related	 genes	 in	 patient	 CNVs	 was	
present	in	each	of	the	CNV	datasets	(Table	3.1).	These	results	suggest	that	CNVs	which	
increase	an	individual’s	susceptibility	to	developing	schizophrenia	impact	selectively	on	
genes	involved	in	the	extinction	of	associative	fear	memories.		
To	 test	 the	 specificity	 of	 these	 findings	 to	 schizophrenia-associated	 CNVs,	 a	 control	
analysis	was	performed	observing	the	enrichment	of	each	learning-related	gene	set	in	
the	CNVs	of	patients	with	melanoma.	Using	logistic	regression	analysis,	no	enrichment	
of	consolidation-,	retrieval-	or	extinction-related	genes	 in	melanoma-associated	CNVs	
was	measured	(consolidation	P	=	0.59;	retrieval	P	=	1.0;	extinction	P	=	1.0;	Bonferroni-
corrected;	Table	3.2).		
In	 order	 to	 explore	 this	 association	 between	 extinction-regulated	 genes	 and	
schizophrenia	CNVs	 further	and	to	 identify	specific	genes	driving	 the	association,	 the	
contribution	of	 individual	genes	was	assessed.	Single-gene	 logistic	regression	analysis	
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was	 performed	 on	 each	 extinction-related	 gene	 from	 the	 top	 5%.	 The	 statistical	
association	of	a	gene	with	extinction	was	a	significant	predictor	of	the	gene’s	enrichment	
in	CNVs	of	patients	with	schizophrenia	(R2	=	0.087,	F(1,141)	=	13.49,	P	=	0.0003;	Figure	3.4).	
Even	within	the	top	1%	extinction-related	genes,	this	association	was	maintained	(R2	=	
0.15,	F(1,29)	=	5.3,	P	=	0.029;	Figure	3.4,	inset).		
A	number	of	the	genes	contributing	to	this	enrichment	have	already	been	implicated	in	
schizophrenia	through	CNV	studies	(Table	3.3):	MFI2,	CLDN5,	ATP10A,	SNRPN,	CGNL1	
and	 PDZK1	 (Goodbourn	 et	 al.,	 2014;	 Rees	 et	 al.,	 2014a,	 2014b).	 A	 further	 three	
extinction-related	 genes	 have	 been	 implicated	 through	 genome-wide	 association	
studies:	ERCC4,	GALNT10	and	SLC39A8	(Ripke	et	al.,	2014).		 	
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Figure	3.1	Distinct	groups	of	genes	are	associated	with	different	components	of	fear	memory	processing.	
Represented	here	is	the	overlap	of	the	top	5%	genes	by	significance	of	differential	expression	in	the	CA1	
region	of	the	hippocampus	two	hours	after	each	learning	phase.	Only	one	gene	was	common	to	all	three	
gene	sets	(ICOS).	The	degree	of	overlap	is	no	greater	than	chance	levels	(consolidation	vs	retrieval	P	=0.85,	
consolidation	vs	extinction	P	=	0.39,	retrieval	vs	extinction	P	=	0.29	in	Fisher’s	exact	test).	
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Figure	3.2	Extinction-related	genes	are	enriched	in	CNVs	from	patients	with	schizophrenia.	(a)	The	top	
5%	genes	differentially	expressed	following	fear	extinction,	but	not	consolidation	(Consol)	or	retrieval,	
are	overrepresented	 in	schizophrenia	CNVs	vs	control	CNVs	(P	=	3.9	×	10-4).	Bars	represent	-log10(P-
value)	after	 logistic	regression	enrichment	analysis	and	Bonferroni	P-value	correction.	 (b)	Deletions	
from	schizophrenic	patients	alone	show	an	overrepresentation	of	 fear	extinction-related	genes	(P	 =	
0.0034,	Bonferroni	corrected).	(c)	The	enrichment	of	fear	extinction-related	genes	in	duplications	from	
schizophrenic	patients	is	significant	(P	=	0.042,	Bonferroni	corrected)	yet	weaker	than	in	deletions.	(a-
c)	Dotted	line	represents	a	P=0.05	threshold	for	statistical	significance	
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Figure	3.3	Secondary	CNV	enrichment	analyses	performed	over	the	top	1,	2,	5,	10,	15,	20	and	25%	genes	
associated	with	consolidation,	retrieval	and	extinction	of	fear	memory.	Points	represent	-log10(P-value)	×	
sgn(Z-value).	(a-c)	Prior	to	P-value	correction,	enrichment	becomes	more	significant	with	gene	set	size.	(d)	
The	statistical	association	of	a	gene	set	with	case	CNVs	was	proportional	to	the	gene	set	size.	All	genes	
were	permuted	2000	times,	each	time	yielding	random	gene	sets	from	the	top	1-25%.	This	data	was	used	
to	 correct	 P-values	 obtained	 from	 the	 secondary	 analyses	 of	 the	 experiment.	 Boxplots	 display	 the	
minimum,	 first	 quartile,	 median,	 third	 quartile	 and	maximum	 -log10(P-value)	×	 sgn(Z-value)	 following	
logistic	regression	analyses.	 (e-g)	Enrichment	of	the	top	1-25%	learning-related	genes	following	P-value	
adjustment	by	permutation	 correction.	Only	the	top	1-5%	extinction-related	gene	sets	are	enriched	 in	
schizophrenia-related	CNVs.	(d-g)	Dotted	line	represents	a	P=0.05	threshold	for	statistical	significance.	
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Extinction	gene	
set	
CLOZUK	
P	
GAIN	
P	
ISC	
P	
Top	1%	 0.00067	 0.029	 0.041	
Top	2%	 0.0056	 0.11	 0.043	
Top	5%	 0.00030	 0.18	 0.11	
	
Table	3.1	The	enrichment	of	extinction-related	genes	in	schizophrenia	patient	CNVs	exists	in	each	cohort	
independently.	The	top	1,	2	and	5%	extinction-related	genes	were	analysed	for	enrichment	in	each	CNV	
dataset	using	logistic	regression	analysis.	Sample	sizes:	CLOZUK	6,307	cases,	10,675	controls;	MGS	2,215	
cases,	2,556	controls;	ISC	3,395	cases,	3,185	controls.	
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Gene	set	 All	CNVs	 Deletions	 Duplications	
P	 Padj	 P	 Padj	 P	 Padj	
Consolidation	 0.20	 0.59	 0.62	 1.0	 0.17	 0.50	
Retrieval	 0.50	 1.0	 0.34	 1.0	 0.68	 1.0	
Extinction	 0.75	 1.0	 0.09	 0.28	 0.56	 1.0	
	
Table	3.2	No	learning-related	gene	sets	were	enriched	in	the	CNVs	of	patients	with	melanoma.	The	top	
5%	learning-related	genes	were	subjected	to	enrichment	analysis	in	melanoma	CNVs	from	the	CLOZUK2	
control	dataset,	using	 logistic	 regression	analysis.	Displayed	are	uncorrected	and	Bonferroni-corrected	
(Padj)	 P-values	 representing	 the	 association	 between	 consolidation-,	 retrieval-	 and	 extinction-related	
genes	and	all	melanoma	CNVs,	as	well	as	deletions	and	duplications	separately.		
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Figure	3.4	Within	the	top	5%	extinction-related	genes,	those	more	strongly	associated	with	extinction	
learning	are	also	more	enriched	in	schizophrenia	case	CNVs	(R2	=	0.087,	F(1,141)	=	13.49,	P	=	0.0003).	This	is	
also	true	within	the	top	1%	extinction-related	genes	(R2	=	0.15,	F(1,29)	=	5.3,	P	=	0.029;	inset).	Dots	represent	
-log10(P-value)	of	the	significance	of	differential	expression	following	extinction	learning	regressed	against	
-log10(P-value)	×	 sgn(Z-value)	of	 the	enrichment	 in	 case	CNVs	 following	 single-gene	 logistic	 regression	
analysis.	 Outliers,	 which	 were	 excluded	 from	 analysis,	 are	 displayed	 in	 blue.	 Genes	 that	 gave	 no	
contribution	to	the	model	were	excluded	from	this	analysis	and	are	not	displayed.		
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Gene	
symbol	
Gene	
ID	
Gene	
name	
Region	 Mutation	
type	
Extinction	
P	
Case	
hits	
Control	
hits	
CNV	enrich	
P	
ATP10A	 57194	 ATPase	class	V	type	10A	 15q11.2-13.3	 Duplication	 0.007	 10	 1	 0.4	
CGNL1	 84952	 Paracingulin	 15q21.3	 Duplication	 0.001	 52	 29	 0.0001	
CLDN5	 7122	 Claudin	5	 22q11.2	 Deletion	 0.002	 47	 14	 0.2	
MFI2	 4241	 Melanotransferrin	 3q29	 Deletion	 0.00005	 10	 1	 0.04	
PDZK1	 5174	 PDZ	domain	containing	1	 1q21.1	 Del	/	Dup	 0.004	 66	 57	 0.1	
SNRPN	 6638	 Small	nuclear	ribonucleoprotein-associated	protein	N	 15q11.2-13.3	 Duplication	 0.03	 11	 2	 0.6	
ERCC4	 2072	 Excision	repair	cross-complementation	group	4	 16p13.12	 SNP	 0.004	 0	 0	 NA	
GALNT10	 55568	 Polypeptide	N-acetylgalactosaminyltransferase	10	 5p33.2	 SNP	 0.00009	 1	 0	 0.89	
SLC39A8	 64116	 Solute	carrier	family	39	member	8	 4q24	 SNP	 0.03	 0	 0	 NA	
	
Table	3.3	Extinction	learning-related	genes	within	loci	previously	implicated	in	schizophrenia	through	CNV	studies	(deletions	or	duplications)	and	genome-wide	association	
studies	 (single-nucleotide	polymorphisms,	 SNP).	Gene	 symbols,	 gene	 IDs	 (Entrez)	and	 regions	 listed	pertain	 to	 the	Homo	sapiens	genome.	 “Extinction	P”	 relates	 to	 the	
significance	of	differential	expression	following	extinction	learning.	“CNV	enrich	P”	relates	to	the	significant	of	the	single-gene	enrichment	in	schizophrenia-associated	CNVs.	
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3.3 Comparing	the	enrichment	of	learning-related	genes	in	CNVs	from	
patients	with	schizophrenia,	autism,	ADHD	and	intellectual	disability	
3.3.1 Methods	
Gene	 sets	 relating	 to	 consolidation,	 retrieval	 and	 extinction	 were	 unchanged	 from	
above.	
3.3.1.1 Collating	patient	CNV	data	and	quality	control	
Autism-associated	CNVs	 (2446	 cases,	 2640	 controls)	were	obtained	 from	 the	Autism	
Genome	 Project	 (Pinto	 et	 al.,	 2014).	 Intellectual	 disability-associated	 CNVs	 were	
obtained	from	two	sources:	15767	cases	from	Signature	Genomic	Laboratories	(Cooper	
et	 al.,	 2011)	 and	 15749	 cases	 from	 International	 Standards	 for	 Cytogenomic	 Arrays	
consortium	(Kaminsky	et	al.,	2011).	The	latter	source	contained	CNVs	associated	with	
various	intellectual	and	developmental	disabilities,	from	which	608	CNVs	from	patients	
whose	Subject	Phenotype	contained	the	words	“Intellectual	disability”	were	selected.	
Control	CNVs	for	the	intellectual	disability	analyses	were	taken	from	the	MGS,	ISC	and	
CLOZUK	 control	 cohorts	 (16416	 controls).	 ADHD-associated	 CNVs	 (1508	 cases,	 3057	
controls)	were	obtained	from	the	International	Multi-Centre	for	ADHD	Genetics	(IMAGE)	
2	project	and	a	UK	Cardiff	Study	(Thapar	et	al.,	2015).	CNVs	were	annotated	(Pinto:	Build	
36,	Cooper	and	Kaminsky:	Builds	36/37,	ADHD:	Build	36)	and	subjected	to	quality	control	
and	filtering	as	above.	
3.3.2 Results	
CNV	datasets	from	patients	with	ADHD,	autism,	schizophrenia	and	intellectual	disability	
were	subjected	to	the	same	filtering	and	quality	control	procedures,	as	described	in	the	
methods.	 Past	 studies	 have	 shown	 variations	 in	 CNV	 frequencies	 and	 sizes	 among	
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patients	with	different	psychiatric	diseases	(Malhotra	and	Sebat,	2012).	Therefore,	to	
make	a	comparison	of	these	CNV	datasets,	the	CNV	size	distributions	for	each	disorder	
were	 examined	 (Figure	 3.5).	 CNVs	 from	 patients	 with	 intellectual	 disability	 were	 on	
average	much	 larger	 than	 CNVs	 from	 control	 subjects	 (P	 <	 2.2	×	 10-16,	 independent	
Mann-Whitney	U	test;	Figure	3.5).		Moreover,	the	frequency	of	large	CNVs	(>1	Mbp)	was	
significantly	greater	in	intellectual-disability	CNVs	compared	to	controls	(P	<	2.2	×	10-16,	
Binomial	test).	These	observations	are	in	keeping	with	previous	studies	(Girirajan	et	al.,	
2011),	although	may	also	be	a	reflection	of	the	CNV	detection	methods.	
The	top	1-25%	learning-related	gene	sets	were	subjected	to	logistic	regression	against	
each	CNV	dataset.	 In	order	to	correct	the	P-values	obtained	from	these	analyses,	the	
same	14000	permutation-generated	gene	sets	were	tested	for	enrichment	in	the	CNVs	
associated	 with	 each	 disorder,	 giving	 distributions	 of	 P-values	 that	 were	 used	 for	
permutation	correction.	The	top	1-25%	consolidation-,	retrieval-	and	extinction-related	
genes	showed	no	enrichment	in	CNVs	from	patients	with	ADHD,	autism	or	intellectual	
disability	(P	>	0.05	following	permutation	correction	in	all	instances;	Figure	3.6).	The	only	
significant	enrichment	observed	was	that	of	the	top	1-5%	extinction-related	genes	in	the	
CNVs	of	patients	with	schizophrenia	(Figure	3.6),	as	described	previously	(Figure	3.3).		 	
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Figure	3.5	The	size	distribution	of	CNVs	from	patients	with	different	psychiatric	diseases.	CNVs	associated	
with	intellectual	disability	(ID)	are	considerably	larger	than	those	from	healthy	control	subjects	or	patients	
with	ADHD,	autism	and	schizophrenia.	Control	CNVs	were	taken	from	the	ISC,	MGS	and	CLOZUK	control	
subjects.	CNV	size	is	plotted	on	a	logarithmic	scale	following	the	exclusion	of	CNVs	<	100	kb.	It	should	be	
noted	 that	 variations	 in	 the	 CNV	 identification	 methods	 between	 CNV	 datasets	 may	 influence	 the	
distribution	of	observed	CNV	sizes.	
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Figure	3.6	The	enrichment	of	 learning-related	genes	 in	the	CNVs	of	patients	with	different	psychiatric	
diseases.	Only	the	top	1-5%	extinction-related	gene	sets	are	enriched	in	schizophrenia-related	CNVs.	For	
each	CNV	dataset,	enrichment	analysis	was	performed	over	the	top	1,	2,	5,	10,	15,	20	and	25%	genes	
associated	with	consolidation,	retrieval	and	extinction	of	fear	memory.	Points	represent	-log10(P-value)	
×	sgn(Z-value)	following	permutation	correction.	Dotted	lines	represents	a	P=0.05	threshold	for	statistical	
significance.	
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3.4 The	enrichment	of	learning-related	genes	in	schizophrenia-
associated	common	variants	
3.4.1 Methods	
Two	different	analysis	methods	were	used	to	 investigate	the	enrichment	of	 learning-
related	genes	in	schizophrenia-associated	common	variants:	PLINK	and	MAGMA.	For	all	
analyses,	gene	sets	were	the	top	1,	2,	5,	10,	15,	20	and	25%	consolidation-,	retrieval-	
and	extinction-related	genes.	
3.4.1.1 Sample	
SNP	data	from	schizophrenia	patients	and	controls	was	obtained	from	the	Psychiatric	
GWAS	Consortium	(PGC)	repository.	The	sample	includes	cases	and	controls	from	UK,	
Ireland,	US,	Bulgaria,	Portugal,	Sweden,	Germany,	Denmark,	Norway,	The	Netherlands	
and	Australia,	with	a	total	of	34,241	cases	and	45,604	controls.		
3.4.1.2 PLINK	enrichment	analysis	
The	SNPs	were	filtered	to	exclude	those	with	an	imputation	score	<	0.8,	a	minor	allele	
frequency	<	1%	and	those	within	the	major	histocompatibility	complex	(MHC)	region.	
Consolidation-,	 retrieval-	 and	 extinction-related	 genes	 were	 converted	 to	 genomic	
locations	using	the	genome	build	37.3	seq_gene37.3.md	file.	1000	Genomes	reference	
files	(http://www.1000genomes.org)	were	used	for	linkage	disequilibrium	calculations.	
Plink’s	“--extract”	function	was	used	to	reduce	the	genome	reference	data	to	regions	
covered	by	genes	analysed	in	the	microarray.	The	“--set-screen”	function	mapped	the	
case-control	 SNPs	 to	 each	 gene	 set	 and	 calculated	 the	 enrichment	 probability.	 Each	
analysis	 yielded	 2	 P-values:	 P1	 and	 P2.	 P2	 is	 obtained	 following	 a	 more	 stringent	
correction.	In	order	to	correct	the	P-values	produced	by	this	analysis,	1000	gene	sets	of	
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random	 size,	 consisting	 of	 genes	 randomly	 selected	 from	 the	 full	 microarray,	 were	
subjected	 to	PLINK	enrichment	analysis,	using	a	supercomputer.	For	each	of	 the	 two	
levels	 of	 P-value	 stringency,	 a	 curve	 was	 fitted	 to	 the	 output	 from	 these	 analyses	
representing	the	expected	P-value	for	a	gene	set	hit	by	a	given	number	of	SNPs,	which	
was	used	to	adjust	the	observed	P-values.	
3.4.1.3 MAGMA	enrichment	analysis	
MAGMA	 (Multi-marker	 Analysis	 of	 GenoMic	 Annotation)	 is	 a	 gene	 set	 analysis	 tool	
developed	 more	 recently	 than	 PLINK,	 and	 provides	 improved	 statistical	 power	 and	
speed	 (de	 Leeuw	 et	 al.,	 2015).	 The	 analysis	 uses	 a	 multiple	 regression	 model	 and	
performs	 single	 gene	 analysis	 in	 conjunction	 with	 the	 gene	 set	 analyses	 for	 added	
flexibility.		
Case-control	 SNP	data	was	annotated	with	gene	 location	using	NCBI	Build	37.3	gene	
locations.	Then	followed	a	gene-wide	analysis,	using	the	1000	Genomes	reference	files	
(as	above)	for	linkage	disequilibrium	calculations.	The	gene	set	analysis	was	performed	
using	the	output	from	the	gene-wide	analysis.	During	this	analysis,	MAGMA	executed	a	
correction	for	false	discovery	rate	using	100,000	data	permutations.	
3.4.2 Results	
Common	variant	enrichment	analysis	performed	using	PLINK	revealed	that	gene	sets	hit	
by	a	greater	number	of	SNPs	tended	to	yield	a	lower	P-value	(Figure	3.7a-d).	P-values	
obtained	from	permuted	gene	sets	fit	the	following	models,	where	n	is	the	number	of	
SNPs	within	genes	from	a	gene	set.	
− log&' (& = 0.0031.'./0/	− log&' (1 = 0.009.'.3'3/	
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However,	 there	was	 high	 variability	 in	 the	P-values	 obtained	 from	 smaller	 gene	 sets	
(Figure	 3.7d).	 These	 models	 were	 used	 to	 correct	 the	 enrichment	 P-values.	 After	
correction,	 there	 was	 no	 significant	 enrichment	 of	 SNPs	 from	 patients	 with	
schizophrenia	in	the	top	5%	genes	associated	with	consolidation,	retrieval	or	extinction	
of	contextual	fear	(Figure	3.7).		
Results	 obtained	 from	 the	 MAGMA	 common	 variant	 enrichment	 analysis	 were	
consistent	 with	 those	 observations	 from	 PLINK.	 No	 learning-related	 gene	 set	 had	 a	
significant	enrichment	of	patient	SNPs	(Figure	3.8).		 	
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Figure	 3.7	 PLINK	 common	 variant	 enrichment	 analysis	 of	 the	 top	 1-25%	 genes	 associated	 with	
consolidation,	retrieval	and	extinction	of	fear	memory.	Gene	set	size	is	proportional	to	the	number	of	SNPs	
hit	 by	 it.	 Data	 represented	 by	 -log10(P1)	 and	 -log10(P2).	 (a-c)	 Enrichment	 analysis	 output	 prior	 to	
permutation	correction.	(d)	Permutation	analysis	output.	1000	gene	sets	of	random	sizes	were	selected	
from	randomly	permuted	genes.	(e-g)	Permutation-corrected	enrichment	values.	Dotted	lines	represent	
a	P=0.05	threshold	for	statistical	significance.	
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Figure	3.8	MAGMA	common	variant	enrichment	analysis	of	the	top	1-25%	consolidation-,	retrieval-	and	
extinction-related	genes.	No	significant	enrichment	of	any	gene	set	was	observed.	Data	represented	by	-
log10(P).	Dotted	lines	represent	a	P=0.05	threshold	for	statistical	significance.	
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3.5 Discussion	
The	results	herein	show	that	CNVs	from	patients	with	schizophrenia	selectively	impact	
on	 genes	 related	 to	 extinction	 learning,	 implying	 that	 these	 structural	 variants	 may	
confer	 vulnerability	 to	 the	 disorder	 by	 effecting	 molecular	 pathways	 involved	 in	
inhibitory-type	learning	and	thereby	contributing	to	psychotic	symptoms	characteristic	
of	schizophrenia.	This	relationship	was	observed	in	schizophrenia-associated	CNVs	only;	
no	enrichment	of	consolidation-,	retrieval-	or	extinction-related	genes	was	observed	in	
CNVs	from	patients	with	autism,	ADHD	or	intellectual	disability,	or	in	common	variants	
from	patients	with	schizophrenia.		
The	 link	 between	 extinction-related	 genes	 in	 hippocampal	 CA1	 and	 schizophrenia	
highlighted	in	this	study	is	consistent	with	previous	work	showing	that	patients	exhibit	
impaired	extinction	of	fear	associations	(Holt	et	al.,	2009)	and	furthers	the	hypothesis	
that	 altered	 associative-	 and,	 specifically,	 inhibitory-type	 learning	 contributes	 to	 the	
manifestation	 of	 schizophrenia	 (Serra	 et	 al.,	 2001;	 Millan	 et	 al.,	 2012).	 It	 also	
corroborates	past	evidence	reporting	irregular	hippocampal	responses	to	fearful	stimuli	
(Schobel	et	al.,	2009),	heightened	activation	of	CA1	(Holt	et	al.,	2012;	Talati	et	al.,	2014)	
and	CA1	synaptic	pathology	(Matosin	et	al.,	2016)	in	the	disorder.		
These	results	extend	past	studies	linking	genes	involved	in	synaptic	plasticity,	associative	
learning	and	contextual	conditioning	to	CNVs	from	patients	with	schizophrenia	(Kirov	et	
al.,	2012;	Pocklington	et	al.,	2015).	In	contrast	to	these	previous	studies,	which	rely	on	
documented	annotation	of	individual	genes,	the	current	analysis	used	gene	sets	derived	
from	experimental	quantification	by	microarray.	This	permits	the	integration	of	genes	
into	the	analysis	whose	function	 is	poorly	understood	and	overcomes	the	knowledge	
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bias	associated	with	traditional	pathway	analyses.	However,	this	approach	is	vulnerable	
to	false	positives,	due	to	the	multiple	testing	involved	in	the	microarray	method,	and	
incorporates	only	a	select	set	of	genes	expressed	at	a	certain	time	point	(2	h)	from	a	
certain	brain	region	(CA1).		
The	 enrichment	 of	 extinction-related	 genes	 in	 case	 CNVs	 was	 observed	 both	 in	 the	
combined	schizophrenia	CNV	dataset	from	three	European	case-control	cohorts,	and	in	
each	cohort	individually,	thereby	providing	internal	replication	and	reinforcement	of	the	
main	finding.	Compared	with	the	CLOZUK	cohort	the	enrichment	was	less	significant	in	
GAIN	and	ISC	cohorts,	and	the	top	5%	extinction	gene	set	(used	for	primary	analyses)	
was	not	 significantly	 enriched	 in	 case	CNVs,	 although	 this	 is	 unsurprising	 due	 to	 the	
smaller	sample	size	of	the	GAIN	and	ISC	case-control	groups.	Interestingly,	within	both	
the	top	5%	and	top	1%	gene	sets,	 the	association	of	 individual	genes	with	extinction	
learning	was	related	to	its	single	gene	enrichment	in	case	CNVs,	whereby	those	more	
strongly	 associated	 with	 extinction	 learning	 were	 also	 more	 enriched	 in	 CNVs	 from	
patients	with	 schizophrenia.	 This	 suggests	 that	 the	main	 finding	extends	beyond	 the	
principle	gene	sets	analyses	to	the	single	gene	level.	It	should	be	noted,	however,	that	
the	potential	co-localisation	of	multiple	genes	from	the	same	gene	set	within	the	same	
CNVs	may	bias	this	single	gene	relationship.		
Extinction-related	genes	were	enriched	in	case	CNVs	when	deletions	and	duplications	
were	analysed	together	and	when	they	were	analysed	separately,	 implying	that	both	
structural	variants	impinge	on	extinction	learning	in	schizophrenia.	However,	since	the	
enrichment	was	most	significant	in	deletions,	these	variants	may	contribute	the	most	to	
inhibitory	learning	impairments.	The	same	learning-related	gene	sets	were	also	tested	
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for	enrichment	in	deletions	and	duplications	from	patients	with	melanoma.	There	was	
no	enrichment	of	consolidation-,	retrieval-	or	extinction-related	genes	in	these	variants	
when	analysed	together	or	separately.	This	result	supports	the	view	that	the	enrichment	
of	 extinction-related	 genes	 in	 schizophrenia-associated	 CNVs	 is	 disease-specific	 and	
unlikely	to	be	a	reflection	of	the	general	properties	of	disease-linked	CNVs.	
Prior	to	permutation	correction,	observed	P-values	were	inflated	by	the	size	of	the	gene	
set	used	 in	the	analysis.	This	was	confirmed	by	the	generation	and	analysis	of	14000	
randomly	permuted	gene	sets,	which	were	used	to	resolve	the	influence	of	gene	set	size.	
The	cause	of	the	statistical	inflation	is	likely	a	background	enrichment	within	those	genes	
which	 were	 possible	 to	 convert	 to	 human	 homologs	 for	 inclusion	 in	 the	 gene	 set	
enrichment	 analyses.	 Hence,	 larger	 gene	 sets	 incorporated	more	 of	 this	 background	
signal	and	tended	to	yield	smaller	P-values.	Those	genes	which	were	possible	to	convert	
to	human	homologs	are	sufficiently	homologous	due	 to	conservation	over	evolution.	
Since	schizophrenia-related	alleles	are	enriched	in	mutation-intolerant	genes	(Pardiñas	
et	 al.,	 2016),	 a	 background	 enrichment	 may	 have	 emerged	 from	 increasing	 the	
concentration	 of	 mutation-intolerant	 genes	 in	 the	 available	 dataset	 during	 the	
conversion	of	rat	to	human	homologs.		
I	did	not	find	a	relationship	between	learning-related	genes	and	CNVs	from	patients	with	
autism,	 ADHD	 or	 intellectual	 disability,	 suggesting	 that	 the	 enrichment	 observed	 in	
schizophrenia-related	CNVs	does	not	extend	to	these	related	psychiatric	disorders.	This	
is	interesting,	considering	the	shared	genetic	risk	and	overlapping	phenotypes	between	
these	disorders	(Lee	et	al.,	2013;	Doherty	and	Owen,	2014),	and	implies	that	despite	the	
shared	 genetic	 risk,	 these	 disorders	 are	 segregated	 by	 clusters	 of	 genetic	 variants	
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impacting	on	specific	cognitive	processes.	Indeed,	the	link	between	associative	learning	
/	 fear	memory	 and	 schizophrenia	 does	 not	 extend	 to	 autism,	 ADHD	 and	 intellectual	
disability	in	the	existing	literature	(Hall	et	al.,	2009;	Holt	et	al.,	2009,	2012;	Pollard	et	al.,	
2012).	Still,	care	should	be	taken	when	comparing	the	results	from	these	cross-disorder	
CNV-enrichment	 analyses	 since	 the	 sample	 sizes	 varied	 considerably.	 Furthermore,	
different	 CNV	 identification	 methods	 were	 used	 in	 each	 study,	 which	 affects	 the	
reliability	 of	 CNV	 calling	 over	 the	 range	 of	 CNV	 sizes.	Whilst	 the	 CNV	 identification	
methods	 were	 matched	 between	 cases	 and	 controls	 of	 the	 same	 analysis	 where	
possible,	this	was	not	true	for	the	intellectual	disability	CNV	cohort,	since	a	matching	
control	cohort	did	not	exist,	which	may	have	created	bias	in	the	enrichment	analysis.		
A	 number	 of	 extinction-related	 genes	 driving	 the	 enrichment	 in	 schizophrenia-
associated	CNVs	are	situated	within	loci	recurrently	implicated	in	schizophrenia.	One	of	
the	 strongest	 contributors	 was	 the	 gene	 Claudin-5	 (CLDN5),	 which	 lies	 within	 the	
recurrent	 CNV	 located	 at	 22q11.2	 and	 is	 a	 component	 of	 tight	 junctions	 (Escudero-
Esparza	 et	 al.,	 2012).	 Interestingly,	 another	 extinction-related	 gene	was	 Paracingulin	
(CGNL1)	 previously	 implicated	 in	 schizophrenia	 through	duplications	 (Levinson	et	 al.,	
2011;	Rees	et	al.,	2014a).	Paracingulin	protein	is	also	a	component	of	tight	junctions	and	
adherens	junctions	where	it	interacts	with	Rho	GTPases	and	actin	filaments	(Paschoud	
et	 al.,	 2012).	 Its	 role	 in	 the	 central	 nervous	 system,	 however,	 is	 yet	 to	 be	 explored.	
Indeed,	 gene	 ontology	 analysis	 revealed	 an	 enrichment	 of	 genes	 involved	 in	 cell	
adhesions	in	the	extinction-related	gene	set	(Scholz	et	al.,	2016).		
There	 was	 no	 enrichment	 of	 extinction-related	 genes	 in	 common	 variants,	 as	
determined	 by	 two	 independent	 analysis	 methods,	 suggesting	 that	 these	 genetic	
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variants	do	not	confer	vulnerability	to	schizophrenia	by	influencing	molecular	pathways	
responsible	for	extinction	learning.	It	is	perhaps	not	surprising	that	the	same	gene	set	is	
not	associated	with	both	CNVs	and	common	variants.	With	the	exception	of	some	broad	
functional	 annotations,	 such	 as	 NMDA	 receptor	 signalling,	 abnormal	 behaviour	 and	
immune	function,	the	overlap	between	pathways	implicated	in	schizophrenia	through	
each	 type	 of	 genetic	 variant	 is	 minimal	 at	 present	 (Harrison,	 2015).	 Furthermore,	
common	 variants	 individually	 confer	 less	 risk	 than	 rare	 variants	 and	 are	 less	 reliably	
attributed	to	specific	genes	(Fromer	et	al.,	2014;	Purcell	et	al.,	2014).	Still,	several	of	the	
genes	 linked	 to	 schizophrenia	 through	 common	 variants	 are	 involved	 in	 plasticity	
processes	 (Ripke	et	al.,	2014)	and	 further	 investigation	of	 common	variants	 in	genes	
associated	with	specific	types	of	learning	and	memory	is	warranted.		
Through	the	integration	of	human	genetic	data	with	gene	expression	data	from	model	
organisms,	 these	experiments	build	upon	previous	 functional	studies	to	yield	a	novel	
insight	into	the	link	between	associative	learning	and	schizophrenia.	These	results	imply	
that	CNVs	may	confer	risk	for	schizophrenia	by	impairing	extinction	learning,	therefore	
contributing	 to	 the	 development	 of	 cognitive	 symptoms	 and	 the	 persistence	 of	
delusional	beliefs.	The	findings	have	implications	for	the	role	of	other	types	of	inhibitory	
learning	 in	 schizophrenia	 and	 corroborate	 current	 hypotheses	 linking	 inhibitory-type	
learning	processes	to	the	disorder	
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Chapter	4: Associative	Learning	by	
Contextual	Fear	Conditioning	
4.1 Introduction	
Altered	 associative	 learning	 and	 related	 plasticity	 processes	 have	 been	 linked	 to	
schizophrenia	through	genomic	studies	(Ripke	et	al.,	2014;	Pocklington	et	al.,	2015)	and	
have	been	proposed	to	contribute	to	the	manifestation	of	positive	symptoms	(Serra	et	
al.,	2001;	Corlett	et	al.,	2009;	Fletcher	and	Frith,	2009;	Hall	et	al.,	2009).	This	chapter	
employs	 the	 contextual	 fear	 memory	 paradigm	 in	 order	 to	 explore	 components	 of	
associative	learning	in	the	context	of	psychiatric	disease.		
4.1.1 Contextual	fear	conditioning	and	extinction	learning	
Fear	 conditioning	 is	 an	 evolutionarily-conserved	 behaviour,	 making	 it	 a	 suitably	
translational	 paradigm	 for	 studying	 the	 regulation	 and	 dysregulation	 of	 aversive	
associative	memories	(Milad	and	Quirk,	2012).	Associative	learning	by	fear	conditioning	
has	 been	 extensively	 studied	 for	 over	 a	 century	 and	 its	 psychology	 has	 been	 well	
characterised	(McGaugh,	1966;	Maren	et	al.,	2013).	As	described	in	the	Chapter	3,	three	
distinct	 component	 processes	 of	 learning	 can	 be	 discerned	 by	 the	 paradigm:	
consolidation	 of	 the	 fear	 memory,	 maintenance	 of	 the	 memory	 after	 retrieval	
(“reconsolidation”)	and	memory	extinction	(Pedreira	and	Maldonado,	2003;	Lee	et	al.,	
2004).	We	also	know	that	each	process	 is	accompanied	by	the	de	novo	expression	of	
distinct	 sets	of	 genes	 (Duvarci	 et	 al.,	 2008;	Mamiya	et	al.,	 2009;	Barnes	et	 al.,	 2012;	
Scholz	et	al.,	2016).		
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Both	the	consolidation	and	extinction	of	a	fear	memory	are	considered	forms	of	new	
learning	(Ochs,	1968),	yet	relate	to	behaviourally	antagonistic	components	of	Pavlovian	
conditioning	(Pavlov,	1927).	Consolidation	is	the	time-delimited	process	that	stabilizes	
an	 association	 between	 a	 neutral	 stimulus	 (conditioning	 stimulus,	 CS)	 and	 an	 event	
(unconditioned	 stimulus,	 US)	 such	 as	 an	 aversive	 footshock	 association	 when	 these	
stimuli	are	contiguous,	so	that	presentation	of	the	CS	elicits	a	conditioned	fear	response.	
Extinction	of	conditioned	fear	typically	occurs	when	the	subject	is	re-exposed	to	the	CS	
in	the	absence	of	the	US	repeatedly	or	for	an	extended	period	of	time.	Extinction	results	
in	the	loss	of	the	conditioned	response.	Importantly,	however,	since	the	consolidated	
CS-US	 association	 can	 be	 recovered	 after	 extinction,	 by	 re-exposure	 to	 the	 US,	 for	
example,	 such	 studies	 indicate	 that	 extinction	 is	 new	 learning	 itself,	 which	 inhibits	
expression	of	the	original	memory	rather	than	erasing	it	(Ochs,	1968;	Rescorla	and	Heth,	
1975;	Bouton,	1993;	Gale	et	al.,	2004).	Poor	retrieval	of	the	extinction	memory,	if	not	
due	to	reinstatement	of	 the	conditioned	fear	memory,	may	be	due	to	a	pathological	
process	 impairing	the	extinction	mechanisms	or	 the	recall	of	 the	CS-no	US	extinction	
memory	(Quirk	and	Mueller,	2008).		
The	potential	to	study	consolidation,	retrieval	and	extinction	processes	independently	
in	rodents	using	single	trials	makes	fear	conditioning	a	reliable	and	clinically	relevant	
behavioural	 paradigm.	 Such	 features	 also	 make	 the	 paradigm	 amenable	 to	 the	
administration	of	pharmacological	agents,	lending	it	potential	for	the	creation	of	models	
of	diseases	characterised	by	impairments	in	fear	learning.		
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4.1.2 NMDA	receptors	in	contextual	fear	memory	and	inhibitory	learning	
Glutamate	is	one	of	the	neurotransmitter	systems	most	frequently	associated	with	the	
aetiology	 of	 schizophrenia,	 along	 with	 dopamine	 and	 GABA.	 One	 of	 the	 strongest	
sources	of	evidence	for	a	role	of	NMDA-type	glutamate	receptors	in	schizophrenia	is	the	
observation	that	NMDA	antagonists,	such	as	phencyclidine	(PCP)	and	ketamine,	induce	
psychotic	and	cognitive	symptoms	characteristic	of	the	disorder	in	healthy	humans	and	
worsen	the	symptoms	of	schizophrenia	patients	(Javitt	and	Zukin,	1991;	Krystal	et	al.,	
1994;	 Newcomer	 et	 al.,	 1999).	 For	 this	 reason,	 PCP	 and	 ketamine	 have	 been	 used	
extensively	in	the	generation	of	animal	models	of	schizophrenia.	Some	work	has	been	
done	 to	 test	 the	 effect	 of	 these	 NMDA	 antagonists	 on	 components	 of	 associative	
learning,	although	the	results	have	been	largely	inconclusive	and	it	has	principally	been	
directed	 at	 cued	 tone-shock,	 amygdala-mediated	 learning,	 rather	 than	 single	 trial	
contextual	fear	conditioning	mediated	by	the	hippocampus.	
Using	 rats,	 Pietersen	 et	 al.	 (2006)	 found	 that	 pre-training	 ketamine	 (16	 mg/kg,	
subcutaneous)	blocked	fear	conditioning	to	a	tone-shock	CS-US	pairing	and	abolished	
the	induction	of	amygdalar	cFos	expression	(Pietersen	et	al.,	2006).	Conversely,	others	
have	found	that	pre-training	ketamine	at	a	lower	dose	(8	mg/kg,	subcutaneous)	or	post-
training	 with	 high-doses	 (four	 injections	 of	 100/50/50/50	 mg/kg	 spaced	 at	 60	 min	
intervals,	 intramuscular	 /	 intraperitoneal)	 had	 no	 effect	 on	 cued	 fear	 conditioning	
(Bolton	 et	 al.,	 2012;	 Groeber	 Travis	 et	 al.,	 2015).	 However,	 ketamine	 (8	 mg/kg,	
subcutaneous)	 or	 microinfusion	 of	 another	 NMDA	 antagonist,	 2-amino-5-
phosphonovaleric	acid	(APV),	to	the	prefrontal	cortex	profoundly	impaired	conditioned	
response	 in	 a	more	 complex	 trace	 conditioning	protocol	 (Gilmartin	 and	Helmstetter,	
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2010;	Bolton	et	al.,	2012).	Bolton	et	al.	(2012)	also	reported	that	a	decrease	in	simple	
contextual	fear	conditioning	by	ketamine	was	not	statistically	significant.	It	is	likely	that	
some	of	the	discrepancy	between	these	studies	can	be	explained	by	dose	variations	or	
complexity	of	the	behavioural	conditioning	task.		
A	 small	 volume	 of	 literature	 exists	 investigating	 the	 effect	 of	 NMDA	 receptor	
manipulation	 on	 inhibitory	 fear	 learning,	 including	 extinction.	 High-dose	 ketamine	
administration	in	rats	following	multiple	extinction	trials	of	cued	fear	conditioning	had	
no	effect	on	subsequent	 freezing	responses	 (Groeber	Travis	et	al.,	2015),	while	post-
extinction	training	PCP	dose-dependently	impaired	the	extinction	of	cued	fear	memory	
(Pollard	 et	 al.,	 2012).	 Interestingly,	 pre-administration	 of	 an	 NMDA	 receptor	 partial	
agonist,	 ᴅ-cycloserine,	 dose-dependently	 facilitated	 the	 extinction	 of	 cued	 fear	
conditioning	(Walker	et	al.,	2002).	Further	evidence	suggests	that	NMDA	antagonism	by	
ketamine	(25	mg/kg,	intraperitoneal)	or	MK-801	can	inhibit	a	second	type	of	inhibitory	
fear	 learning	 known	 as	 latent	 inhibition	 (Razoux	 et	 al.,	 2007;	 Traverso	 et	 al.,	 2012).	
Latent	inhibition	is	a	process	whereby	extensive	prior	exposure	to	the	CS	in	absence	of	
the	US,	before	pairing	of	the	two,	masks	their	association	upon	pairing.	It	 is	plausible	
that	ketamine	acts	to	broadly	impair	inhibitory-type	learning,	which	could	be	a	major	
contributor	to	its	psychotomimetic	effects.		
The	amygdala	 is	 central	 to	 the	expression	of	 conditioned	 fear	 responses,	 through	 its	
projections	 to	 the	 hypothalamus,	 periaqueductal	 grey	 and	 other	 brainstem	 regions	
(Applegate	 et	 al.,	 1982;	 Pitkänen	 et	 al.,	 1997).	 Conversely,	 the	 hippocampus	 is	
responsible	 for	 the	 contextual	 gating	 of	 fear	 conditioning	 to	 an	 explicit	 conditioned	
stimulus	 (Ji	 and	 Maren,	 2007;	 Radulovic	 and	 Tronson,	 2010;	 Tronson	 et	 al.,	 2012)	
Associative	Learning	by	Contextual	Fear	Conditioning	
	
101	
	
through	direct	projections	 to	 the	amygdala	via	 the	pre-limbic	and	 infralimbic	cortical	
areas	 (Hugues	 and	 Garcia,	 2007).	 Hence,	 the	 hippocampus	 is	 able	 to	modulate	 fear	
learning	and	fear	responses.	Since	context	representations	are	an	essential	component	
of	information	retrieval	and	logical	inference	(Maren	et	al.,	2013),	altered	hippocampal	
functioning	may	contribute	to	inappropriate	associative	learning,	which	in	humans	could	
translate	to	delusions	and	paranoia	characteristic	of	schizophrenia.	Indeed,	substantial	
evidence	implicates	hippocampal	abnormalities	and	impaired	contextual	processing	in	
schizophrenia	(Taylor	et	al.,	2012).	Here,	I	measured	the	effects	of	pre-	and	post-training	
ketamine	(8	mg/kg	and	25	mg/kg,	intraperitoneal)	on	the	consolidation	and	extinction	
of	 contextual	 fear	 memory	 in	 rats	 to	 determine	 the	 sensitivity	 of	 excitatory	 and	
inhibitory	associations,	respectively,	to	ketamine.	
4.2 Generating	context-specific	fear	memory		
4.2.1 Methods	
General	methodology	used	for	contextual	fear	conditioning	experiments	is	described	at	
length	in	section	2.4.	
Adult	Lister	hooded	rats	(275-325	g)	were	individually	exposed	to	one	of	two	novel	but	
distinct	contexts	(Context	A	or	Context	B)	 for	a	3	min	conditioning	training	trial.	Rats	
received	a	single	scrambled	footshock	(0.5	mA	for	2	sec)	2	min	after	being	placed	in	the	
novel	context.	Rats	were	then	returned	to	the	home	cages.		
Contextual	fear	memory	and	the	specificity	of	the	memory	was	assessed	by	exposing	
the	 rats	 to	 either	 the	 same	 context	 within	 which	 the	 animal	 was	 conditioned,	 or	 a	
different	context	(n	=	6	per	group),	during	a	short	recall	trial	(2	min),	48	h	later.	Freezing	
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behaviour	 was	 recorded	 and	 assessed	 pre-	 and	 post-shock	 during	 the	 conditioning	
training	and	during	the	recall	trial,	as	an	index	of	fear	behaviour.		
4.2.2 Results	
Application	of	footshock	increased	the	freezing	response	relative	to	baseline	(Pre	US)	
levels	(F(1,	32)	=	480.4,	P	<	0.001,	repeated	measures	RM	ANOVA;	Figure	4.1).	Returning	
the	 rat	 to	 the	 same	 context	 48	 h	 later	 induced	 an	 increase	 in	 conditioned	 freezing	
behaviour	 comparable	 to	 Post	 US	 freezing	 (P	 =	 0.61,	 paired	 t-test;	 Figure	 4.1),	
demonstrating	 the	 recall	 of	 a	 conditioned	 fear	memory.	 If	 the	 rat	was	placed	 into	 a	
different	context	to	where	the	animal	was	conditioned,	the	freezing	compared	to	the	
post-US	response	was	reduced	(P	<	0.01,	paired	t-test;	Figure	4.1).	Thus,	this	behavioural	
paradigm	results	in	fear	memory	recall	and	expression	in	the	conditioned	context	only.		 	
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Figure	4.1	Contextual	fear	conditioning	(CFC)	to	a	footshock	(unconditioned	stimulus,	US).	Recall	of	the	
associative	memory	 generated	 by	 CS-US	 pairing	 is	 specific	 to	 the	 context	 within	which	 the	 animals	 is	
conditioned	and	can	be	extinguished	be	a	long	recall	trial	(10	min),	but	not	a	short	recall	trial	(2	min).	Rats	
placed	into	a	novel	context	received	a	0.5	mA	footshock.	Conditioning	and	recall	trials	were	48	hours	apart.	
Freezing	was	sampled	every	10	sec.	During	the	extinction	trial,	percent	freezing	was	calculated	in	2	min	
bins	(Ext	2-Ext	10).	Data	represented	by	mean	±	SEM	of	percent	freezing	response.	n	=	6-12.	
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4.3 Extinction	of	contextual	fear	memory		
4.3.1 Methods	
Adult	Lister	hooded	rats	(n	=	6)	were	fear	conditioned	as	above.	Forty-eight	h	later,	rats	
were	returned	into	the	same	context	for	a	long	recall	extinction	training	trial	(10	min)	in	
the	absence	of	the	US.	To	test	for	the	extinction	(loss	of	the	conditioned	response),	rats	
were	returned	to	the	conditioning-extinction	context	for	a	2	min	recall	test,	48	h	after	
extinction	training.	Freezing	behaviour	was	recorded	as	previously.		
4.3.2 Results	
Separate	cohorts	of	fear-conditioned	rats	were	replaced	into	the	conditioned	context	
for	either	a	short	recall	trial	(2	min)	or	a	long	recall	trial	(10	min).	Within	the	long	recall	
trial,	 the	 freezing	 response	decreased	over	 time	 (F(2.859,	31.45)	=	22.21,	P	<	0.0001,	RM	
ANOVA;	Figure	4.1).	In	a	subsequent	recall	trial,	48	hours	later,	the	freezing	response	
was	 substantially	 reduced	 compared	 to	 the	 conditioned	 response	 (first	 2	 min	 of	
extinction	training,	Ext	2;	P	<	0.0001,	t-test),	which	represents	extinction	of	the	CS-US	
association	by	the	long	recall	trial.	The	short	recall	trial	did	not	produce	extinction	(P	=	
0.192,	t-test;	Figure	4.1).	
4.4 Investigating	the	effect	of	ketamine	on	the	consolidation	of	
contextual	fear	memory	
4.4.1 Methods	
Adult	male	Lister	hooded	rats	(275-325	g)	underwent	a	single	3	min	conditioning	training	
trial	using	a	footshock	(0.5	mA	for	2	sec	at	2	min).	This	conditioning	trial	was	preceded	
by	 the	 administration	 of	 the	 NMDA	 receptor	 antagonist,	 ketamine	 (ketamine	
hydrochloride,	 Ketaset,	 Henry	 Schein	 Animal	 Health;	 8	 mg/kg	 or	 25	 mg/kg,	
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intraperitoneal	 (IP))	 or	 saline	 vehicle	 (n	 =	 6	per	 group)	 30	min	prior	 to	 conditioning.	
These	doses,	time	scales	and	route	of	administration	were	chosen	in	accordance	with	
previous	studies	(Razoux	et	al.,	2007;	Bolton	et	al.,	2012).	Contextual	fear	memory	was	
tested	in	short	recall	(2	min)	trials	in	up	to	three	subsequent	time	points:	2	days	(Recall	
1),	4	days	 (Recall	2)	and	7	days	 (Recall	3)	post-conditioning.	Ketamine	or	vehicle	was	
administered	30	min	prior	to	the	recall	trials.	Freezing	behaviour	was	recorded	during	
all	training	and	recall	trials.	
4.4.2 Results	
4.4.2.1 High	dose	ketamine	pre-treatment	creates	a	state-dependent	fear	memory	
A	footshock	stimulus	induced	a	robust	freezing	response	in	both	vehicle-	and	25	mg/kg	
ketamine-treated	animals	(F(1,	10)	=	91.63,	P	<	0.0001,	two-way	RM	ANOVA;	Figure	4.2a).	
There	was	no	effect	of	treatment	on	freezing	response	(F(1,	10)	=	1.003e-013,	P	=	1,	two-
way	RM	ANOVA),	indicating	that	ketamine-treated	rats	exhibit	a	normal	level	of	baseline	
freezing	 and	 are	 able	 to	 acquire	 a	 contextual	 fear	 memory	 comparably	 to	 control	
subjects.	In	a	first	test	phase,	48	h	later,	rats	pre-treated	with	25	mg/kg	ketamine	prior	
to	conditioning	displayed	substantially	less	freezing	than	their	control	counterparts	(P	<	
0.0001,	 t-test;	 Figure	 4.2a),	 demonstrating	 that	 these	 animals	 failed	 to	 recall	 a	 fear	
memory	 and	 hints	 towards	 a	 failure	 to	 consolidate	 the	memory	 in	 the	 presence	 of	
ketamine.	 However,	 when	 the	 same	 animals	 were	 re-exposed	 to	 the	 same	 context	
following	the	administration	of	the	same	dose	of	ketamine,	their	freezing	response	was	
not	different	from	control	 levels	 (P	=	0.24,	t-test;	Figure	4.2a).	 In	a	subsequent	recall	
trial,	without	 the	 administration	 of	 ketamine,	 the	 two	 groups	were	 discernible	 once	
more:	 rats	 treated	 with	 ketamine	 prior	 to	 conditioning	 showed	 reduced	 freezing	
Associative	Learning	by	Contextual	Fear	Conditioning	
	
106	
	
compared	 to	 controls	 (P	 <	 0.01,	 t-test;	 Figure	 4.2a).	 These	 results	 suggest	 that	 fear	
conditioning	in	the	presence	of	25	mg/kg	ketamine	induces	a	state-dependent	memory,	
which	is	only	recalled	upon	exposure	to	the	context	following	the	re-administration	of	
ketamine	and	hence	the	return	to	the	previously-experienced	state.		 	
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Figure	4.2	The	effect	of	ketamine	on	contextual	fear	conditioning.	(a)	25	mg/kg	ketamine	induced	the	
generation	of	a	state-dependent	contextual	fear	memory.	Ketamine	(25	mg/kg)	or	saline	vehicle	were	
administered	IP	30	min	before	conditioning	and	recall	trial	2	(indicated	by	arrows).	n	=	6.	(b)	8	mg/kg	
does	not	 induce	 the	 creation	of	a	 state-dependent	 contextual	 fear	memory.	Ketamine	 (8	mg/kg)	or	
saline	vehicle	was	administered	IP	30	min	before	conditioning	and	recall	trials,	indicated	by	arrows.	n	=	
4.	(a,	b)	Data	represented	by	mean	±	SEM	of	percent	freezing	response..	
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4.4.2.2 Low	dose	ketamine	does	not	affect	contextual	fear	conditioning	
I	next	sought	to	probe	the	effect	of	a	lower	dose	of	ketamine	on	memory	consolidation,	
with	 the	 aim	 to	 avoid	 the	 induction	 of	 a	 state-dependent	 memory.	 Rats	 were	
conditioned	following	the	administration	of	8	mg/kg	ketamine	and	were	given	a	recall	
trial	48	h	 later	 following	either	8	mg/kg	ketamine	or	 vehicle.	 There	was	no	effect	of	
treatment	on	the	freezing	response	(F(1,	6)	=	0.8745,	P	=	0.39,	RM	ANOVA;	Figure	4.2b),	
indicating	that	this	dose	of	ketamine	does	not	generate	a	state-dependent	contextual	
fear	memory,	and	retrieval	is	solely	dependent	on	exposure	to	the	physical	context.	
4.5 Investigating	the	effect	of	ketamine	on	the	extinction	of	contextual	
fear	memory	
4.5.1 Methods	
All	rats	underwent	a	3	min	contextual	fear	conditioning	training	trial	by	footshock	(0.5	
mA	for	2	sec	at	2	min),	a	long	recall	trial	(10	min)	2	days	after	conditioning	(extinction)	
and	two	short	recall	trials	(2	min)	at	4	days	and	7	days	after	conditioning.	Ketamine	(8	
mg/kg	 or	 25	 mg/kg)	 or	 saline	 vehicle	 were	 administrated	 either	 30	 min	 before	 or	
immediately	after	trials	(n	=	6	per	group).	Freezing	behaviour	was	recorded	for	all	trials.	
4.5.2 Results	
In	 order	 to	 assess	 the	 effect	 of	 ketamine	 on	 the	 extinction	 of	 fear	 memory,	 rats	
underwent	contextual	fear	conditioning	followed	by	an	extinction	trial	48	h	afterwards.	
Since	25	mg/kg	 induces	a	 state-dependent	memory,	 ketamine	at	 this	dose,	or	 saline	
vehicle,	was	administered	before	both	trials.	In	a	separate	cohort,	8	mg/kg	ketamine	or	
saline	 vehicle	 was	 administered	 prior	 to	 extinction.	 Extinction	 training	 caused	 a	
reduction	 in	 freezing	 behaviour	 over	 time	 in	 all	 treatment	 groups,	 as	 shown	 by	 the	
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difference	in	freezing	response	between	the	first	and	last	2	min	period	of	the	extinction	
trial	(25	mg/kg	P	<	0.0001,	8	mg/kg	P	<	0.0001,	RM	ANOVA;	Figure	4.3a,	b).	Recall	of	the	
extinction	memory	was	 assessed	 following	 the	 administration	 of	 either	 ketamine	 or	
vehicle.	By	comparing	freezing	during	the	last	2	min	of	the	extinction	trial	to	the	first	
recall	trial,	a	statistically	significant	interaction	between	treatment	and	learning	phase	
was	observed,	at	both	doses	(25	mg/kg	F(2,	15)	=	11.59,	P	<	0.001,	8	mg/kg	F(3,	20)	=	3.471,	
P	<	0.05,	RM	ANOVA).	To	improve	the	validity	of	post-hoc	testing,	freezing	responses	
were	normalized	to	those	exhibited	during	the	Post-US	phase	(Figure	4.3c,	d)	and	the	
data	grouped	by	pre-extinction	treatment	(Figure	4.3e,	 f).	 In	recall	 trials,	rats	treated	
with	either	25	mg/kg	or	8	mg/kg	ketamine	prior	to	extinction	exhibited	greater	freezing	
compared	 to	 controls	 (25	mg/kg	P	 <	 0.001;	8	mg/kg	P	 <	 0.01,	 t-tests;	 Figure	4.3e,	 f)	
indicating	 that,	 at	 these	 doses,	 ketamine	 blocks	 the	 extinction	 of	 contextual	 fear	
memory.	At	the	higher	dose,	subsequent	administration	of	a	different	treatment	given	
prior	to	conditioning	reversed	the	elevation	of	freezing	response	(Saline	vs	Ketamine	P	
=	0.42,	t-test;	Figure	4.3e),	presumably	due	to	state-dependency	of	the	fear	memory.	
The	ketamine-induced	impairment	in	fear	extinction	at	8	mg/kg	persisted	in	a	second	
recall	trial	(P	<	0.05,	t-test;	Figure	4.3f).	
In	order	to	investigate	whether	ketamine	impairs	extinction	learning	due	to	its	action	
during	 the	 acquisition	 of	 new	 learning	 or	 because	 of	 its	 action	 during	 the	 memory	
consolidation	processes	that	occur	after	the	trial,	ketamine	(25	mg/kg)	or	vehicle	was	
administered	 immediately	 after	 conditioning	 and	 extinction	 trials.	 Post-conditioning	
ketamine	had	no	effect	on	freezing	during	the	first	two	minutes	of	the	long	recall	trial	
(F(2,	15)	=	0.4050,	P	=	0.17,	ANOVA;	Figure	4.4b),	indicating	that	there	was	no	effect	of	the	
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drug	 on	 memory	 consolidation.	 The	 extinction	 trial	 caused	 a	 decrease	 of	 freezing	
response	in	all	treatment	groups	(F(1,	15)	=	53.62,	P	<	0.0001,	RM	ANOVA).	Post-extinction	
ketamine	had	no	effect	on	total	freezing	during	subsequent	recall	trials	(Recall	1	F(2,	15)	=	
0.07557,	P	=	0.93;	Recall	2	F(2,	15)	=	1.122,	P	=	0.35,	one-way	ANOVA,	normalised	data;	
Figure	4.4b).	These	results	indicate	that	ketamine	impairs	fear	extinction	memory	only	
when	present	during	the	acquisition	of	new	learning.		 	
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Figure	4.3	Ketamine	impairs	the	extinction	of	contextual	fear	memory.	Displayed	are	the	first	(Ext	Start)	
and	last	(Ext	End)	2	mins	of	the	extinction	trial	(10	min).	25	mg/kg	(a,	c,	e)	or	8	mg/kg	(b,	d	,f)	ketamine	or	
saline	vehicle	was	administered	 IP	30	min	before	trials	 indicated	by	red	arrows.	n	=	6.	(a,	c,	e)	In	recall	
trials,	ketamine-treated	rats	received	either	the	same	(Recall	1)	or	different	(Recall2)	administration	to	
that	received	prior	to	conditioning.	The	same	data	is	presented	in	three	ways,	replicated	vertically:	(a,	b)	
Data	represented	by	mean	±	SEM	of	percent	freezing	response.	(c,	d)	Data	normalised	to	Post-US	freezing	
response.	(e,	f)	Data	grouped	by	pre-extinction	saline-	and	ketamine-treatment.			
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Figure	4.4	Post-trial	administration	of	25	mg/kg	ketamine	has	no	effect	on	the	consolidation	or	extinction	
of	contextual	fear	memory.	Displayed	are	the	first	(Ext	Start)	and	last	(Ext	End)	2	mins	of	the	extinction	
trial.	Ketamine	(25	mg/kg)	or	saline	vehicle	was	administered	IP	immediately	after	each	trial,	indicated	
by	arrows.	n	=	6.	(a)	Data	represented	by	mean	±	SEM	of	percent	freezing	response.	(b)	Data	normalised	
to	Post-US	freezing.	
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4.6 Discussion	
One	 of	 the	 biggest	 advantages	 of	 a	 one-trial	 learning	 paradigm	 for	 research	 is	 its	
amenability	to	pharmacological	interrogation.	In	these	experiments,	a	contextual	fear	
conditioning	protocol	is	presented	as	a	reliable	one-trial	learning	paradigm	in	which	rats	
undergo	the	consolidation	of	contextual	fear	memory	in	a	single	CS-US	pairing,	before	
context-dependent	retrieval	of	that	fear	memory	in	a	recall	trial	48	h	later,	as	manifested	
by	quantifiable	freezing	behaviour.	A	single	long	recall	trial	induced	extinction	of	the	fear	
memory,	which	was	confirmed	by	reduced	freezing	in	a	subsequent	recall	trial.		
The	 pharmacological	 experiments	 herein	 show	 that	 systemic	 administration	 of	 the	
NMDA	antagonist,	ketamine,	prior	to	consolidation	generates	a	state-dependent	fear	
memory	at	25	mg/kg	–	that	is,	the	rats	were	better	able	to	recall	association	information	
about	the	context	when	they	were	subjected	to	the	same	internal	context	to	which	the	
information	was	acquired	 in.	 It	has	been	shown	previously	 that	ketamine	can	 induce	
state-dependent	retrieval	(Oberling	et	al.,	1996),	and	indeed	from	use	at	this	dose	and	
route	of	administration	(Aguado	et	al.,	1994).	Just	as	this	result	informed	subsequent	
experiments	herein,	 it	 too	has	 implications	 for	 the	use	of	 this	dose	 in	other	 studies,	
particularly	 those	which	 fail	 to	 control	 for	 state-dependent	effects.	 For	example,	 the	
finding	that	25	mg/kg	intraperitoneal	ketamine	blocked	latent	inhibition	of	conditioned	
fear	(Razoux	et	al.,	2007)	may	be	confounded	by	a	change	of	internal	context	from	CS	
pre-exposure	 to	 CS-US	 conditioning,	 since	 the	 study	 did	 not	 include	 a	 group	
administered	with	ketamine	prior	to	both	learning	phases.		
Ketamine	did	not	affect	the	conditioned	response	when	it	was	administered	before	or	
immediately	after	fear	conditioning,	indicating	that	the	treatment	had	no	effect	on	the	
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acquisition	or	consolidation	of	the	associative	memory.	This	is	consistent	with	the	small	
amount	 of	 existing	 literature	 on	 contextual	 fear	 learning	 (Bolton	 et	 al.,	 2012)	 and	
parallels	the	majority	of	findings	from	cued	fear	learning	(Bolton	et	al.,	2012;	Groeber	
Travis	 et	 al.,	 2015).	However,	 inconsistencies	 in	 dose,	 protocol	 and	 the	potential	 for	
state-dependency	make	it	difficult	to	compare	the	data.		
Acute	ketamine	administration	may	elicit	a	worse	model	of	psychiatric	pathology	than	
chronic	administration.	Amann	et	al	used	chronic	ketamine	to	investigate	the	effect	of	
prolonged	NMDA	receptor	antagonism	on	contextual	 fear	conditioning	 in	mice.	They	
report	that	whilst	two	weeks	of	daily	ketamine	administrations	prior	to	conditioning	had	
no	 effect	 on	 freezing	 response,	 a	 further	 two	 weeks	 of	 chronic	 ketamine	 impaired	
retrieval	of	the	conditioned	memory	(Amann	et	al.,	2009).	Equally,	the	psychotomimetic	
effects	of	NMDA	antagonists	may	be	more	pronounced	when	the	drug	is	administered	
to	 coincide	with	 a	 critical	 developmental	 period.	 Indeed,	 neonatal	 PCP	 treatment	 is	
frequently	used	as	a	model	of	schizophrenia	phenotypes	(Jones	et	al.,	2011;	Clifton	et	
al.,	 2013).	 Consistent	 with	 this	 approach,	 the	 neonatal	 treatment	 of	 mice	 with	 PCP	
impaired	conditioned	fear	when	tested	at	P60	(Yuede	et	al.,	2010).	 It	 is	 important	to	
note,	however,	that	in	humans	a	single	administration	of	ketamine	or	PCP	is	sufficient	
to	 induce	 schizophrenia-like	phenotypes	 (Javitt	 and	 Zukin,	 1991;	 Krystal	 et	 al.,	 1994;	
Newcomer	et	al.,	1999).		
Our	results	indicate	that	ketamine	selectively	impairs	the	extinction	of	contextual	fear	
memory.	This	finding	is	consistent	with	previous	reports	that	NMDA	receptor	activation	
is	required	for	fear	extinction	(Burgos-Robles	et	al.,	2007;	Sotres-Bayon	et	al.,	2007).	This	
finding	was	not	due	to	underlying	effects	of	the	treatment	on	baseline	or	conditioned	
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freezing	 responses,	 since	 there	 was	 no	 difference	 in	 pre-US	 and	 post-US	 freezing	
between	saline-	and	ketamine-treated	groups.	Ketamine	at	25	mg/kg	and	8	mg/kg	did	
not	 influence	within-session	 freezing	 response	during	 the	 long	 recall	 trial,	 suggesting	
that	 ketamine	 has	 no	 effect	 on	 the	 acquisition	 of	 extinction	 learning	 and	 instead	
mediates	 its	 effects	 by	 interfering	 with	 molecular	 processes	 responsible	 for	 the	
subsequent	 “consolidation”	 of	 extinction	 memory.	 However,	 administration	 of	
ketamine	 immediately	 after	 extinction	 training	 did	 not	 induce	 the	 same	 deficit.	
Therefore,	 extinction	memory	 is	 only	 impaired	when	 ketamine	 is	 present	during	 the	
acquisition	of	extinction.	This	is	contradictory	to	reports	of	the	effect	of	ketamine	and	
PCP	administration	following	the	extinction	of	cued	fear	memory	(Pollard	et	al.,	2012;	
Groeber	Travis	et	al.,	2015),	which	may	highlight	mechanistic	differences	between	the	
involvement	of	NMDA	receptors	in	the	molecular	processes	required	for	hippocampal-	
and	amygdalar-mediated	extinction	learning.	
Due	 to	 the	 state-dependent	 effects	 of	 25	 mg/kg	 ketamine	 observed	 previously,	
extinction	experiments	were	performed	on	cohorts	of	rats	that	were	conditioned	in	the	
presence	and	absence	of	ketamine.	The	increase	in	fear	memory	retrieval	in	ketamine-
treated	rats	only	occurred	when	an	equivalent	pre-administration	was	given	to	that	prior	
to	conditioning,	which	was	to	be	expected	given	the	state-dependency.	However,	the	
conditioned	response	was	elevated	regardless	of	whether	the	rats	were	administered	
with	ketamine	prior	to	extinction	and	recall	trials	or	just	extinction,	making	it	unlikely	
that	the	apparent	extinction	deficit	is	explained	by	state-dependency	of	the	extinction	
memory.	In	support	of	this,	8	mg/kg	ketamine,	which	does	not	induce	state-dependent	
retrieval	of	contextual	fear	conditioning,	also	impaired	extinction.		
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Whilst	 this	 is,	 to	 my	 knowledge,	 the	 first	 time	 that	 ketamine	 has	 been	 shown	 to	
selectively	impair	the	extinction	of	contextual	fear	memory,	the	same	25	mg/kg	dose	of	
ketamine	has	been	found	to	impair	inhibitory	fear	learning	in	other	studies.	One	such	
study	 examined	 the	 effect	 of	 ketamine	 on	 latent	 inhibition,	 which	 refers	 to	 the	
weakening	of	a	CS-US	association	due	to	extensive	pre-exposure	to	the	CS	in	the	absence	
of	the	US,	before	conditioning.	In	this	study,	ketamine	administration	prior	to	CS	pre-
exposure	 abolished	 latent	 inhibition	 of	 conditioned	 fear,	 which	 was	 correlated	 with	
increased	 extracellular	 glutamate	 in	 the	 nucleus	 accumbens	 and	 increased	 synaptic	
efficacy	in	the	prefrontal-accumbens	pathway	(Razoux	et	al.,	2007).	The	same	effect	was	
also	 observed	 following	 administration	 of	 the	 NMDA	 receptor	 antagonist	 MK-801	
(Traverso	 et	 al.,	 2012).	 This	 is	 understandable,	 considering	 the	 overlap	 in	molecular	
requirement	 for	extinction	and	 latent	 inhibition	 (Barad	et	al.,	 2004).	 Together,	 these	
results	imply	that	NMDA	antagonism	by	ketamine	and	related	psychotomimetic	drugs	
may	have	a	selective	effect	on	inhibitory	fear	learning	processes.	This	is	consistent	with	
a	substantial	body	of	evidence	proposing	that	altered	inhibitory	learning	may	contribute	
to	the	development	of	psychotic	symptoms	in	schizophrenia	(Serra	et	al.,	2001;	Holt	et	
al.,	2009;	Millan	et	al.,	2012),	as	discussed	previously	(Section	3.5),	and	reinforces	the	
translational	validity	of	rodent	ketamine	administration	as	a	model	of	schizophrenia-like	
phenotypes.		
It	 is	 feasible	 to	 suggest	 that	 rather	 than	 blocking	 extinction	 learning,	 the	 increased	
freezing	 response	 observed	 during	 recall	 is	 instead	 due	 to	 an	 enhancement	 in	 the	
retrieval	of	the	original	CS-US	association.	Indeed,	in	humans,	ketamine	administration	
leads	 to	 stronger	 fear	 conditioning	 (Corlett	 et	 al.,	 2013),	 which	 could	 reflect	 the	
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emergence	 of	 delusional	 beliefs	 in	 schizophrenia.	 However,	 when	 rats	 were	
administered	with	saline	prior	to	extinction	and	8	mg/kg	ketamine	prior	to	retrieval,	the	
freezing	 response	was	 comparable	 to	 animals	 treated	with	 saline	 before	 both	 trials,	
indicating	 that	 ketamine	 had	 no	 effect	 on	 retrieval	 at	 this	 dose.	 Whilst	 the	 same	
comparison	cannot	be	made	for	the	higher	ketamine	dose,	rats	treated	with	25	mg/kg	
prior	to	conditioning	and	retrieval	exhibited	no	greater	freezing	response	than	control	
subjects.	It	appears	therefore,	that	the	effects	of	ketamine	observed	herein	are	due	to	
NMDA	receptor	antagonism	during	extinction	acquisition.		
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Chapter	5: The	Regulation	of	Postsynaptic	
Density	Homer1	Proteins	by	Associative	
Learning	
5.1 Introduction	
As	 addressed	 in	 previous	 chapters,	 converging	 genetic	 evidence	 points	 towards	
postsynaptic	 density	 proteins	 in	 the	 aetiology	 of	 schizophrenia	 (Kirov	 et	 al.,	 2012;	
Fromer	 et	 al.,	 2014)	 and	 particularly	 those	 involved	 in	 the	 regulation	 of	 associative	
learning	(Pocklington	et	al.,	2015).	In	Chapter	3,	an	enrichment	of	genes	involved	in	a	
particular	 component	 of	 associative	 learning,	 extinction,	 in	 CNVs	 from	 patients	with	
schizophrenia	was	 found.	Within	 the	 set	 of	 extinction-related	 genes	was	Homer1,	 a	
protein	 with	 key	 roles	 at	 the	 postsynaptic	 density	 and	 in	 the	 control	 of	 synaptic	
plasticity,	 learning	 and	 memory	 (see	 Literature	 Review	 Section	 1.4).	 Furthermore,	
Homer1	 has	 previously	 been	 linked	 to	 several	 psychiatric	 diseases,	 including	
schizophrenia	(Norton	et	al.,	2003;	Spellmann	et	al.,	2011;	Matosin	et	al.,	2016).	
5.1.1 Postsynaptic	density	Homer	proteins	in	psychiatric	disease,	learning	and	memory	
The	Homer1	gene	codes	for	several	isoforms,	most	of	which	are	long	and	constitutively	
expressed	 whilst	 two	 shorter	 isoforms,	 Homer1a	 and	 Ania-3,	 are	 activity-induced	
immediate	early	genes	(Fagni	et	al.,	2002).	All	Homer1	isoforms	share	the	same	binding	
domain,	 and	hence	have	 common	 targets	 (Hayashi	 et	 al.,	 2009),	 although,	 upon	 the	
recruitment	to	the	postsynaptic	density,	short	Homers	disrupt	interactions	of	the	long	
Homers	 through	 dominant	 negative	 regulation	 (Xiao	 et	 al.,	 1998;	 Kammermeier	 and	
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Worley,	 2007).	 It	 is	 understood	 that,	 through	 this	mechanism,	 Homer1a	 and	 Ania-3	
regulate	mGluR	function	(Tu	et	al.,	1999;	Bertaso	et	al.,	2010;	Sylantyev	et	al.,	2013)	and	
calcium	homeostasis	(Kim	et	al.,	2006;	Huang	et	al.,	2007;	Yuan	et	al.,	2012).		
Homer1	 has	 been	 linked	 to	 schizophrenia	 and	 other	 psychiatric	 disorders.	 Homer1	
protein	is	decreased	in	the	post-mortem	hippocampus	of	patients	with	schizophrenia	
(Engmann	et	al.,	2011)	and	the	frontal	cortex	of	autistic	patients	(Fatemi	et	al.,	2013).	A	
more	recent	study	similarly	found	a	decrease	in	long	Homer1	isoforms	in	post-mortem	
CA1	from	patients	with	schizophrenia,	but	an	increase	in	Homer1a	(Matosin	et	al.,	2016),	
suggesting	that	these	patients	had	a	higher	ratio	of	short	to	long	Homer1	protein	in	this	
hippocampal	 subregion.	 Furthermore,	 Homer1a	 and	 Ania-3	 are	 induced	 rapidly	 by	
psychoactive	compounds	(Szumlinski	and	Kippin,	2008),	such	as	ketamine	(Iasevoli	et	al.,	
2007;	De	Bartolomeis	et	 al.,	 2013)	 and	 cocaine	 (Brakeman	et	 al.,	 1997;	 Zhang	et	 al.,	
2007;	Ghasemzadeh	et	al.,	2009).		
Genetic	 variants	within	 the	HOMER1	 gene	 have	 been	 associated	with	 schizophrenia	
(Norton	et	al.,	2003;	Spellmann	et	al.,	2011)	and	other	psychiatric	disorders	(Rietschel	
et	al.,	2010a;	Kelleher	et	al.,	2012;	Strauss	et	al.,	2012),	although	more	recent	genome-
wide	association	studies	do	not	find	a	link	between	HOMER1	SNPs	and	schizophrenia	
(Ripke	et	al.,	2014).	Still,	Homer1	functionally	interacts	with	proteins	recurrently	linked	
to	schizophrenia,	such	as	FMRP	(Ronesi	et	al.,	2012;	Fromer	et	al.,	2014;	Ripke	et	al.,	
2014),	Arc	(Vazdarjanova	et	al.,	2002;	Kirov	et	al.,	2012)	and	the	calcium	channel	subunit	
CaV1.2	(Huang	et	al.,	2007;	Ripke	et	al.,	2014).		
Alterations	of	short	Homer1	expression	have	been	shown	to	affect	synaptic	strength.	
Overexpression	 of	 Homer1a	 in	 the	 hippocampus	 induces	 a	 glutamate-independent	
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modulation	of	surface	AMPA	receptors	(Hennou	et	al.,	2003;	Sala	et	al.,	2003;	Hu	et	al.,	
2010;	Rozov	et	al.,	2012),	reduced	GluA2	subunit	tyrosine	phosphorylation	(Hu	et	al.,	
2010)	and	blockade	of	long-term	potentiation	(Celikel	et	al.,	2007;	Rozov	et	al.,	2012).	It	
is	considered	that	the	ratio	of	short	to	long	Homer1	in	dendritic	spines	is	a	key	mediator	
of	AMPA	currents	(Gray	et	al.,	2003;	Van	Keuren-Jensen	and	Cline,	2006).	Other	studies	
have	 shown	 that	 hippocampal	 Homer1a	 overexpression	 impairs	 spatial	 working	 and	
reference	memory	 (Klugmann	 et	 al.,	 2005;	 Celikel	 et	 al.,	 2007),	 whilst	 knocking	 out	
Homer1	short	forms	causes	deficits	in	fear	conditioning	(Inoue	et	al.,	2009b;	Mahan	et	
al.,	2012).	However,	the	respective	roles	of	Homer1a	and	Ania-3	in	learning	and	memory	
cannot	yet	be	distinguished.		
Whilst	 there	has	been	 substantial	 investigation	of	 the	 induction	of	Homer1	 isoforms	
following	exposure	to	psychoactive	compounds	(e.g.	Nichols	et	al.,	2003;	Iasevoli	et	al.,	
2007;	de	Bartolomeis	et	al.,	2013)	and	environmental	stressors	(e.g.	Igaz	et	al.,	2004;	Ary	
et	al.,	2007)	 in	rodents,	 fewer	studies	have	focussed	on	 its	expression	after	 learning.	
Hernandez	 et	 al	 (2006)	 demonstrated	 that	 the	 corticostriatal	 expression	 pattern	 of	
Homer1a	varies	with	successive	trial	of	instrumental	learning	(Hernandez	et	al.,	2006).	
More	recently,	Mahan	et	al	(2012)	reported	that	de	novo	Homer1a	expression	occurs	in	
the	hippocampus	and	amygdala	of	mice	following	fear	conditioning	(Mahan	et	al.,	2012).	
However,	the	induction	of	Ania-3	with	learning,	or	the	examination	of	learning	phase-
specific	expression,	such	as	extinction	learning,	of	either	isoform,	has	yet	to	be	studied.			
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5.1.2 Further	dissecting	 the	molecular	correlates	of	associative	 learning:	 the	context	
pre-exposure	facilitation	effect	
In	order	to	explore	the	contribution	from	activity-induced	Homer1	proteins	to	different	
components	of	associative	fear	learning,	I	quantified	the	respective	expression	patterns	
of	Homer1	isoforms	after	the	consolidation,	retrieval	and	extinction	of	conditioned	fear	
memory.	To	enable	further	interrogation	of	the	precise	role	of	these	proteins	in	memory	
consolidation,	I	employed	a	protocol	which	separates	the	contextual	fear	conditioning	
paradigm	into	its	constitutive	parts.	In	the	context	pre-exposure	facilitation	effect	(CPFE)	
protocol,	 learning	 about	 the	 context	 and	 associating	 the	 contextual	memory	with	 a	
footshock	occur	during	separate,	consecutive	training	events.	Since	context	encoding	is	
necessary	for	context	conditioning	(Fanselow,	1990),	only	rats	that	are	pre-exposed	to	
the	 same	 context	 they	 are	 subsequently	 given	 an	 immediate	 shock	 in	 undergo	
associative	 fear	 learning	 about	 the	 context.	 Thus,	 immediate	 early	 gene	 expression	
related	 to	 exposure	 to	 a	 novel	 context	 versus	 the	 context-shock	 association	 can	 be	
quantified	independently	(Fanselow,	1990;	Asok	et	al.,	2013).		
5.2 Determining	the	regulation	of	Homer1	expression	by	contextual	fear	
memory	conditioning	
5.2.1 Methods	
The	 general	 methodology	 for	 contextual	 fear	 conditioning,	 in	 situ	 hybridization	 and	
immunoblotting	is	described	in	full	in	sections	2.4,	2.5	and	2.6,	respectively.	Contextual	
fear	conditioning	behaviour	described	in	section	5.2.1.1	was	performed	by	Dr	K	Thomas	
and	Dr	S	Trent.	The	generation	of	coronal	brain	section	libraries	from	these	animals	was	
performed	in	collaboration	with	Miss	L	Sykes.	
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5.2.1.1 Behaviour	
To	investigate	memory	consolidation-induced	gene	expression	of	Homer1,	adult	Lister	
Hooded	rats	(n	=	6)	were	subjected	to	a	conditioning	training	trial	(3	min	novel	context	
exposure	with	2	sec	0.5	mA	footshock	at	2	min).	Rats	were	killed	by	CO2	inhalation	30	
min,	2	h,	4	h	or	24	h	after	conditioning	(n	=	6	per	group),	in	order	to	capture	the	rapid	
and	slower	induction	of	mRNA	species	and	to	observe	their	regulation	over	time.	Control	
subjects	were	naïve	littermates,	killed	at	the	same	time	of	day	as	those	undergoing	fear	
conditioning.		
Whole	brains	were	immediately	dissected	and	snap	frozen	on	dry	ice	before	storage	at	
-80°C	until	use	in	in	situ	hybridization.	
5.2.1.2 In	situ	hybridization	
Oligonucleotide	probes	were	designed	to	target	specific	mRNA	sequences	of	interest.	
Since	 it	was	necessary	 to	 target	 individual	Homer	 isoforms,	 a	 tool	was	developed	 in	
MATLAB	to	select	optimal	nucleotide	sequences	for	generating	probes.	Table	5.1	shows	
the	oligonucleotide	probes	sequences	that	were	designed	to	target	Homer1a	and	Ania-
3,	as	well	as	a	pan-probe	for	the	 long	 isoforms	of	the	Homer1	gene.	The	rat	Homer1	
mRNA	sequence	used	has	accession	number	NM_031707.	
Coronal	brain	sections	(14	µm)	containing	dorsal	regions	of	the	hippocampus	were	cut,	
thaw-mounted	onto	glass	slides	and	fixed	in	4%	paraformaldehyde	prior	to	dehydration	
in	ethanol	and	storage	in	95%	ethanol	at	4°C,	as	described.	Oligonucleotide	probes	were	
end-labelled	with	35S-dATP,	before	being	hybridised	to	the	tissue	sections	(see	section	
2.5.4).	For	each	subject,	two	sections	were	incubated	with	radiolabelled	probe	whilst	
one	section	was	incubated	with	100X	excess	of	un-labelled	probe,	as	a	negative	control	
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(see	General	Methods).	Bound	radiolabelled	probe,	corresponding	to	mRNA	quantity,	
was	measured	 using	 radiographic	 film.	 Exposure	 times	were	 as	 follows:	Homer1a,	 5	
days;	Ania-3,	10	days;	long	Homer1,	7	days.	Films	were	developed	and	regional	mRNA	
expression	quantified	by	sampling	the	densitometry	from	the	autoradiograph.		 	
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Target	
mRNA	 Oligonucleotide	probe	sequence	
Max	non-
specific	
homology	
Homer1
a	 CATGATTGCTGAATTGAATGTGTACCTATGTGAAAATGGCAATGC	 62%	
Ania-3	 GGTAGGGCGGAGGATTCATGACAGACAATACATGAACTTGGGCAG	 53%	
Long	
Homer1	 CTCTGTCTTGTGGCTGTGCACCGCGTTTGCTTGACTACTAACACA	 47%	
	
Table	 5.1	 Specific	 45mer	 oligonucleotide	 probe	 sequences	 targeting	 Homer1	 isoforms.	 Probes	 were	
designed	with	a	CG:AT	ratio	close	to	1	and	without	long	trains	of	the	same	nucleotide.	Max	non-specific	
homology	 denotes	 the	 maximum	 sequence	 homology	 with	 other	 Homer	 isoforms.	 The	 rat	 Homer1	
accession	number	is	NM_031707.	
	 	
The	Regulation	of	Postsynaptic	Density	Homer1	Proteins	by	Associative	Learning	
	
126	
	
5.2.2 Results	
5.2.2.1 Regional	expression	of	Homer1	
In	situ	hybridization	yielded	quantifiable	autoradiographs,	such	as	those	in	Figure	5.1,	
which	show	the	expression	of	the	short	Homer1	isoforms,	Homer1a	and	Ania-3,	and	the	
long	isoforms	(Homer1b/c/f/g)	across	coronal	sections	of	rat	brain	at	approximately	-3.5	
mm	posterior	to	bregma.	Each	isoform	is	strongly	expressed	in	cortical	and	hippocampal	
regions	of	 this	 section,	 as	well	 as	 some	areas	 surrounding	 the	basolateral	 amygdala.	
Within	the	hippocampus,	Homer1	isoforms	are	expressed	strongly	throughout,	with	the	
exception	of	Homer1a,	which	shows	weak	expression	in	the	dentate	gyrus	(Figure	5.1).	
These	expression	patterns	are	consistent	with	those	observed	previously,	using	similar	
methods	(Iasevoli	et	al.,	2010).		 	
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Figure	5.1	Regional	expression	of	Homer1	isoforms.	Coronal	sections	of	rat	brain	taken	from	approximate	
location	 from	 bregma:	 -3.5	 mm	 posterior.	 Short	 isoforms,	 Homer1a	 and	 Ania-3,	 and	 long	 isoforms,	
Homer1b/c/f/g,	are	expressed	throughout	hippocampal	regions	CA1,	CA3	and	dentate	gyrus.	
Homer1a	
Ania-3	
Long	Homer1	
CA1	
CA3	
DG	
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5.2.2.2 Differential	regulation	of	short	and	long	Homer1	isoforms	following	contextual	
fear	memory	training	
During	contextual	fear	conditioning	training,	rats	displayed	robust	post-shock	freezing,	
compared	to	baseline	(P	<	0.001,	t-test;	Figure	5.2).	Hippocampal	expression	of	Homer1	
transcripts	was	visualised	over	24	h	following	the	acquisition	of	contextual	fear	memory	
(Figure	5.3).	Quantitative	analysis	 showed	 that	 the	expression	of	both	 short	Homer1	
isoforms,	Homer1a	and	Ania-3,	was	increased	by	fear	conditioning,	compared	to	naïve	
controls	(effect	of	group:	Homer1a	F(5,	90)	=	21.70,	P	<	0.001;	Ania-3	F(5,	90)	=	30.17,	P	<	
0.001,	 two-way	 ANOVA;	 Figure	 5.4a,b).	 The	 expression	 of	 long	Homer1	 isoforms,	 as	
indicated	by	a	pan-Homer1b/c/f/g	oligonucleotide	probe,	was	unchanged	 from	naïve	
controls	 (F(5,	 90)	 =	 1.31,	 P	 =	 0.27;	 Figure	 5.3,	 Figure	 5.4c).	 For	 Homer1a	 and	 Ania-3	
isoforms,	 there	was	 a	 significant	 effect	 of	 hippocampal	 subregion	 (Homer1a	 F(2,	 90)	 =	
6.30,	P	<	0.01;	Ania-3	F(2,	90)	=	5.34,	P	<	0.01,	two-way	ANOVA),	indicating	that	the	change	
in	Homer1a	and	Ania-3	expression	following	conditioning	was	not	uniform	across	the	
hippocampus.	Post-hoc	tests	indicated	that	Homer1a	expression	was	increased	in	the	
CA1	region	at	30	min	(P	<	0.001,	Dunnett’s	multiple	comparisons	test),	2	h	(P	<	0.05)	and	
4	h	(P	<	0.05)	after	conditioning	and	in	the	dentate	gyrus	at	30	min	only	(P	<	0.001;	Figure	
5.4a),	but	not	CA3.	Conversely,	Ania-3	expression	was	increased	in	all	three	hippocampal	
regions,	 yet	 solely	 at	 the	 30	 min	 time	 point:	 CA1	 (P	 <	 0.001,	 Dunnett’s	 multiple	
comparisons	test),	CA3	(P	<	0.05),	dentate	gyrus	(P	<	0.001;	Figure	5.3,	Figure	5.4b).	At	
24	h	after	conditioning,	neither	Homer1a	nor	Ania-3	mRNA	levels	differed	from	control	
in	any	of	the	regions	investigated.		 	
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Figure	5.2	Contextual	fear	conditioning	induced	robust	post-shock	freezing.	Rats	were	exposed	to	a	novel	
context	for	3	min	and	received	a	footshock	after	2	min.	Data	representative	of	all	experimental	groups	
culled	30	min,	2	h,	4	h	and	24	h	after	conditioning	for	in	situ	hybridization	and	immunoblotting	(n	=	6).	
Data	represented	by	mean	±	SEM	percent	freezing.		
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Figure	5.3	Heat	map	hippocampal	autoradiograph	of	representative	mRNA	expression	of	Homer1a,	Ania-
3	and	 long	Homer1	following	contextual	 fear	conditioning.	False-colour	heat	map	 indicates	the	optical	
density	of	the	autoradiograph,	which	represents	the	level	of	gene	expression	in	that	region.	Specifically	
designed	 oligonucleotide	 probes	 were	 radiolabelled	 with	 dATP-35S.	 Times	 indicate	 the	 duration	 after	
contextual	fear	conditioning	that	the	animals	were	culled	and	the	brains	dissected.	Note	that	the	method	
does	not	allow	one	to	compare	the	relative	expression	levels	of	genes	of	interest	in	a	subregion.	
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Figure	5.4	Hippocampal	mRNA	expression	of	Homer1a,	Ania-3	and	long	Homer1	following	contextual	fear	
conditioning	(CFC).	mRNA	expression	from	the	CA1,	CA3	and	dentate	gyrus	(DG)	regions	is	represented	
by	mean	±	SEM	standardised	optical	density	values,	standardised	to	naïve	controls	(100%).	Brains	were	
dissected	30	min,	2	h,	4	h	or	24	h	after	conditioning.	n=6	per	group.	Asterisks	represent	significance	of	
group	vs.	naïve	control	(*P	<	0.05,	**P	<	0.01,	***P	<	0.001).	
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5.3 The	regulation	of	short	Homer1	isoforms	by	novelty	exposure	
5.3.1 Methods	
In	order	 to	determine	Homer	expression	 following	uniquely	 the	exposure	 to	novelty,	
Lister	 Hooded	 rats	 (n	 =	 6)	 were	 placed	 in	 a	 novel	 context	 for	 3	 min	 without	 the	
administration	 of	 a	 footshock.	 Subjects	 were	 killed	 by	 CO2	 inhalation	 30	 min	 after	
context	exposure.	These	were	compared	to	a	cohort	of	naïve	rats	(n	=	6),	as	well	as	rats	
which	had	undergone	a	conditioning	training	trial	and	killed	at	the	same	time	point	(n	=	
6).	Whole	brains	were	immediately	dissected	and	snap	frozen	on	dry	ice	before	storage	
at	 -80°C.	 In	 situ	 hybridization,	 targeting	 Homer1a,	 Ania-3	 and	 long	 Homer1,	 was	
performed	as	above.		
5.3.2 Results	
The	 previous	 experiments	 show	 that	 both	 Homer1a	 and	 Ania-3	 are	 induced	 in	 the	
hippocampus	 by	 contextual	 fear	 conditioning.	 Since	 this	 procedure	 involves	 the	
exposure	of	the	animal	to	a	novel	context,	and	past	studies	have	shown	Homer1a	to	be	
upregulated	by	novelty	alone	(Vazdarjanova	et	al.,	2002),	the	expression	of	Homer1a	
and	 Ania-3	 was	 compared	 30	 min	 after	 novelty	 and	 fear	 conditioning	 in	 separate	
cohorts.	I	again	show	that	contextual	fear	conditioning	induced	the	expression	of	both	
short	Homer1	isoforms,	compared	to	naïve	controls	(effect	of	group:	Homer1a	F(1,	30)	=	
20.26,	P	<	0.001;	Ania-3	F(1,	30)	=	27.08,	P	<	0.001,	two-way	ANOVA).	Exposure	to	a	novel	
context	for	3	min	was	sufficient	to	induce	the	expression	of	Homer1a	(effect	of	group:	
F(1,	30)	=	35.95,	P	<	0.001,	two-way	ANOVA)	and	Ania-3	(F(1,	30)	=	25.98,	P	<	0.001),	but	not	
the	long	Homer1	isoforms	(F(1,	30)	=	2.62,	P	=	0.12).	Novelty	exposure	increased	Ania-3	
expression	in	each	hippocampal	subregion	(CA1	P	<	0.001,	CA3	P	<	0.05,	DG	P	<	0.05,	
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Tukey’s	multiple	comparisons	test;	Figure	5.5b),	while	Homer1a	was	induced	in	the	CA1	
(P	<	0.001)	and	dentate	gyrus	(P	<	0.001),	but	not	 in	CA3	(P	=	0.43;	Figure	5.5a).	The	
change	in	hippocampal	Ania-3	expression	did	not	differ	between	the	fear	conditioned	
and	novelty-exposed	groups.	 Interestingly,	novelty	exposure	alone	 induced	a	greater	
expression	of	Homer1a	 in	the	dentate	gyrus	than	fear	conditioning	(P	<	0.05,	Tukey’s	
multiple	comparisons	test).		 	
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Figure	5.5	mRNA	expression	of	Homer1a,	Ania-3	and	long	Homer1	following	exposure	to	a	novel	context	
or	 contextual	 fear	 conditioning	 (CFC).	mRNA	 expression	 is	 represented	 by	mean	±	 SEM	 standardised	
optical	density	values,	standardised	to	naïve	controls	(100%).	Brains	were	dissected	30	min	after	context	
exposure.	n	=	6	per	group.	Asterisks	represent	significance	of	group	vs.	naïve	control	(*P	<	0.05,	**P	<	
0.01,	***P	<	0.001).	Hash	symbol	represents	significance	of	group	vs.	novelty	(#P	<	0.05).	
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5.4 Determining	the	regulation	of	Homer1	expression	using	the	Context	
Pre-exposure	Facilitation	Effect	(CPFE)	behavioural	model	of	contextual	
fear	conditioning	
5.4.1 Methods	
In	 an	 immediate	 shock	 paradigm,	 Lister	 Hooded	 rats	 were	 exposed	 to	 one	 of	 two	
different	contexts,	context	A	or	context	B,	for	20	min/day	for	three	consecutive	days,	in	
order	to	familiarise	the	animals	to	one	context.	On	the	fourth	day,	rats	were	placed	into	
either	their	familiar	context	or	the	novel	context.	One	group	(n	=	6)	was	placed	into	the	
familiar	context	(context	pre-exposure	facilitation	effect,	or	CPFE	group)	and	received	a	
footshock	(0.5	mA,	2	sec)	immediately	and	then	removed.	Two	groups	(n	=	6	per	group)	
were	placed	into	the	novel	context	for	the	same	short	duration:	one	group	received	a	
footshock	whilst	the	other	group	did	not.	Groups	were	counterbalanced	between	the	
two	contexts.	Rats	were	killed	by	CO2	inhalation	30	min	after	the	final	context	exposure.	
Control	subjects	were	naïve	littermates.	Whole	brains	were	rapidly	dissected	and	snap	
frozen	on	dry	ice	before	storage	at	-80°C.	In	situ	hybridization,	targeting	Homer1a,	Ania-
3	and	long	Homer1,	was	performed	as	above.		
5.4.2 Results	
In	order	to	determine	whether	Homer1a	or	Ania-3	are	induced	specifically	by	associative	
learning	 or	 by	 the	 novelty	 exposure	 associated	 with	 the	 standard	 contextual	 fear	
conditioning	paradigm	I	used	a	context	pre-exposure	facilitation	effect	(CPFE)	procedure	
to	further	dissect	the	regulation	of	short	Homer1	isoforms	by	training.	Training	was	split	
into	three	components:	brief	exposure	to	a	novel	context	with	no	presentation	of	the	
unconditioned	stimulus	(Novelty);	immediate	footshock	given	upon	exposure	to	a	novel	
context	(Novelty	IS);	brief	exposure	to	a	familiar	context	with	an	immediate	footshock	
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(CPFE).	 Only	 the	 CPFE	 procedure	 is	 sufficient	 to	 generate	 an	 associative	 context-
footshock	 fear	 memory	 (Fanselow,	 1990).	 Thirty	 minutes	 following	 training,	 the	
induction	of	Homer1a	 and	Ania-3	within	 the	hippocampus	was	 subregion-dependent	
(effect	of	brain	region:	Homer1a	F(2,	60)	=	11.62,	P	<	0.001;	Ania-3	F(2,	60)	=	4.60	P	<	0.05).	
Compared	to	naïve	controls,	the	expression	of	both	Homer1a	and	Ania-3	was	increased	
following	each	stimulus,	irrespective	of	context-footshock	pairing,	but	only	in	the	CA1	
region	(Homer1a:	Novelty	P	<	0.001,	Novelty	IS	P	<	0.001,	CPFE	P	<	0.01;	Ania-3:	Novelty	
P	<	0.05,	Novelty	IS	P	<	0.01,	CFPE	P	<	0.05,	two-way	ANOVA	with	post-hoc	Dunnett’s	
multiple	comparisons	test;	Figure	5.6).	These	results	imply	that	short	Homer1	isoforms	
are	 induced	 in	 some	 regions	 of	 the	 hippocampus	 by	 constitutive	 events	 of	 the	 fear	
conditioning	procedure,	but	not	by	associative	learning	per	se.	Long	Homer1	isoforms	
remained	unchanged	in	all	experimental	groups.		 	
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Figure	5.6	Hippocampal	mRNA	expression	of	Homer1a,	Ania-3	and	long	Homer1	following	a	brief	exposure	
to	a	novel	context	(Novelty),	brief	novel	context	exposure	with	an	immediate	footshock	(Novelty	IS)	and	
brief	exposure	to	a	familiar	context	with	an	immediate	footshock	(context	preexposure	facilitation	effect,	
CPFE).	mRNA	expression	is	represented	by	mean	±	SEM	standardised	optical	density	values,	standardised	
to	naïve	controls	(100%).	Brains	were	dissected	30	min	after	context	exposure.	n	=	6	per	group.	Asterisks	
represent	significance	of	group	vs.	naïve	control	(*P	<	0.05,	**P	<	0.01,	***P	<	0.001).	 	
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5.5 Differential	expression	of	short	and	long	Homer1	isoforms	following	
contextual	fear	memory	retrieval	and	extinction	
5.5.1 Methods	
Associative	 fear	memory	 retrieval	and	extinction	behavioural	 testing	and	subsequent	
generation	of	a	coronal	brain	section	library	were	performed	previously	by	Dr	K	Thomas.	
Rats	were	subjected	to	a	conditioning	training	trial	followed	by	either	a	short	recall	trial	
(2	min)	or	a	long	recall	trial	(10	min),	48	h	later.	Rats	were	killed	by	CO2	inhalation	30	
min	 or	 2	 h	 after	 testing	 (n	 =	 6	 per	 group).	 Conditioned	 control	 rats	 underwent	 a	
conditioning	training	trial	and	were	killed	48	h	later	(n	=	6).	Whole	brains	were	rapidly	
dissected	 and	 snap	 frozen	 on	 dry	 ice	 before	 storage	 at	 -80°C.	 In	 situ	 hybridization,	
targeting	Homer1a,	Ania-3	and	long	Homer1,	was	performed	as	above.		
5.5.2 Results	
In	order	to	investigate	whether	short	Homer1	isoforms	are	induced	in	the	hippocampus	
by	other	contextual	encoding	processes,	gene	expression	was	quantified	after	the	recall	
(retrieval)	 and	 extinction	 of	 contextual	 fear.	 All	 groups	 displayed	 robust	 post-shock	
freezing	(effect	of	time:	F(1,	33)	=	385.5,	P	<	0.001,	two-way	repeated	measures	ANOVA)	
and	extinction	training	induced	a	within-trial	reduction	of	freezing	(P	<	0.001,	paired	t-
test;	Figure	5.7).	Re-exposure	to	the	context	modified	the	expression	of	Homer1a	(effect	
of	group:	F(4,	147)	=	12.05,	P	<	0.001,	two-way	ANOVA)	and	Ania-3	(F(4,	147)	=	20.75,	P	<	
0.001).	For	all	three	targets,	there	was	no	effect	of	brain	region	on	gene	expression,	nor	
was	there	an	interaction	effect.	Following	a	2	min	recall	trial,	which	is	not	sufficient	to	
induce	extinction	(Barnes	and	Thomas,	2008),	Homer1a	expression	was	increased	at	30	
min	(P	<	0.05,	Dunnett’s	multiple	comparisons	test)	and	at	2	h	in	CA1	(P	<	0.001)	and	at	
2	h	only	in	the	dentate	gyrus	(P	<	0.001;	Figure	5.8a).	Conversely,	Ania-3	expression	was	
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upregulated	 at	 30	 min	 in	 all	 three	 hippocampal	 regions:	 CA1	 (P	 <	 0.01,	 Dunnett’s	
multiple	comparisons	test),	CA3	(P	<	0.05)	and	dentate	gyrus	(P	<	0.01;	Figure	5.8b),	but	
not	at	2	h.		
Extinction	 induced	 a	 similar	 pattern	 of	 Homer1a	 and	 Ania-3	 expression.	 Homer1a	
expression	was	increased	in	all	hippocampal	regions	at	30	min	(CA1	P	<	0.01,	CA3	P	<	
0.01,	DG	P	<	0.05,	Dunnett’s	multiple	comparisons	test)	and	2	h	(P	<	0.001	all	instances;	
Figure	5.8a)	after	extinction	training.	Again,	Ania-3	expression	was	solely	increased	at	
30	min,	and	in	all	regions	(CA1	P	<	0.001,	CA3	P	<	0.05,	DG	P	<	0.001;	Figure	5.8b).	There	
were	no	significant	differences	between	the	recall-	and	extinction-induced	expression	
of	either	short	Homer1	isoform	(two-way	ANOVA).	Despite	a	significant	modulation	of	
the	expression	of	the	longer	Homer1	isoforms	by	context	re-exposure	(F(4,	93)	=	12.05,	
P	<	0.01,	 two-way	ANOVA),	 there	were	no	post-hoc	differences	observed	 in	multiple	
comparison	tests	(Dunnett;	Figure	5.8c).		 	
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Figure	5.7	 In	the	retrieval	and	extinction	of	contextual	fear	memory,	rats	displayed	robust	conditioned	
freezing	and	an	extinguished	response	after	 long	recall	(10	min).	Retrieval	and	extinction	(Ext)	training	
took	 place	 48	 h	 after	 conditioning.	 Control,	 “no	 recall”	 animals	 were	 conditioned	 and	 culled	 48	 h	
afterwards.	 Data	 representative	 of	 experimental	 groups	 culled	 30	 min	 and	 2	 h	 after	 retrieval	 and	
extinction	for	in	situ	hybridization	or	immunoblotting	(n	=	12).	Data	represented	by	mean	±	SEM	percent	
freezing	normalised	to	post-unconditioned	stimulus	(US)	levels.	
The	Regulation	of	Postsynaptic	Density	Homer1	Proteins	by	Associative	Learning	
	
141	
	
Figure	5.8	mRNA	expression	of	Homer1a,	Ania-3	and	long	Homer1	in	the	hippocampus	following	the	recall	
or	extinction	of	contextual	fear	memory.	mRNA	expression	is	represented	by	mean	±	SEM	standardised	
optical	density	values,	standardised	to	no	recall	controls	(100%).	Brains	were	taken	30	min	or	2	h	after	re-
exposure.	n	=	6-12	per	group.	Asterisks	represent	significance	of	group	vs.	no	recall	control	(*P	<	0.05,	**P	
<	0.01,	***P	<	0.001).		
	
50
100
150
200
250
%
 N
o 
R
ec
al
l
****
***** ***** *** ****
50
100
150
200
250
%
 N
o 
R
ec
al
l Recall + 30 min
Recall + 2 h
Extinction + 30 min
Extinction + 2 h
** ***
* *
**
***
No recall
CA1 CA3 DG
50
100
150
200
250
%
 N
o 
R
ec
al
l
a. Homer1a
b. Ania-3
c. Long Homer1
The	Regulation	of	Postsynaptic	Density	Homer1	Proteins	by	Associative	Learning	
	
142	
	
5.6 Quantification	of	Homer1a	protein	following	contextual	fear	
conditioning	and	extinction	
5.6.1 Methods	
5.6.1.1 Behaviour	
For	protein	quantification	assays,	separate	cohorts	of	rats	underwent	either	contextual	
fear	conditioning	or	conditioning	training	with	10	min	recall	trial	48	h	later,	in	order	to	
measure	 protein	 changes	 associated	 with	 the	 consolidation	 and	 extinction	 of	 fear	
memory,	respectively.	Rats	were	then	killed	2	h	(n	=	6	per	group)	or	4	h	(n	=	6	per	group)	
after	training.	Conditioning	only	control	subjects	were	naïve	rats	and	extinction	controls	
underwent	conditioning	training	but	no	recall	(killed	48	h	post-conditioning).	
Rats	were	killed	by	CO2	inhalation	and	whole	hippocampi	were	rapidly	micro-dissected	
and	snap	frozen	before	storage	at	-80°C	until	Western	blotting.		
5.6.1.2 Immunoblotting	
For	each	subject,	the	hippocampus	from	one	hemisphere	was	used	to	produce	whole	
tissue	 hippocampal	 homogenates	 and	 the	 contralateral	 hippocampus	 was	 used	 to	
produce	synaptosomal	fractions.	Protein	concentration	per	sample	was	measured	using	
the	 BCA	 assay	 (whole	 tissue	 homogenates)	 or	 the	 Bradford	 assay	 (synaptosomes).	
Samples	 were	 diluted	 to	 standardise	 the	 protein	 concentration	 added	 to	 gels	 for	
electrophoresis	and	15	µl	of	each	diluted	sample	(typically	containing	10-40	µg	protein)	
was	 loaded	 to	 a	 lane.	 Proteins	 were	 transferred	 to	 a	 nitrocellulose	 membrane	 and	
blocked	in	5%	milk	solution	(Amersham	ECL	Prime,	GE	Healthcare,	UK).	The	membrane	
was	incubated	with	anti-Homer1a	polyclonal	rabbit	antibody	(160013,	Synaptic	Systems,	
Germany),	1:1000,	and	either	anti-GAPDH	monoclonal	mouse	antibody	(ab8245,	Abcam,	
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UK;	 whole	 tissue	 homogenates),	 1:5000,	 or	 anti-Calnexin	 polyclonal	 rabbit	 antibody	
(ab22595,	Abcam;	synaptosomes),	1:5000,	overnight	at	4°C.	The	anti-Homer1a	antibody	
targets	the	following	amino	acid	sequence	at	the	C-terminus	of	the	Homer1a	protein:	
HRYTFNSAIMIK.	Since	an	antibody	targeting	Ania-3	does	not	exist	at	present,	protein	
quantification	 could	 only	 be	 performed	 for	 Homer1a.	 After	 washing	 in	 TBST,	 the	
membrane	was	 incubated	with	 1:10000	 goat	 anti-rabbit	 (680	 nm)	 and	 donkey	 anti-
mouse	(GAPDH;	800	nm)	or	donkey	anti-rabbit	(Calnexin;	800	nm)	fluorescent	secondary	
antibodies	 (LI-COR),	 for	1	h	at	 room	temperature	and	washed	 in	TBST	again.	Protein	
bands	were	imaged	and	quantified	using	an	infrared	imaging	system.	Homer1a	quantity	
was	standardised	to	the	housekeeping	gene	of	the	same	lane.	
5.6.2 Results	
With	 the	aim	to	gain	a	greater	 insight	 into	 the	 functional	 induction	of	 short	Homer1	
isoforms	 following	 phases	 of	 contextual	 fear	 learning,	 immunoblotting	 was	 used	 to	
quantify	 protein	 in	 samples	 of	 rat	 hippocampus	 following	 the	 consolidation	 and	
extinction	of	contextual	fear.		
There	 was	 no	 effect	 of	 contextual	 fear	 conditioning	 on	 Homer1a	 protein	 in	 whole	
hippocampal	 fractions	 (F(1,	 18)	 =	 4.265,	 P	 =	 0.054,	 two-way	 ANOVA;	 Figure	 5.9a).	 In	
contrast,	extinction	learning	significantly	modified	Homer1a	protein	(F(1,	20)	=	7.114,	P	<	
0.05).	Post-hoc	tests	showed	that	extinction	increased	Homer1a	protein	at	4	h	(P	<	0.05,	
Sidak’s	multiple	comparisons	test),	but	not	at	2	h	(P	=	0.63;	Figure	5.9c).		
Since	Homer1a	functions	predominantly	at	the	postsynaptic	density,	the	same	protein	
quantification	 assays	 were	 performed	 on	 synaptosome	 fractions	 of	 hippocampal	
samples	 from	 the	 same	 animals	 (i.e.	 the	 contralateral	 hippocampus).	 No	 change	 in	
The	Regulation	of	Postsynaptic	Density	Homer1	Proteins	by	Associative	Learning	
	
144	
	
Homer1a	protein	was	observed	in	hippocampal	synaptomes	following	contextual	fear	
conditioning	(F(1,	20)	=	0.2576,	P	=	0.62;	two-way	ANOVA;	Figure	5.9b)	or	extinction	(F(1,	
20)	=	0.0824,	P	=	0.78;	two-way	ANOVA;	Figure	5.9d).		 	
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Figure	 5.9	 Hippocampal	 Homer1a	 protein	 following	 contextual	 fear	 conditioning	 and	 extinction.	 Rat	
hippocampal	samples	were	homogenised	as	either	whole	tissue	fractions	(a,	c)	or	synaptosomal	fractions	
(b,	d).	Homer1a	protein	quantity	is	represented	by	mean	±	SEM	optical	density	values,	standardised	to	
controls	(100%).	Brains	were	dissected	2	h	or	4	h	after	fear	conditioning	or	extinction.	n	=	6	per	group.	
Asterisks	represent	significance	of	group	vs.	naïve	or	no	recall	control	(*P	<	0.05).	
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5.7 Discussion	
The	 present	 findings	 indicate	 that	 the	 expression	 of	 short	 Homer1	 isoforms	 in	 the	
hippocampus	is	correlated	with	the	processing	of	a	Pavlovian	association	between	the	
conditioned	and	unconditioned	stimuli	concurrent	with	the	contextual	fear	conditioning	
paradigm.	Within	this,	the	relative	expression	of	Homer1a	and	Ania-3	within	different	
subregions	of	the	hippocampus	depended	on	the	type	of	memory	processing	involved.	
Crucially,	in	some	instances,	the	region-specific	regulation	of	Homer1a	differed	to	that	
of	 Ania-3.	 Long	 forms	 of	 Homer1,	 which	 were	 identified	 as	 a	 group	 with	 one	
oligonucleotide	probe,	were	not	regulated	by	contextual	fear	conditioning,	retrieval	or	
extinction	 in	any	hippocampal	 subregion	or	 time	point	measured,	 consistent	with	 its	
previously	reported	constitutive	expression	(Fagni	et	al.,	2002).		
Short	 forms	 of	 Homer1	 mRNA	 were	 increased	 in	 CA1	 following	 contextual	 fear	
conditioning,	hinting	at	a	role	for	Homer1a	and	Ania-3	in	associative	memory	formation.	
Equally,	Homer1a	and	Ania-3	were	regulated	by	3	min	novel	context	exposure,	which,	
in	the	formation	of	a	context	representation,	is	considered	an	associative	learning	event	
(Fanselow,	 1990;	 Matus-Amat	 et	 al.,	 2004).	 Increased	 hippocampal	 Homer1a	 after	
Pavlovian	 fear	 conditioning	 and	 novel	 context	 exposure	 has	 been	 demonstrated	
previously	 (Vazdarjanova	 et	 al.,	 2002;	Mahan	 et	 al.,	 2012).	However,	 I	 show	 that	 an	
increase	in	short	Homer1	CA1	expression	is	induced	by	arousal,	irrespective	of	a	context-
footshock	 pairing.	 Both	 Homer1a	 and	 Ania-3	 mRNA	 was	 elevated	 in	 CA1	 following	
exposure	 to	 the	 novel	 context	 alone	 or	 footshock	 alone.	 Upon	 breaking	 down	 the	
components	of	contextual	fear	conditioning	in	the	CPFE	experiments,	expression	levels	
in	the	only	group	that	engages	associative	learning,	the	CPFE	group,	are	not	different	
The	Regulation	of	Postsynaptic	Density	Homer1	Proteins	by	Associative	Learning	
	
147	
	
from	the	brief	novelty	exposure	or	immediate	shock	groups.	Therefore,	the	regulation	
of	 short	Homer1	 isoforms	 in	 CA1	may	 be	 related	 to	 the	 activity	 associated	with	 the	
processing	of	external	stimuli,	rather	than	the	consolidation	of	associative	fear	memory.		
The	 regulation	 of	 Homer1a	 and	 Ania-3	 in	 the	 dentate	 gyrus	 after	 contextual	 fear	
conditioning	 and	 novelty	 exposure	 is	 more	 likely	 to	 be	 related	 to	 the	 Pavlovian	
associative	events	of	contextual	memory	 formation.	The	expression	of	both	 isoforms	
was	increased	in	the	dentate	gyrus	following	fear	conditioning	training,	but	not	after	an	
immediate	 footshock	 or	 brief	 novelty	 exposure,	 suggesting	 that	 short	 Homer1	
expression	solely	occurs	during	the	pairing	of	the	two.	This	is	consistent	with	the	view	
that	 the	 dentate	 gyrus	 mediates	 the	 formation	 of	 conjunctive	 contextual	
representations	(Morris	et	al.,	2013).	The	lack	of	regulation	in	this	subregion	with	CPFE	
may	be	due	to	the	temporal	separation	of	context	representation	and	context-footshock	
pairing.		
Whilst	homer1a	and	Ania-3	expression	was	induced	by	the	same	stimuli,	their	regulation	
after	contextual	fear	conditioning	exhibited	temporal	and	spatial	differences.	The	most	
striking	 of	 these	 was	 the	 duration	 for	 which	 the	 elevated	 expression	 level	 was	
detectable.	 Regulated	 Ania-3	 expression	 was	 considerably	 more	 transient	 than	
Homer1a,	 in	 all	 hippocampal	 subregions.	 This	 observation,	 which	 is	 previously	
unreported,	 implies	 that	 the	 post-transcriptional	 regulation	 of	 these	 two	 activity-
induced	 isoforms	 occurs	 through	 different	 mechanisms.	 It	 is	 possible	 that	 the	
discrepancy	 occurs	 due	 to	 differences	 in	 metabolic	 processing,	 yet	 may	 also	 have	
functional	implications	for	the	subsequently	translated	proteins.		
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Following	contextual	fear	conditioning,	only	Ania-3	was	regulated	in	CA3.	The	same	was	
observed	 following	 brief	 fear	 memory	 retrieval.	 This	 regional	 discrepancy	 between	
Homer1a	and	Ania-3	implies	that	the	two	isoforms	are	independently	regulated	and	are	
likely	to	play	different	functional	roles	in	long-term	contextual	fear	memory.	Since	CA3	
is	posited	to	participate	in	the	encoding	of	new	representations,	pattern	completion	and	
spatial	 short-term	memory	 (Ji	 and	Maren,	 2008;	 Kesner	 and	 Rolls,	 2015),	 it	may	 be	
hypothesised,	based	on	the	current	observations,	that	Ania-3	has	a	more	predominant	
role	in	such	processes	than	Homer1a.		
Interestingly,	in	contrast	to	the	lack	of	changes	in	CA3	expression	following	contextual	
fear	conditioning	and	retrieval,	Homer1a	was	upregulated	in	CA3	by	extinction	learning,	
suggesting	that	the	expression	of	short	Homer1	isoforms	in	CA3	is	dissociated	by	the	
type	of	associative	memory	process.	This	is	the	first	time	that	evidence	for	a	role	of	short	
Homer	proteins	 in	 extinction	 learning	has	been	presented,	 and	may	 represent	 a	 key	
distinction	between	Homer1a	and	Ania-3	function.	It	also	implicates	Homer1	in	specific	
cognitive	 processes	 relevant	 to	 schizophrenia	 and	 other	 psychiatric	 disorders.	 The	
differential	upregulation	of	Homer1a	 in	CA3	and	dentate	gyrus	may	be	related	to	the	
respective	 pattern	 completion	 and	 pattern	 separation	 processes	 of	 these	 two	
subregions	 (Rolls,	 2016)	 that	 serve	 to	 encode	 the	 context-no	 footshock	 extinction	
memory	(Ji	and	Maren,	2008)	distinct	from	the	context-footshock	memory	supporting	
the	fear	response.		
The	expression	of	mRNA	does	not	guarantee	its	translation	to	functional	protein.	Using	
Western	blot	assays,	I	observed	an	increase	in	Homer1a	protein	in	whole	hippocampal	
samples	4	h	after	extinction	 learning,	but	not	 in	synaptosomal	 fractions	or	after	 fear	
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conditioning.	 Since	 short	Homers	 are	 synthesised	 in	 the	 soma	before	 recruitment	 to	
active	dendritic	spines	(Brakeman	et	al.,	1997;	Okada	et	al.,	2009b),	the	lack	of	protein	
change	in	the	synaptosomal	fraction	after	extinction	may	indicate	that	recruitment	to	
dendritic	spines	is	yet	to	occur	at	the	time	points	observed.	However,	previous	evidence	
suggests	that	Homer1a	can	be	recruited	into	spines	within	4	h	(Okada	et	al.,	2009b).	It	
is	more	likely	that	these	observations	are	due	to	the	recruitment	of	Homer1a	to	too	few	
synapses	in	particular	subregions	of	the	hippocampus	for	detection	within	fractions	of	
all	 synaptosomes	 from	 the	 entire	 hippocampus,	 yet	 sufficient	 surplus	 translation	 in	
somata	for	detection	in	whole	hippocampal	fractions,	by	Western	blot.	The	absence	of	
increased	 Homer1a	 protein	 following	 fear	 conditioning	may	 also	 reflect	 a	 failure	 to	
detect	 small	 changes	 in	 protein	 with	 this	 method,	 yet	 may	 also	 reflect	 functional	
differences	between	Homer1a	and	Ania-3.	Since	an	antibody	against	Ania-3	does	not	
exist	at	present,	it	was	not	possible	to	compare	the	protein	expression	of	the	two	short	
Homer1	 isoforms.	 Considering	 the	 differential	 expression	 of	 the	 mRNA	 in	 each	
subregion	of	 the	hippocampus,	 future	experiments	 should	be	designed	 to	determine	
region-specific	short	Homer1	protein	expression	after	components	of	fear	learning.	This	
approach	 may	 also	 facilitate	 the	 detection	 of	 more	 subtle	 protein	 changes	 from	
concentrating	functionally	relevant	tissue.		
In	conclusion,	the	present	results	build	on	previous	studies	showing	that	short,	activity-
induced	Homer1	immediate	early	genes	are	involved	in	learning	and	memory.	I	present	
novel	findings	showing	that	regulation	of	these	short	Homer1	variants	accompany	the	
retrieval	and	extinction	of	associative	 fear	memories,	 and	 replicate	previous	 findings	
demonstrating	their	expression	after	consolidation.	I	also	demonstrate	for	the	first	time	
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that	Homer1a	and	Ania-3	are	differentially	regulated	in	the	hippocampus	during	learning	
processes	and	may	function	differently	in	long-term	contextual	fear-memory.	It	is	thus	
far	 unclear	whether	 Homer1a	 and/or	 Ania-3	 expression	 is	 required	 for	 processes	 of	
associative	 fear	 learning	 in	 the	 hippocampus.	 These	 data	 pave	 the	 way	 for	 the	
exploration	of	the	respective	roles	of	short	Homer1	isoforms	in	the	consolidation	and	
extinction	of	contextual	fear	memory.	This	is	the	subject	of	Chapter	6	
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Chapter	6: The	Role	of	Short	Homer	
Proteins	in	Fear	Memory	Consolidation	and	
Extinction	
6.1 Introduction	
The	previous	chapter	highlighted	the	differential	regulation	of	Homer1	isoforms	in	the	
hippocampus	by	contextual	 fear	conditioning,	 retrieval	and	extinction.	 I	 showed	 that	
hippocampal	 Homer1a	 and	 Ania-3	 expression,	 but	 not	 long	 Homer1	 expression,	 is	
increased	 following	 each	 of	 these	 phases	 of	 associative	 learning,	 yet	 the	 respective	
expression	 pattern	 of	 each	 isoform	 in	 subregions	 of	 the	 hippocampus	 is	 regulated	
independently.	Moreover,	an	increase	in	Homer1a	protein	was	only	observed	following	
extinction	learning.	However,	 it	 is	still	unclear	whether	the	expression	of	either	short	
Homer1	isoform	is	required	for	associative	learning.	Little	is	known	about	the	functional	
differences	 between	 Homer1a	 and	 Ania-3	 and	 it	 is	 feasible	 that	 their	 roles	 are	
accommodated	 by	 both	 proteins	 and	 therefore	 redundant.	 However,	 their	 distinct	
activity-regulated	expression	profiles	 suggest	 that	Homer1a	and	Ania-3	may	 function	
separately	in	separate	processes.		
Few	studies	have	manipulated	the	expression	of	short	Homer1	isoforms	in	vivo	in	order	
to	 provide	 insight	 into	 their	 role	 in	 learning	 and	 memory.	 Klugmann	 et	 al	 (2005)	
overexpressed	Homer1a	in	the	dorsal	hippocampus	of	rats	using	adeno-associated	virus	
vectors.	These	animals	exhibited	impaired	encoding	in	a	novel	object	recognition	task	
and	impaired	spatial	reference	memory	in	the	Morris	water	maze	task,	both	of	which	
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are	hippocampal-dependent	tasks	(Klugmann	et	al.,	2005).	A	later	study	also	reported	
that	 Homer1a	 overexpression	 in	 the	 dorsal	 hippocampus	 impaired	 spatial	 working	
memory	 in	 a	 Y-maze	 task	 (Celikel	 et	 al.,	 2007).	Most	 recently,	 Banerjee	et	 al	 (2016)	
showed	 that	 overexpression	 of	 Homer1a	 in	 the	 basal	 and	 lateral	 amygdala	 of	 rats	
induced	deficits	in	cued	fear	conditioning	and	social	interaction	(Banerjee	et	al.,	2016).	
Knocking	out	Homer1	short	forms	also	affected	fear	learning.	Homer1a/Ania-3	double	
knockout	mice	exhibited	impaired	cued	fear	conditioning	(Mahan	et	al.,	2012).	In	a	study	
of	 contextual	 fear,	 whilst	 the	 acquisition	 and	 short-term	 recall	 of	 fear	memory	was	
normal	 in	 short	 form-specific	 Homer1	 knockout	 mice,	 long-term	 fear	 memory	 was	
impaired,	suggesting	that	these	animals	have	a	deficit	in	the	consolidation	of	contextual	
fear	 memory	 (Inoue	 et	 al.,	 2009c).	 These	 mice	 also	 displayed	 poor	 fear	 memory	
retention	 and	 reconsolidation	 (Inoue	 et	 al.,	 2009c).	 Hence,	 the	 expression	 of	 short	
Homer1	 isoforms	 appears	 to	 be	 necessary	 for	 hippocampal-dependent	 learning.	
However,	 these	 studies	 do	 not	 address	 the	 potential	 divergence	 of	 the	 functions	 of	
Homer1a	and	Ania-3	in	fear	learning,	nor	their	roles	in	fear	memory	extinction,	another	
form	of	 associative	 learning	 important	 for	 the	 flexibility	 of	 behavioural	 responses	 to	
conditioned	stimuli	(Bouton,	2004).	
I	 thus	 investigated	 the	 effect	 of	 knocking	 down	 hippocampal	 short	 Homer1	 on	 the	
consolidation	and	extinction	of	contextual	fear	memory.	To	do	this,	I	delivered	antisense	
oligonucleotides	specific	to	each	short	Homer1	isoform	via	intracerebral	microinjection	
to	 acutely	 knockdown	 their	 expression	 during	 specific	 training	 phases.	 We	 have	
successfully	used	this	approach	to	show	the	causal	relationship	between	the	expression	
of	specific	genes	and	memory	formation	and	maintenance	(e.g.	Lee	et	al.,	2004;	Trent	
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et	al.,	2015).	The	CA1,	CA3	and	dentate	gyrus	hippocampal	subfields	are	distinguished	
dorsally	and	ventrally	by	distinct	connectivity,	gene	expression	patterns	and	functions	
(Strange	and	Dolan,	1999;	Bannerman	et	al.,	2004,	2014;	Strange	et	al.,	2014).	Whilst	
the	ventral	regions	are	associated	with	motivational	and	emotional	behaviour,	common	
to	other	parts	of	the	temporal	 lobe,	the	dorsal	hippocampus	is	principally	involved	in	
learning	and	memory	in	relation	to	navigation,	locomotion	and	exploration	(Czemiawski	
et	 al.,	 2009;	 Fanselow	 and	 Dong,	 2010).	 Hence,	 the	 experiments	 herein	 targeted	
Homer1a	and	Ania-3	in	the	dorsal	hippocampus.			
Antisense	knockdown	 is	 a	well-established	 technology	 that	has	been	used	 to	 further	
understanding	 of	 gene	 function	 (Stephenson	 and	 Zamecnik,	 1978).	 More	 recent	
advances	 in	 the	 technology	 has	 made	 them	 suitable	 for	 therapeutic	 procedures	 in	
humans	 and	 have	 shown	promise	 for	 the	 treatment	 of	 neurodegenerative	 disorders	
(Evers	et	al.,	2015).	Antisense	oligonucleotides	are	synthetic	single-stranded	nucleotide	
sequences,	which	are	able	to	bind	to	RNA	and	block	their	translation	into	protein.	They	
are	ideal	for	customisation	and	specific	targeting	of	individual	mRNA	variants.	Compared	
to	 alternative	 knockdown	 techniques,	 antisense	 oligonucleotides	 hold	 advantages	 in	
their	use	in	acute	in	vivo	studies,	in	part	due	to	their	short	duration	of	action	(<	24	h)	
and	superior	specificity	(Achenbach	et	al.,	2003;	Watts	and	Corey,	2012).		
6.2 Knockdown	of	Homer1a	by	intracerebral	microinjection	of	antisense	
oligonucleotides	
6.2.1 Methods	
Detailed	methodology	 concerning	 the	 intrahippocampal	microinjection	of	 substances	
can	be	found	in	General	Methods	chapter	section	2.7.		
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6.2.1.1 Antisense	design	
A	specific	antisense	oligonucleotide	sequence,	20	bases	 long,	was	designed	 to	 target	
Homer1a	using	strict	filtering	criteria.	Motifs	known	to	weaken	antisense	activity	were	
avoided	(i.e	GGGG,	ACTG,	AAA	and	TAA),	whilst	motifs	known	to	strengthen	antisense	
activity	were	favoured	(i.e.	CCAC,	TCCC,	ACTC,	GCCA	and	CTCT;	Matveeva	et	al.,	2000).	
Sequences	with	a	high	GC	content	(>	50%)	were	favoured	(Matveeva	et	al.,	2000;	Chan	
et	al.,	2006).	Sfold	(http://sfold.wadsworth.org/)	tool	was	used	for	target	accessibility	
predictions,	binding	energy	optimisation	and	target	visualisation.	Regions	of	the	mRNA	
with	a	high	degree	of	secondary	folding	were	also	favoured.	Oligonucleotide	candidates	
were	 subjected	 to	 BLAST	 analysis	 (www.ncbi.nlm.nih.gov/blast/)	 to	 remove	 those	
sequences	 complimentary	 to	 other,	 non-specific	 mRNA	 targets.	 Selected	 antisense	
oligonucleotides	 were	 synthesised	 (Sigma	 Genosys,	 UK)	 with	 phosphoroththioate	
linkages	between	bases	1	and	2	and	bases	19	and	20,	to	 increase	the	stability	of	the	
oligonucleotides	in	the	tissue,	and	PAGE	purified.		
The	mRNA	coding	sequence	of	Homer1a	has	high	homology	to	other	Homer1	isoforms.	
Therefore,	to	generate	an	antisense	oligonucleotide	with	high	specificity	to	Homer1a,	I	
targeted	the	untranslated	region	of	the	mRNA	strand,	which	is	unique	to	the	Homer1a	
transcription	variant.	An	intronic	sequence	flanking	the	Homer1a	gene	continues	as	a	
three	prime	untranslated	region	in	the	mRNA	for	approximately	4.4	Kb	(Brakeman	et	al.,	
1997;	Kato	et	al.,	1998b;	Bottai	et	al.,	2002).	The	Homer1a	antisense	oligonucleotide	
selected	(5’-AGAAGTCTGACCTGGGATTT-3’)	targeted	this	region	as	shown	in	Figure	6.1.	
A	 missense	 oligonucleotide	 sequence	 was	 designed	 for	 administration	 to	 control	
animals.	 This	 sequence	 was	 comprised	 of	 the	 same	 nucleotides	 as	 the	 antisense	
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oligonucleotide,	yet	was	not	complimentary	to	any	mRNA	sequences	in	BLAST	analysis.	
Clustal	Omega	(http://www.ebi.ac.uk/Tools/msa/clustalo/)	analysis	was	performed	to	
ensure	that	the	missense	and	antisense	oligonucleotide	sequences	would	not	bind	to	
one	another.		 	
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Figure	 6.1	 Homer1a	 antisense	 oligonucleotide	 target	 region	 within	 the	 predicted	 structure	 of	
Homer1a	 mRNA.	 Arrow	 indicates	 target	 location.	 Oligonucleotide	 sequence	 =	 5’-
AGAAGTCTGACCTGGGATTT-3’.	 Sfold	 (http://sfold.wadsworth.org/)	 tool	 was	 used	 for	 target	
accessibility	predictions,	binding	energy	optimisation	and	target	visualisation.	
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6.2.1.2 Surgery	
6	adult	male	Lister	hooded	Rats	underwent	surgery	for	the	placement	of	an	indwelling	
cannula	 into	 the	 dorsal	 hippocampus.	 Anaesthetised,	 rats	 were	 positioned	 in	 a	
stereotaxic	frame	and	two	holes	drilled	through	the	skull	at	the	following	coordinates	
from	 Bregma:	 -3.5	mm	 anterior-posterior,	 ±	 1.9	mm	medial-lateral.	 A	 bilateral	 steel	
guide	cannula	(Plastics	One,	Bilaney	Ltd,	UK)	was	implanted	through	the	holes,	targeting	
the	dorsal	hippocampus	(3	mm	below	the	pedestal).	A	dummy	stylet	extending	1	mm	
from	 cannula	 tips	was	 inserted	 into	 the	 cannula	 until	 use	 for	 injections	 to	 preserve	
cannula	patency.		
6.2.1.3 Intracerebral	microinjection	and	behaviour	
Homer1a	antisense	oligonucleotides	were	diluted	to	2	nmol/µl	in	0.01	M	sterile	PBS	and	
kept	 under	 4°C.	 Awake	 rats	 were	 administered	 with	 unilaterally	 with	 antisense	
oligonucleotides	and/or	missense	oligonucleotides	via	intracerebral	microinjection.	To	
do	this,	dummy	stylets	were	replaced	with	injectors	and	connected	to	Hamilton	syringes	
via	polyethylene	micropore	tubing	(PE50),	and	infused	1	µl	Homer1a	antisense	into	one	
hemisphere	and	1	µl	of	the	Homer1a	missense	oligonucleotide	to	the	other	hemisphere	
(n	=	6),	at	a	rate	of	0.5	µl/min.	 Injectors	were	 left	 in	place	for	2	min	to	prevent	back	
diffusion	of	the	injectate	from	the	target	region.	At	least	one	week	after	recovery	from	
surgery,	infusions	were	performed	90	min	before	contextual	fear	conditioning	training,	
thereby	allowing	for	sufficient	time	for	the	oligonucleotides	to	penetrate	the	tissue	and	
enter	cells	(Lee	et	al.,	2004;	Barnes	et	al.,	2012).	The	behavioural	intervention	was	used	
to	stimulate	the	expression	of	de	novo	Homer1a	expression,	thereby	permitting	the	intra	
animal	assessment	of	the	effects	on	Homer1a	mRNA	by	the	antisense	oligonucleotide	
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on	Homer1a	protein	 in	 the	dorsal	hippocampus.	 Specifically,	 rats	were	placed	 into	a	
novel	context	for	3	min	and	received	a	footshock	(0.5	mA,	2	sec)	after	2	min.	Rats	were	
housed	in	their	home	cages	between	microinfusion	and	behavioural	manipulations.		
6.2.1.4 Immunoblotting	
Antisense	knockdown	was	quantified	by	Western	blot	analysis	of	Homer1a	protein.	Rats	
were	culled	by	CO2	inhalation	4	h	after	conditioning	and	each	dorsal	hippocampus	was	
micro-dissected	and	snap	frozen.	Whole	cell	 fractions	of	 the	dorsal	hippocampi	were	
made	using	RIPA	buffer	and	a	Western	blot	assay	performed	as	described	 in	General	
Methods	 section	 2.6.	 The	 membrane	 was	 incubated	 with	 anti-Homer1a	 polyclonal	
rabbit	 antibody	 (160013,	 Synaptic	 Systems,	 Germany),	 1:1000,	 and	 anti-GAPDH	
monoclonal	mouse	antibody	(ab8245,	Abcam,	UK;	whole	tissue	homogenates),	1:5000,	
overnight	 at	 4°C.	 Secondary	 antibodies	were	 1:10000	 goat	 anti-rabbit	 (680	 nm)	 and	
donkey	anti-mouse	(800	nm)	fluorescent	secondary	antibodies	(LI-COR),	for	1	h	at	room	
temperature.	Relative	Homer1a	intensity	was	standardised	to	the	housekeeping	gene	of	
the	 same	 lane.	 A	 paired	 statistical	 analysis	 was	 used	 to	 compare	 the	 quantity	 of	
Homer1a	protein	in	hippocampi	from	ipsilateral	and	contralateral	hemispheres	to	the	
antisense	injection	site.		
6.2.2 Results	
Rats	 subjected	 to	 contextual	 fear	 conditioning	 displayed	 robust	 post-shock	 freezing	
compared	 to	 baseline	 (P	 <	 0.001,	 t-test;	 Figure	 6.2).	 Intracerebral	 microinjection	 of	
Homer1a	 antisense	 oligonucleotides	 into	 the	 dorsal	 hippocampus	 90	 min	 prior	 to	
contextual	 fear	 conditioning	 decreased	 Homer1a	 protein	 by	 approximately	 20%	
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compared	to	rats	treated	with	missense	oligonucleotides	4	h	after	training	(P	<	0.05,	
two-tailed	t-test;	Figure	6.3).		 	
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Figure	 6.2	 Rats	 administered	 with	 unilateral	 intrahippocampal	 infusions	 of	 Homer1a	 antisense	
oligonucleotides	exhibited	robust	post-shock	freezing.	Rats	were	exposed	to	a	novel	context	for	3	min	and	
received	a	footshock	after	2	min	(n	=	6).	Rats	were	culled	4	h	after	conditioning	for	hippocampal	dissection	
and	immunoblotting.	Data	represented	by	mean	±	SEM	percent	freezing.	
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Figure	6.3	Homer1a	protein	knockdown	 in	whole	 cell	 lysates	of	 the	dorsal	hippocampus	by	Homer1a	
antisense	oligonucleotides	(ASO).	Data	are	expressed	as	mean	±	SEM	relative	abundance	in	Western	blot	
compared	to	protein	level	following	administration	of	Homer1a	missense	oligonucleotides	(MSO)	to	the	
contralateral	hemisphere.	Rats	were	administered	90	min	prior	to	contextual	fear	conditioning	and	dorsal	
hippocampi	were	micro-dissected	4	h	after	conditioning.	n	=	6.	*P	<	0.05.	
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6.3 The	role	of	Homer1a	in	the	consolidation	of	contextual	fear	memory:	
antisense-targeted	knockdown	in	the	dorsal	hippocampus	
6.3.1 Methods	
6.3.1.1 Intracerebral	microinjection	and	behaviour	
14	adult	male	Lister	Hooded	rats	were	given	surgically	implanted	indwelling	cannulae	to	
the	dorsal	hippocampus,	as	described	above.	Rats	received	a	bilateral	infusion	of	1	µl	2	
nmol/µl	Homer1a	antisense	or	missense	(n	=	7)	oligonucleotides	at	a	rate	of	0.5	µl	/	min,	
90	min	before	a	contextual	fear	conditioning	trial	 (see	above).	Rats	were	returned	to	
their	home	cages	and	subjected	to	2	min	context	re-exposure	recall	trials	48	h	and	4	
weeks	 later.	 Freezing	 behaviour	 was	 recorded	 and	 quantified	 offline	 throughout	 all	
trials.	
6.3.1.2 Histology	
After	 behavioural	 testing,	 rats	 were	 killed	 by	 CO2	 inhalation	 and	 the	 brains	 were	
dissected	and	snap	frozen	for	histology.	This	enabled	verification	of	cannula	placement	
positioning.	 The	 region	 of	 the	 brain	 around	 the	 site	 of	 the	 implant	 was	 sectioned	
coronally	at	14	µm,	taking	every	fifth	section	and	thaw	mounted	onto	glass	microscope	
slides	prior	to	counterstaining	in	0.1%	β-Thionin,	followed	by	dehydration	using	ethanol,	
clearing	using	Histoclear	and	coverslipping	using	DePeX	mountant.	The	sections	were	
then	imaged	at	50X	using	a	bright	field	microscope	to	identify	and	record	the	injection	
site.	 Subjects	 were	 only	 included	 if	 the	 ventral-most	 part	 of	 the	 cannula	 tracts	
terminated	bilaterally	in	the	dorsal	hippocampus	and	there	was	no	sign	of	damage	to	
adjacent	brain	structures	or	gross	ventricular	enlargement.		
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6.3.2 Results	
6.3.2.1 Verification	of	injection	site	
Cannula	 histology	 verified	 the	 bilateral	 placement	 of	 cannulas	 to	 the	 dorsal	
hippocampus	 in	 all	 14	 rats	 used	 for	 Homer1a	 knockdown	 prior	 to	 contextual	 fear	
conditioning	(Figure	6.4).	All	injection	sites	were	situated	between	-3.14	mm	and	-3.80	
mm	 posterior	 to	 Bregma	 bilaterally	 within	 the	 dorsal	 hippocampus.	 One	 rat	 was	
excluded	 from	the	MSO	group	due	 to	detachment	of	 the	cannula	prior	 to	behaviour	
testing.		 	
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Figure	6.4	Homer1a	 oligonucleotide	 injection	 sites	prior	 to	 contextual	 fear	 conditioning.	Blue	 crosses	
mark	the	ventral-most	point	of	the	cannula	placement,	determined	by	histology.	Paxinos	and	Watson	
(1997)	rat	brain	atlas	images	shown	from	-3.80	mm	to	-3.14	mm	posterior	to	Bregma.	
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6.3.2.2 The	effect	of	Homer1a	knockdown	on	the	consolidation	of	contextual	fear	memory	
Rats	 treated	 with	 intracerebral	 microinjection	 of	 Homer1a	 antisense	 or	 missense	
(control)	oligonucleotides	into	the	dorsal	hippocampus	90	min	prior	to	contextual	fear	
conditioning	 exhibited	 normal	 levels	 of	 pre-	 and	 post-shock	 freezing	 (main	 effect	 of	
time:	F(1,	11)	=	178.8,	P	<	0.0001,	two-way	repeated	measures	ANOVA;	Figure	6.5).	There	
was	no	difference	 in	pre-	and	post-shock	 freezing	between	antisense-	and	missense-
treated	groups	(pre	US	P	=	0.92,	post	US	P	=	1.00;	post-hoc	Sidak’s	multiple	comparison	
test).	In	recall	trials	48	h	and	4	weeks	after	conditioning,	there	was	no	effect	of	treatment	
on	conditioned	freezing	(F(1,	11)	=	0.02891,	P	=	0.87,	two-way	repeated	measures	ANOVA;	
Figure	 6.5),	 indicating	 that	 the	 administration	 of	 Homer1a	 antisense	 to	 the	 dorsal	
hippocampus	had	no	effect	on	the	consolidation	of	contextual	fear.		 	
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Figure	6.5	Antisense-mediated	knockdown	of	Homer1a	had	no	effect	on	the	consolidation	of	contextual	
fear	memory.	Homer1a	antisense	 (ASO)	or	missense	 (MSO)	oligonucleotides	were	administered	to	the	
dorsal	hippocampus	by	 intracerebral	microinjection	90	min	before	 fear	 conditioning,	 indicated	by	 red	
arrow.	Recall	(2	min	context	re-exposure)	trials	took	place	48	h	and	4	weeks	after	conditioning.	Data	are	
represented	by	mean	±	SEM	percent	freezing	normalised	to	post-unconditioned	stimulus	(US)	levels.	n	=	
6	(MSO)	or	7	(ASO).	
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6.4 The	role	of	Homer1a	in	the	extinction	of	contextual	fear	memory	
6.4.1 Methods	
14	 adult	male	 Lister	 Hooded	 rats	 were	 surgically	 implanted	with	 indwelling	 cannula	
targeting	 the	 dorsal	 hippocampus,	 as	 described	 before.	 All	 rats	 similarly	 underwent	
contextual	 fear	 conditioning.	 48	 h	 later,	 rats	 received	 bilateral	 intra-hippocampal	
infusions	of	2	nmol/µl	Homer1a	antisense	 (n	=	6)	 in	a	 total	volume	of	1	µ	or	cogent	
missense	sequences	(n	=	5)	at	a	rate	of	0.5	µl/min,	90	min	before	extinction	training.	A	
third,	 smaller	 group	 (n	 =	 3)	 received	 1	 µl	 phosphate	 buffer	 saline	 (PBS)	 vehicle	
administered	at	the	same	rate,	to	control	for	any	effects	of	the	oligonucleotide	infusion.	
Extinction	training	consisted	of	a	10	min	recall	trial	in	the	conditioned	context.	All	rats	
then	underwent	a	recall	trial	48	h	later.	At	the	start	of	a	subsequent	recall	trial,	7	days	
later,	rats	were	given	a	2	sec	0.25	mA	reminder	footshock,	which	itself	is	insufficient	to	
induce	fear	conditioning	in	naïve	rats	and	serves	to	dissociate	extinction	from	amnesia	
(Trent	 et	 al.,	 2015).	 A	 final	 recall	 trial	 took	place	 at	 4	weeks	 after	 fear	 conditioning.	
Freezing	behaviour	was	quantified	throughout	all	trials	(see	above).	
After	 behavioural	 testing,	 rats	 were	 killed	 by	 CO2	 inhalation	 and	 the	 brains	 were	
dissected	and	snap	frozen	for	histology,	as	described.		
6.4.2 Results	
6.4.2.1 Verification	of	injection	site	
Cannula	 histology	 verified	 the	 bilateral	 placement	 of	 cannulas	 to	 the	 dorsal	
hippocampus	in	all	animals	(Figure	6.6).	Bilateral	injection	sites	were	situated	between	
-3.14	mm	and	-3.60	mm	posterior	to	Bregma,	within	the	dorsal	hippocampal	region.		 	
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Figure	 6.6	Homer1a	 oligonucleotide	 injection	 sites	 prior	 to	 extinction	 training.	 Blue	 crosses	mark	 the	
ventral-most	point	of	the	cannula	placement,	determined	by	histology.	Paxinos	and	Watson	(1997)	rat	
brain	atlas	images	shown	from	-3.60	mm	to	-3.14	mm	posterior	to	Bregma.	
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6.4.2.2 The	effect	of	Homer1a	knockdown	on	the	extinction	of	contextual	fear	memory	
In	a	comparison	of	the	level	of	freezing	at	the	start	and	end	of	the	extinction	trial	in	all	
groups,	there	was	 lower	freezing	at	the	end	of	the	trial	 (main	effect	of	time:	F(1,	11)	=	
7.342,	P	 <	 0.05,	 two-way	 repeated	measures	ANOVA;	 Figure	 6.7),	 and	 there	was	 no	
interaction	between	 time	and	 treatment	group	 (F(2,	 11)	 =	0.01594,	P	 =	0.98),	 showing	
normal	within-trial	extinction	of	the	conditioned	response	in	all	groups.	A	main	effect	of	
treatment	was	observed	(F(2,	11)	=	5.518,	P	<	0.05),	characterised	by	lower	conditioned	
freezing	responses	in	the	missense-treated	group,	although	there	were	no	differences	
between	the	treatment	groups	at	the	start	or	end	of	the	extinction	trial	(P	>	0.05,	post-
hoc	Sidak’s	multiple	comparisons	 test).	 Low	 levels	of	conditioned	 freezing	were	seen	
during	a	recall	trial	48	h	after	extinction	training	and	there	was	no	effect	of	treatment	
(F(2,	11)	=	0.4627,	P	=	0.64,	one-way	ANOVA;	Figure	6.7),	indicating	that	extinction	was	
consolidated	 in	 all	 treatment	 groups	 and	 that	 Homer1a	 knockdown	 in	 the	 dorsal	
hippocampus	had	no	effect	on	extinction	learning.	 In	a	subsequent	recall	trial,	a	 low-
intensity	reminder	footshock	was	used	to	test	the	strength	of	the	original	fear	memory.	
Analysed	together,	the	freezing	response	after	the	reminder	was	increased	compared	
to	the	first	recall	trial	(main	effect	of	time:	F(1,	11)	=	11.52,	P	<	0.01,	two-way	repeated	
measures	ANOVA),	although	there	was	no	 interaction	with	 treatment	group	 (F(2,	11)	=	
1.455,	P	 =	 0.28).	 No	 difference	 between	 the	 treatment	 groups	was	 observed	 in	 this	
second	recall	trial	(F(2,	11)	=	2.089,	P	=	0.17,	one-way	ANOVA),	nor	a	third	recall	trial	at	4	
weeks	post-conditioning	(F(2,	11)	=	1.437,	P	=	0.28).		 	
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Figure	6.7	Antisense-mediated	knockdown	of	Homer1a	in	the	dorsal	hippocampus	did	not	influence	the	
extinction	(Ext)	of	contextual	fear	memory.	Homer1a	antisense	(ASO)	or	missense	(MSO)	oligonucleotides	
or	 phosphate	 buffer	 saline	 (PBS)	 was	 administered	 to	 the	 dorsal	 hippocampus	 by	 intracerebral	
microinjection	90	min	prior	to	extinction	training,	indicated	by	the	red	arrow.	Recall	trials	 (2	min)	took	
place	48	h,	7	days	and	4	weeks	after	extinction	training.	A	reminder	shock	was	given	at	the	beginning	of	
the	second	recall	trial,	as	indicated.	Data	represented	by	mean	±	SEM	percent	freezing	normalised	to	post-
unconditioned	stimulus	(US)	levels.	n	=	3	(PBS),	n	=	5	(MSO)	or	n	=	6	(ASO).	
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6.5 The	effect	of	Homer1a	and	Ania-3	double	knockdown	on	the	
extinction	of	contextual	fear	memory	
6.5.1 Methods	
6.5.1.1 Antisense	design	
An	 Ania-3	 antisense	 oligonucleotide	 was	 designed	 to	 target	 the	 three	 prime	
untranslated	region	of	Ania-3,	which	shows	little	homology	to	the	equivalent	region	of	
Homer1a	 (Bottai	 et	 al.,	 2002).	 The	 same	 criteria	 used	 for	 the	 design	 of	 Homer1a	
antisense	were	used	in	filtering	candidate	oligonucleotides	for	Ania-3.	Since	Homer1a	
and	Ania-3	antisense	were	to	be	co-infused,	Clustal	Omega	analyses	were	performed	to	
ensure	 that	 the	 two	 antisense	 oligonucleotides	 and	 also	 the	 two	 missense	
oligonucleoides	 would	 not	 interact	 when	 in	 solution	 together.	 The	 selected	 Ania-3	
antisense	 oligonucleotide	 sequence	 (5’-GATTACATAGCCAAGAGATC-3’)	 was	 only	 fully	
complimentary	to	Ania-3	mRNA	and	only	20%	homologous	to	Homer1a	mRNA	and	30%	
homologous	to	long	Homer1	variants	(Figure	6.8).		
No	Ania-3-specific	 antibody	 currently	 exists,	 therefore	making	 it	 impossible	 to	 verify	
knockdown	of	Ania-3	by	the	targeting	antisense	oligonucleotide	using	Western	blot.		 	
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Figure	6.8	Ania-3	antisense	oligonucleotide	target	region	within	the	predicted	structure	of	Ania-3	mRNA.	
Arrow	 indicates	 target	 location.	 Oligonucleotide	 sequence	 =	 5’-GATTACATAGCCAAGAGATC-3’.	 mRNA	
structure	prediction	and	target	visualisation	performed	using	Sfold	(http://sfold.wadsworth.org/)	tool.	
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6.5.1.2 Intracerebral	microinjection	and	behaviour	
14	adult	male	Lister	Hooded	rats	were	surgically	 implanted	with	 indwelling	cannulae	
targeting	 the	 dorsal	 hippocampus,	 as	 before.	 Homer1a	 and	 Ania-3	 antisense	
oligonucleotides	were	mixed	to	create	a	solution	containing	2	nmol/µl	of	each	antisense.	
The	 two	missense	oligonucleotides	were	mixed	 in	 the	 same	manner.	 Rats	were	 first	
subjected	to	a	contextual	fear	conditioning	trial.	48	h	later,	rats	received	bilateral	intra-
hippocampal	infusions	of	1	µl	Homer1a/Ana-3	antisense	mix	or	missense	mix	(N	=	7)	at	
a	 rate	 of	 0.5	 µl	 /	min,	 90	min	 before	 extinction	 training.	 After	 extinction,	 rats	 then	
underwent	three	recall	trials	48	h,	7	days	and	4	weeks	afterwards.	Freezing	behaviour	
was	quantified	throughout	all	trials	as	previously	described.	
After	 behavioural	 testing,	 rats	 were	 killed	 by	 CO2	 inhalation	 and	 the	 brains	 were	
dissected	and	snap	frozen	for	histology,	as	described.		
6.5.2 Results	
6.5.2.1 Verification	of	injection	site	
Cannula	 histology	 verified	 the	 bilateral	 placement	 of	 cannulas	 to	 the	 dorsal	
hippocampus	in	all	14	rats	(Figure	6.9).	Injection	sites	were	bilaterally	situated	between	
-3.30	mm	and	-3.80	mm	posterior	to	Bregma.		 	
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Figure	6.9	Homer1a	/	Ania-3	antisense	injection	sites	prior	to	extinction	training.	Blue	crosses	mark	the	
ventral-most	point	of	the	cannula	placement,	determined	by	histology.	Paxinos	and	Watson	(1997)	rat	
brain	atlas	shown	from	-3.80	mm	to	-3.30	mm	posterior	to	Bregma.	
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6.5.2.2 Behavioural	effect	of	double	knockdown	
A	double	knockdown	of	Homer1a	and	Ania-3	in	the	dorsal	hippocampus	was	performed	
during	extinction	learning	to	account	for	any	residual	support	of	extinction	from	Ania-3	
in	 effect	 in	 the	 previous	 experiment.	 48	 h	 after	 contextual	 fear	 conditioning,	
Homer1a/Ania-3	mixed	antisense	or	missense	oligonucleotides	were	administered	90	
min	before	extinction	training,	which	caused	a	decrease	in	within	session	conditioned	
freezing	 response	 (main	 effect	 of	 time:	 F(1,	 12)	 =	 21.73,	P	 <	 0.001,	 two-way	 repeated	
measures	ANOVA;	Figure	6.10).	There	was	no	interaction	between	time	and	treatment	
group	(F(1,	12)	=	0.3735,	P	=	0.55),	nor	was	there	a	main	effect	of	treatment	group	(F(1,	12)	
=	0.5268,	P	=	0.48).	Three	recall	trials	were	performed	to	test	the	extinction	memory	at	
3	 later	 times.	 Homer1a/Ania-3	 antisense	 infusions	 had	 no	 effect	 on	 the	 freezing	
response	in	any	of	these	trials	compared	to	the	missense	infusion	group	(48	h	P	=	0.25,	
7	days	P	=	0.26,	4	weeks	P	=	0.94;	t-tests;	Figure	6.10).		 	
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Figure	6.10	Homer1a	/	Ania-3	double	antisense	infusion	into	the	dorsal	hippocampus	prior	to	extinction	
training	 had	 no	 effect	 on	 the	 extinction	 (Ext)	 of	 contextual	 fear	memory.	 Homer1a/Ania-3	 antisense	
oligonucleotide	 mix	 (ASO)	 or	 missense	 oligonucleotide	 mix	 (MSO)	 was	 administered	 to	 the	 dorsal	
hippocampus	by	 intracerebral	microinjection	90	min	prior	 to	extinction	 training,	 indicated	by	 the	 red	
arrow.	Recall	(2	min)	trials	took	place	48	h,	7	days	and	4	weeks	after	extinction	training.	Data	represented	
by	mean	±	SEM	percent	freezing	normalised	to	post-unconditioned	stimulus	(US)	levels.	n	=	7	per	group.	
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6.6 Discussion	
The	results	presented	in	the	current	chapter	show	that	the	knockdown	of	Homer1a	in	
the	dorsal	hippocampus	by	microinjection	of	antisense	oligonucleotides	had	no	effect	
on	 the	 consolidation	 or	 extinction	 of	 contextual	 fear	 memory.	 Furthermore,	 the	
administration	of	antisense	sequences	targeting	both	short	Homer1	variants,	Homer1a	
and	Ania-3,	had	no	effect	on	extinction	learning.	These	findings	question	the	changes	in	
mRNA	 which	 parallel	 the	 consolidation	 and	 extinction	 of	 contextual	 fear	 memory	
(Chapter	5)	and	demand	evaluation	of	the	success	of	the	knockdown	technique.	
Unlike	 these	 observations,	 previous	 studies	 have	 shown	 the	 manipulation	 of	 short	
Homer1	expression	to	impair	fear	conditioning	(Inoue	et	al.,	2009c;	Mahan	et	al.,	2012;	
Banerjee	et	al.,	2016).	However,	these	studies	used	different	behavioural	models	and	
methods	for	altering	Homer1	expression	in	different	brain	regions.	Banerjee	et	al	(2016)	
investigated	 the	 effect	 of	 amygdalar	 chronic	 overexpression	 of	 Homer1a	 using	 viral	
vector	on	the	consolidation	of	cued	fear	conditioning	(Banerjee	et	al.,	2016).	Mahan	et	
al	(2012)	also	studied	cued	fear	conditioning,	yet	following	the	global	knockout	of	both	
short	Homer1	isoforms.	Both	these	studies	suggest	that	Homer1a	plays	a	crucial	role	in	
amygdala-dependent	fear	learning	processes	which	may	employ	short	Homer1	proteins	
differently	to	the	dorsal	hippocampus.	They	also	leave	the	role	of	Ania-3	in	cued	fear	
conditioning	under	question.	Inoue	et	al	(2009)	demonstrated	that	short	form-specific	
Homer1	 knockout	 mice	 exhibit	 normal	 acquisition	 but	 impaired	 consolidation	 of	
contextual	 fear	 conditioning.	 It	 is	 possible	 that	 this	 effect	 was	 due	 to	 altered	 short	
Homer1	expression	in	the	amygdala,	since	contextual	fear	conditioning	is	dependent	on	
the	hippocampus	and	amygdala	(Phillips	and	LeDoux,	1992).	The	effect	of	knockout	on	
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fear	memory	consolidation	may	also	be	mediated	by	anxiogenic	effects	(Szumlinski	et	
al.,	2005)	or	developmental	impairments	in	the	hippocampus	or	other	regions.		
The	 disruption	 of	 both	 short	 Homer1	 variants	 in	 the	 dorsal	 hippocampus	 may	 be	
necessary	to	block	the	consolidation	of	contextual	fear.	The	effects	of	knocking	down	
one	isoform	may	be	compensated	by	the	other	sufficiently	for	association	formation.	
Further	studies	should	explore	the	effect	of	knocking	down	both	Homer1a	and	Ania-3	
simultaneously	 by	 administering	 intrahippocampal	 antisense	 against	 Homer1a	 and	
Ania-3	prior	to	contextual	fear	conditioning.		
The	present	study	is	the	first	to	explore	the	role	of	short	Homer1	proteins	in	extinction	
learning.	It	is	also	the	first	to	investigate	the	functional	contributions	of	Homer1a	and	
Ania-3	 independently.	 I	 observed	 no	 effect	 on	 extinction	 by	 the	 intracerebral	
administration	 of	 antisense	 against	 either	 Homer1a	 alone	 or	 Homer1a	 and	 Ania-3	
simultaneously.	This	suggests	that	the	expression	of	short	Homer1	isoforms	in	the	dorsal	
hippocampus	is	not	required	for	the	extinction	of	contextual	fear.	It	is	possible	that	the	
antisense	oligonucleotides	used	were	ineffective	at	generating	sufficient	knockdown	to	
influence	behaviour.	I	demonstrated	that	the	Homer1a	antisense	induced	a	knockdown	
of	 Homer1a	 protein	 after	 contextual	 fear	 conditioning,	 but	 this	 was	 only	 by	 20%	
compared	 to	 missense-treated	 rats.	 This	 is	 below	 the	 commonly	 used	 definition	 of	
successful	knockdown	of	50%	or	greater	(Achenbach	et	al.,	2003;	Vickers	et	al.,	2003;	
Chan	et	al.,	2006).	The	extent	of	knockdown	of	Ania-3	during	extinction	training	using	
my	custom	designed	antisense	oligonucleotide	could	not	be	determined	because	there	
are	currently	no	Ania-3	antibodies	to	quantify	protein	levels	by	Western	blotting.	The	
effectiveness	of	 antisense	oligonucleotides	 is	 influenced	by	 several	 factors,	 including	
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secondary	 structure,	 serum	 stability	 and	 binding	 energy	 (Chan	 et	 al.,	 2006),	 which	
cannot	be	predicted	with	certainty.	Hence,	a	proportion	of	designed	antisense	strands	
have	 weak	 activity	 and	 provide	 poor	 inhibition	 of	 the	 target	 mRNA,	 regardless	 of	
specificity.	It	is	imperative	that	the	effectiveness	of	each	antisense	sequence	at	reducing	
target	protein	levels	is	determined	empirically.		
If	indeed	the	translation	of	short	Homer1	variants	is	not	necessary	for	the	extinction	of	
conditioned	fear,	it	demands	the	question	of	why	both	the	mRNA	of	Homer1a	and	Ania-
3,	and	the	protein	of	Homer1a,	are	increased	following	extinction	training	in	subregions	
of	the	dorsal	hippocampus,	as	presented	in	Chapter	5.	It	is	possible	that,	through	protein	
homeostasis,	 short	 Homer1	 variants	 are	metabolised	 during	 plasticity	 processes	 and	
become	replaced	through	de	novo	gene	expression	but	are	not	functionally	central	to	
the	 process.	 However,	 this	 explanation	 seems	 unlikely,	 or	 at	 least	 insufficient,	
considering	the	specificity	of	Homer1a	recruitment	to	CA3	following	extinction	learning	
(Chapter	5).	
In	order	to	gain	better	insight	into	the	role	of	Homer1a	and	Ania-3	in	associative	learning	
processes,	 future	experiments	may	employ	alternative	knockdown	strategies	with	an	
aim	 to	 achieve	 improved	 protein	 knockdown.	 As	 well	 as	 designing	 new	 antisense	
oligonucleotide	 sequences,	 these	 may	 be	 compared	 to	 RNA	 interference	 methods.	
Whilst	neither	method	has	been	demonstrated	to	be	conclusively	advantageous	in	vivo	
(Watts	 and	 Corey,	 2012),	 some	 studies	 have	 shown	 that	 short	 interfering	 RNA	 has	
superior	potency	over	 single-stranded	antisense	 techniques	 (Grünweller	 et	 al.,	 2003;	
Kretschmer-Kazemi	 Far	 and	 Sczakiel,	 2003).	 The	 use	 of	 gene	 expression	 silencing	
techniques	may	be	complimented	by	disruption	of	the	translated	protein	(Campbell	and	
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Bennett,	 2016).	 In	 particular,	 green	 fluorescent	 protein	 (GFP)-tagged	 protein	
degradation	 techniques	 have	 been	 used	 effectively	 in	 conjunction	 with	 RNA	
interference	to	generate	a	more	effective	depletion	of	protein	levels	(Caussinus	et	al.,	
2011;	 Brankatschk	 et	 al.,	 2014;	 Dunst	 et	 al.,	 2015).	 Greater	 knockdown	 of	 Homer1	
variants	through	such	methods	may	provide	conclusive	evidence	for	their	roles	in	fear	
memory	consolidation	and	extinction,	although	the	validation	of	their	effectiveness	will	
be	limited	by	the	availability	of	Homer1	short-form	specific	antibodies.		
Our	results	do	not	allow	us	to	conclude	whether	Homer1a	and	Ania-3	are	required	in	
the	dorsal	hippocampus	for	the	consolidation	or	extinction	of	contextual	fear	memory.	
Data	currently	indicate	that	Homer1a	and	Ania-3	are	likely	to	overlap	functionally	and	
therefore	exhibit	functional	redundancy.	However,	their	differential	expression	patterns	
with	fear	learning	suggest	that	their	roles	in	the	hippocampus	may	diverge.	The	advent	
of	an	antibody	against	Ania-3	may	help	to	delineate	the	respective	roles	of	the	short	
Homer1	 isoforms.	 Further	 experiments	 may	 benefit	 from	 extending	 knockdown	
techniques	to	RNA	interference	or	protein	degradation	methods.	
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Chapter	7: General	Discussion	
In	this	Chapter,	I	highlight	the	main	findings	from	each	results	chapter	presented	herein	
and	consider	the	primary	implications	of	the	collective	results.	I	then	discuss	how	these	
results	 inform	 future	 research	 directions	 and	 address	 any	 general	 limitations	 to	 the	
methodology	and	 interpretation	of	 the	data.	Below,	 the	principle	 findings	 from	each	
results	chapter	are	summarised.	
7.1 Results	Chapter	Summaries	
7.1.1 The	Enrichment	of	Learning-Related	Genes	in	Genetic	Variants	from	Patients	with	
Schizophrenia	and	Related	Disorders	
• The	enrichment	of	consolidation-,	retrieval-	and	extinction-related	genes	in	CNVs	
from	patients	with	schizophrenia,	autism,	intellectual	disability	and	ADHD,	and	in	
SNPs	from	patients	with	schizophrenia	was	investigated.		
• There	was	an	enrichment	of	extinction-related	genes	 in	CNVs	from	patients	with	
schizophrenia,	 which	 was	 common	 to	 both	 duplications	 and	 deletions,	 but	 no	
enrichment	of	learning-related	genes	in	CNVs	from	patients	with	other	psychiatric	
disorders,	or	melanoma.		
• I	 note	 that	 some	 extinction-related	 genes	 have	 been	 individually	 implicated	 in	
schizophrenia	previously.		
• There	was	no	enrichment	of	consolidation-,	retrieval-	or	extinction-related	genes	in	
single	nucleotide	polymorphisms	from	patients	with	schizophrenia.	
7.1.2 Associative	Learning	by	Contextual	Fear	Conditioning	
• Contextual	fear	conditioning	was	induced	by	a	single	pairing	of	a	novel	context	with	
a	footshock	stimulus,	and	was	subsequently	extinguished	by	10	min	re-exposure	to	
the	context	without	the	footshock.		
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• Administration	 of	 a	 higher	 dose	 (25	mg/kg),	 but	 not	 a	 lower	 dose	 (8	mg/kg),	 of	
ketamine	prior	to	fear	conditioning	 induced	the	generation	of	a	state-dependent	
fear	memory.		
• Neither	 dose	 affected	 the	 consolidation	 of	 contextual	 fear	 memory,	 which	 is	
consistent	with	published	data.		
• Both	low	and	high	dose	ketamine	blocked	the	extinction	of	contextual	fear	memory	
when	administered	prior,	but	not	immediately	after,	extinction	training,	consistent	
with	effects	of	ketamine	on	other	 inhibitory	 learning	processes	observed	 in	past	
studies.	
7.1.3 The	Regulation	of	Postsynaptic	Density	Homer1	Proteins	by	Associative	Learning	
• I	measured	the	expression	pattern	of	Homer1a,	Ania-3	and	long	Homer1	isoforms	
following	different	components	of	associative	fear	learning.		
• Short,	activity-induced	isoforms,	Homer1a	and	Ania-3,	but	not	the	long	isoforms,	
were	 regulated	 in	 the	 hippocampus	 by	 novel	 context	 exposure,	 contextual	 fear	
conditioning,	retrieval	and	extinction.		
• Whilst	the	induction	of	both	short	isoforms	was	rapid	and	transient,	Ania-3	levels	
returned	to	baseline	earlier	(by	2	h	post-conditioning)	than	Homer1a	(sustained	for	
at	least	4	h),	irrespective	of	hippocampal	subregion.		
• Regulation	of	Homer1a	in	CA3	occurred	solely	following	extinction	training.		
• Changes	in	Homer1a	and	Ania-3	mRNA	were	indistinguishable	following	novelty	or	
CPFE,	 although	an	 increase	 in	Homer1a	protein	was	only	detected	4	h	 after	 the	
extinction,	 but	 not	 the	 consolidation,	 of	 fear	 memory,	 in	 whole	 hippocampal	
homogenates.	
7.1.4 The	Role	of	Short	Homer	Proteins	in	Fear	Memory	Consolidation	and	Extinction	
• Antisense	 oligonucleotides	 complimentary	 to	 Homer1a	 or	 Ania-3	 mRNA	 were	
designed	and	administered	via	intracerebral	microinjection	bilaterally	to	the	dorsal	
hippocampus	of	rats	prior	to	contextual	fear	conditioning	and	prior	to	extinction	of	
contextual	fear	memory.		
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• Homer1a	antisense	produced	a	20%	knockdown	in	hippocampal	Homer1a	protein	
levels	after	fear	conditioning,	but	had	no	effect	on	the	consolidation	of	contextual	
fear	memory.		
• The	administration	of	Homer1a	and	Ania-3	antisense	simultaneously	had	no	effect	
on	fear	extinction.		
• The	 weak	 antisense	 activity	 of	 the	 Homer1a	 oligonucleotide	 and	 the	 lack	 of	
antibody	against	Ania-3	to	test	the	effectiveness	of	the	Ania-3	antisense	sequence	
occludes	 evidence	 that	 might	 demonstrate	 that	 the	 synthesis	 of	 de	 novo	 short	
Homer1	proteins	is	necessary	for	processes	of	associative	fear	learning.	
	
7.2 The	role	of	extinction	learning	in	psychopathology		
A	 primary	 point	 of	 convergence	 from	 the	 results	 presented	 in	 this	 thesis	 is	 the	
implication	 that	 extinction	 learning	 processes	 are	 important	 in	 the	 development	 of	
schizophrenia,	specifically	those	concerning	the	extinction	of	associative	fear	memories.	
Firstly,	in	studying	the	relationship	between	associative	learning-related	gene	sets	and	
genetic	variants	from	patients	with	schizophrenia,	I	found	an	enrichment	of	extinction-
related	genes	in	patient	CNVs,	suggesting	that	the	risk	conferred	by	these	rare	variants	
may	be	attributable	to	effects	on	extinction	learning.	Secondly,	the	NMDA	antagonist,	
ketamine,	blocked	the	extinction	of	contextual	fear,	perhaps	revealing	an	origin	to	the	
drug’s	 psychotomimetic	 properties.	 Thirdly,	 products	 of	 the	Homer1	 gene,	 which	 is	
central	to	synaptic	plasticity	and	has	been	linked	to	psychiatric	disease	(Spellmann	et	al.,	
2011;	Luo	et	al.,	2012),	are	differentially	regulated	in	specific	hippocampal	subregions	
following	extinction	learning.		
Extinction	is	widely	interpreted	to	be	a	process	of	new	inhibitory	associative	learning,	
rather	 than	 the	 erasure	 of	 the	 original	 association	 between	 conditioned	 and	
unconditioned	 stimuli	 (Bouton,	 2004;	 Quirk	 and	 Mueller,	 2008).	 This	 is	 due	 to	 the	
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observation	 that	 the	 extinguished	 conditioned	 responses	 can	 become	 renewed	 or	
reinstated	 following	 manipulations	 such	 as	 a	 change	 of	 context	 or	 exposure	 to	 the	
unconditioned	stimulus,	or	over	time	(spontaneous	recovery)	(Rescorla	and	Heth,	1975;	
Bouton,	 1993).	 Through	 competitive	 processes,	 the	 inhibitory	 extinction	 memory	
dominates	over	the	conditioned	association	with	the	unconditioned	stimulus	(Bouton,	
2004).	 An	 important	 characteristic	 of	 extinction	 is	 its	 context-dependency	 (Bouton,	
1993;	 Brooks	 and	 Bouton,	 1994).	 There	 is	 substantial	 evidence	 suggesting	 that	 the	
regulation	of	fear	expression	after	extinction	using	contextual	stimuli	is	mediated	by	the	
dorsal	 hippocampus	 (Corcoran	 and	 Maren,	 2001,	 2004;	 Bouton	 et	 al.,	 2006).	 Such	
studies	lend	support	to	a	model	in	which	the	dorsal	hippocampus	is	responsible	for	the	
contextual	gating	of	inhibitory	associations	(Bouton	and	Bouton,	1994;	Maren	and	Holt,	
2000),	which	provides	a	common	mechanism	for	both	extinction	learning	and	another	
form	of	inhibitory	associative	learning,	latent	inhibition	(Puga	et	al.,	2007).	Both	these	
processes	use	contextual	retrieval	cues	to	delineate	conflicting	memories	concerning	a	
particular	conditioned	stimulus,	influencing	behaviour	(Ji	and	Maren,	2007).		
Both	extinction	and	latent	inhibition	are	impaired	in	patients	with	schizophrenia	(Baruch	
et	 al.,	 1988;	 Jentsch	 and	 Taylor,	 2001;	 Serra	 et	 al.,	 2001;	 Holt	 et	 al.,	 2009,	 2012).	
Together	 with	 the	 results	 presented	 herein,	 these	 studies	 strongly	 implicate	
abnormalities	 in	 inhibitory-type	 learning	 in	 schizophrenia.	 Interestingly,	 yet	 perhaps	
unsurprisingly,	these	inhibitory	learning	processes	are	physiologically	mediated	through	
inhibitory	 cellular	 and	neurotransmitter	 systems.	During	 fear	 extinction	 learning,	 the	
hippocampus	 regulates	 the	 activity	 of	 projections	 from	 the	 ventromedial	 prefrontal	
cortex	to	inhibitory	intercalated	cells	of	the	amygdala	(Vertes,	2004;	Likhtik	et	al.,	2008;	
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Orsini	et	al.,	2011).	The	clustering	of	GABAA	receptors	in	the	amygdala	occurs	following	
extinction	training,	increasing	inhibition	within	this	structure	(Chhatwal	et	al.,	2005)	and	
administration	of	a	beta-carboline	antagonist	of	GABAA	receptors	blocks	the	expression	
of	 extinction	 (Harris	 and	 Westbrook,	 1998).	 It	 is	 notable	 that	 parvalbumin-positive	
inhibitory	interneurons	are	heavily	implicated	in	schizophrenia	(Lewis	et	al.,	2012;	Boley	
et	 al.,	 2014)	 and	 genes	 encoding	 components	 of	 the	 GABAA	 receptor	 complex	were	
enriched	 in	 schizophrenia-associated	 CNVs	 in	 a	 recent	 large-scale	 CNV	 study	
(Pocklington	et	al.,	2015).	This	dysregulation	of	inhibitory	and	excitatory	inputs	to	the	
amygdala,	or	elsewhere	in	fear	memory	circuitry,	will	have	profound	effects	on	stimulus	
regulated	fear	expression.	
Indeed,	it	is	not	only	hippocampal	regions	that	are	required	for	extinction	leaning.	The	
hippocampal-prefrontal-amygdala	 extinction	 circuit	 has	been	extensively	 studied	 (for	
reviews	see	Ji	and	Maren,	2007;	Quirk	and	Mueller,	2008;	Milad	and	Quirk,	2012).	 In	
functional	 studies	 in	 rodents,	 the	 infralimbic	 prefrontal	 cortex	 is	 considered	 to	 be	
functionally	 homologous	 to	 the	 ventromedial	 prefrontal	 cortex	 in	 humans	 for	 the	
facilitation	of	extinction	(Kalisch,	2006;	Sierra-Mercado	et	al.,	2011).	Table	7.1	displays	
the	effects	of	systemic,	hippocampal,	infralimbic	and	amygdalar	manipulations	on	fear	
extinction.		 	
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Manipulation	
Fear	
conditioning	
protocol	
Effect	on	
extinction	 Reference	
Systemic	
TrkB	agonist	 Cued	 ↑	acquisition	 (Andero	et	al.,	2011)	
NR2B	blockade	 Cued	 ↓	acquisition	 (Sotres-Bayon	et	al.,	2007)	
NMDA	agonist	 Cued	 ↑	consolidation	 (Walker	et	al.,	2002)	
Cannabinoid	agonist	 Contextual	 ↑	consolidation	 (Pamplona	et	al.,	2008)	
FGF2	 Cued	 ↑	consolidation	 (Graham	and	Richardson,	2009)	
Oxytocin	 Contextual	 ↓	consolidation	 (Eskandarian	et	al.,	2013)	
NMDA	antagonist	 Contextual	 ↓	consolidation	 Chapter	4	
Hippocampus	
Hippocampal	BDNF	KO	 Cued	 ↓	acquisition	 (Heldt	et	al.,	2007)	
GABAAR	agonist	 Cued	 ↓	acquisition	 (Corcoran	et	al.,	2005)	
Histone	deacetylase	
inhibition	 Contextual	 ↑	consolidation	 (Stafford	et	al.,	2012)	
NMDAR	agonist	 Cued	 ↑	consolidation	 (Ledgerwood	et	al.,	2003)	
Zif268	knockdown	 Contextual	 ↓	consolidation	 (Lee	et	al.,	2004)	
Actin	remodelling		 Contextual	 ↓	consolidation	 (Fischer	et	al.,	2004)	
MEK	inhibition	 Contextual	 ↓	consolidation	 (Fischer	et	al.,	2007)	
Translation	inhibition	 IA	 ↓	consolidation	 (Vianna	et	al.,	2003)	
SRC	inhibition	 IA	 ↓	consolidation	 (Bevilaqua	et	al.,	2005)	
P38MAPK	inhibition	 IA	 ↓	consolidation	 (Rossato	et	al.,	2006)	
CAMKII	inhibition	 IA	 ↓	consolidation	 (Szapiro	et	al.,	2003)	
NMDAR	antagonist	 IA	 ↓	consolidation	 (Szapiro	et	al.,	2003)	
Infralimbic	cortex	
CB1R	agonist	 Cued	 ↑	consolidation	 (Lin	et	al.,	2009)	
BDNF	 Cued	 ↑	consolidation	 (Peters	et	al.,	2010)	
GABAAR	antagonist	 Contextual	 ↑	consolidation	 (Thompson	et	al.,	2010)	
M-K+	channel	block	 Cued	 ↑	consolidation	 (Santini	and	Porter,	2010)	
CB1R	antagonist	 Cued	 ↓	consolidation	 (Lin	et	al.,	2009)	
GABAAR	agonist	 Contextual	
↓	consolidation	
↓	retrieval	
(Laurent	and	Westbrook,	
2009)	
mGluR5	antagonist	 Cued	 ↓	consolidation	 (Fontanez-Nuin	et	al.,	2011)	
Dopamine	D2	antagonist	 Cued	 ↓	consolidation	 (Mueller	et	al.,	2010)	
Dopamine	D4	antagonist	 Cued	 ↓	consolidation	 (Pfeiffer	and	Fendt,	2006)	
Amygdala	
MAPK	inhibition	 Cued	 ↓	acquisition	 (Herry	et	al.,	2006)	
NR2B	antagonist	 Cued	 ↓	acquisition	 (Sotres-Bayon	et	al.,	2007)	
mGluR1	antagonist	 Cued	 ↓	acquisition	 (Kim	et	al.,	2007)	
GABAAR	antagonist	 Contextual	 ↑	consolidation	 (Berlau	and	McGaugh,	2006)	
Translation	inhibition	 Cued	 ↓	consolidation	 (Lin	et	al.,	2003)	
BDNF	knockdown	 Cued	 ↓	consolidation	 (Chhatwal	et	al.,	2006)	
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Table	7.1	Effects	of	systemic,	hippocampal,	infralimbic	and	amygdalar	manipulations	on	the	extinction	of	
conditioned	 fear	memory.	Abbreviations:	 tropomyosin	 receptor	 kinase	B	 (TrkB);	N-methyl-D-aspartate	
receptor	 (NMDAR);	 fibroblast	 growth	 factor	 2	 (FGF2);	 NMDAR	 subunit	 2B	 (NR2B);	 brain-derived	
neurotrophic	 factor	 receptor	 (BDNF);	 γ-aminobutyric	 acid	 A	 receptor	 (GABAAR);	 mitogen-activated	
protein	kinase	(MEK);	sarcoma	kinase	(SRC);	p38	mitogen-activated	protein	kinase	(p38MAPK);	calcium-
calmodulin	protein	kinase	II	(CAMKII);	cannabinoid	receptor	type	1	(CB1R);	M-type	potassium	channel	(M-
K+	channel);	metabotropic	glutamate	receptor	1	(mGluR1);	inhibitory	avoidance	(IA).	 	
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Abnormal	functional	connectivity	within	the	hippocampal-prefrontal-amygdalar	circuit	
has	 been	 proposed	 to	 form	 the	 neurobiological	 basis	 for	 alterations	 in	 extinction	
learning	 observed	 during	 adolescence	 (for	 review	 see	 Baker	 et	 al.,	 2014).	 This	 has	
important	implications	for	the	development	of	schizophrenia,	since	the	emergence	of	
symptoms	typically	occurs	in	late	adolescence	and	early	adulthood.	Clinical	studies	have	
demonstrated	 that	 adolescents	 are	 resistant	 to	 the	 acquisition	 of	 extinction	 when	
compared	 to	 children	 and	 adults	 (Haddad	 et	 al.,	 2011;	 Pattwell	 et	 al.,	 2012).	 These	
findings	 are	 reflected	 in	 adolescent	 rodents,	 which	 present	 impairments	 in	 the	
acquisition	(Pattwell	et	al.,	2012)	and	consolidation	(McCallum	et	al.,	2010;	Kim	et	al.,	
2011;	Pattwell	et	al.,	2012)	of	extinction.		
The	adolescent	period	is	a	“critical	period”	for	neuronal	development	inasmuch	as	it	is	
accompanied	by	a	surge	in	synaptic	maturation,	which	may	involve	above-normal	levels	
of	 synapse	 formation	and	 subsequent	elimination	 (Feinberg,	1982;	Paus	et	al.,	 2008;	
Pantelis	et	al.,	2009).	Hence,	this	period	represents	a	vulnerable	developmental	stage	to	
the	 effects	 of	 environmental	 insult	 (McCormick	 et	 al.,	 2010;	 Romeo,	 2013).	 Rats	
subjected	to	chronic	stress	 in	early	adolescence	display	deficits	 in	extinction	 learning	
which	persist	into	adulthood	(Toledo-Rodriguez	and	Sandi,	2007;	Zhang	and	Rosenkranz,	
2013).	Furthermore,	rats	exposed	to	early-life	stress	exhibit	accelerated	maturation	of	
extinction	learning,	whereby	extinction	is	impaired	pre-adolescence	but	comparable	to	
adults	during	adolescence	(Callaghan	and	Richardson,	2012).	It	has	been	proposed	that	
these	age-specific	effects	of	stress	on	extinction	processing	may	be	due	to	an	imbalance	
between	the	support	of	fear	extinction	and	fear	expression	(Eiland	et	al.,	2012)	and/or	
hypersensitivity	 of	 the	 hippocampus	 in	 its	 regulation	 of	 the	 hypothalamic-pituitary-
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adrenal	axis	(McCormick,	2010).	One	study	showed	that	chronic	stress	in	adolescent	rats	
led	 to	 dendritic	 retraction	 in	 the	 hippocampus	 and	 prefrontal	 cortex,	 yet	 dendritic	
hypertrophy	 in	 the	 amygdala	 (Eiland	 et	 al.,	 2012).	 Interestingly,	 patients	 with	
schizophrenia	 exhibit	 reduced	 ventromedial	 prefrontal	 cortex	 activity	 and	 amygdalar	
hyperactivity	during	extinction	training	(Holt	et	al.,	2012).	
Phenotypically,	schizophrenia	 is	not	the	only	psychiatric	disorder	for	which	extinction	
learning	is	relevant.	Anxiety	disorders	such	as	posttraumatic	stress	disorder	are	thought	
to	 be	 characterised	 by	 strong	 associations	 between	 traumatic	 events	 and	 specific	
sensory	 cues,	 which	 are	 resistant	 to	 extinction	 (Pitman,	 1988).	 Importantly,	 genetic	
variants	 conferring	 risk	 to	 schizophrenia	 also	 contribute	 risk	 to	 other	 psychiatric	
disorders	(Malhotra	and	Sebat,	2012;	Kirov	et	al.,	2014),	raising	the	possibility	that	the	
link	between	CNVs	and	extinction	learning,	presented	herein,	has	further	relevance	to	
other	disorders.	Furthermore,	there	is	evidence	suggesting	that	ketamine	exacerbates	
posttraumatic	stress	 in	accident	victims	 (Schönenberg	et	al.,	2005,	2008),	which	may	
originate	from	effects	on	extinction	learning,	as	observed	in	Chapter	4.		
Due	to	 the	resistance	to	extinction	 learning	exhibited	by	patients	with	posttraumatic	
stress	 disorder,	 current	 treatments	 include	 exposure-based	 cognitive	 behavioural	
therapy	(Kar,	2011)	and	novel	therapeutic	interventions	aim	to	exploit	the	function	of	
circuits	 involved	 in	 inhibitory-type	 learning	 (Yehuda	 and	 LeDoux,	 2007;	 Maren	 and	
Holmes,	 2015;	 Singewald	 et	 al.,	 2015).	 If	 fear	 extinction	 processing	 is	 abnormal	 in	
schizophrenia,	it	is	plausible	that	the	same	approaches	may	have	therapeutic	potential	
in	schizophrenia.	Whilst	extinction	does	not	typically	result	in	the	erasure	of	conditioned	
memories,	some	studies	suggest	 that	 the	precise	timing	of	extinction	training	can	be	
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used	to	prevent	the	return	of	conditioned	fear	in	both	rodents	and	humans	(reviewed	
in	 Quirk	 et	 al.,	 2010).	 Furthermore,	 some	 evidence	 suggests	 that	 the	 partial	 NMDA	
receptor	agonist,	D-cycloserine,	may	be	used	in	conjunction	with	cognitive	behavioural	
therapy	to	normalise	extinction	impairments	(Davis,	2011;	Hofmann	et	al.,	2013).	
7.3 Generalisability	and	limitations	
Evidence	 implicating	altered	associative	 learning	 in	schizophrenia	comes	from	clinical	
studies	 (Miller,	 1976;	 Bazin	 and	 Perruchet,	 1996;	 Friston,	 1998;	 Serra	 et	 al.,	 2001;	
Diwadkar	et	al.,	2008b;	Jensen	et	al.,	2008;	Holt	et	al.,	2012)	and,	as	of	more	recently,	
genetic	 studies	 (Hall	 et	 al.,	 2009;	Pocklington	et	 al.,	 2015),	which	 include	 the	 results	
presented	herein.	The	apparent	role	of	associative	learning	has	been	incorporated	into	
logical	inference	models	of	how	false	beliefs	such	as	delusions	and	hallucinations	may	
come	 about	 (Corlett	 et	 al.,	 2009;	 Fletcher	 and	 Frith,	 2009).	 It	 is	 important	 to	 note,	
however,	 that	other	cognitive	domains	have	also	been	associated	with	schizophrenia	
through	clinical	studies,	including	attention,	working	memory,	episodic	memory,	social	
cognition	 and	 procedural	 learning	 (Millan	 et	 al.,	 2012).	 The	 robust,	 yet	 broad,	
implication	of	synaptic	plasticity	processes	in	schizophrenia	(Hall	et	al.,	2015)	is	of	equal	
relevance	to	these	other	cognitive	processes,	as	it	is	to	associative	learning.	Pocklington	
et	al	(2015)	reported	that	sets	of	genes	annotated	with	the	terms	“associative	learning”	
and	 “contextual	 conditioning	 behaviour”,	 are	 enriched	 in	 CNVs	 from	 patients	 with	
schizophrenia.	However,	the	same	study	also	implicates	some	other	cognitive	domains,	
such	as	“spatial	working	memory”,	“spatial	 learning”	and	“temporal	memory”,	whilst	
schizophrenia-relevant	 cognitive	 domains	 such	 as	 episodic	 memory	 and	 procedural	
learning	 were	 not	 represented	 by	 gene	 set	 analyses	 (Pocklington	 et	 al.,	 2015).	 This	
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limitation	is	not	due	to	poor	experimental	design,	however,	but	originates	from	the	bias	
in	 gene	 ontology	 databases	 towards	 those	 cognitive	 domains	 most	 studied	 and	
therefore	 incorporated	 into	 the	 annotation	 of	 gene	 sets.	 It	 should	 therefore	 be	
acknowledged	that	the	evidence	implicating	specific	components	of	associative	learning	
in	schizophrenia,	reported	here,	do	not	occlude	the	importance	of	additional	cognitive	
processes	in	the	development	of	the	disorder.	
There	is	considerable	overlap	between	psychiatric	disorders,	particularly	with	regards	to	
the	genetic	variants	from	which	their	risk	is	conferred	(Lee	et	al.,	2013;	Kirov	et	al.,	2014).	
Included	in	this	is	the	association	of	Homer1	with	autism	spectrum	disorder	and	major	
depression	 as	well	 as	 schizophrenia	 (Rietschel	 et	 al.,	 2010b;	 Spellmann	 et	 al.,	 2011;	
Kelleher	 et	 al.,	 2012).	 The	 assumption	 that	 psychiatric	 disorders	 can	 be	 defined	 as	
distinct	diseases,	each	with	separate	aetiology	and	pathophysiology,	has	been	said	to	
impede	mental	 health	 research	 (Craddock	 and	Owen,	 2010).	Hence,	 it	would	not	be	
appropriate	to	consider	the	relevance	of	these	findings	to	be	restricted	to	schizophrenia	
alone.	 Instead,	 the	 role	 of	 associative	 learning,	 and	 specifically	 extinction	 learning,	
should	 be	 interpreted	 in	 the	 context	 of	 a	 range	 of	 psychiatric	 disorders,	 particularly	
those	in	which	CNVs	play	a	role.		
Several	of	the	experiments	I	have	described	centre	around	the	measurement	of	gene	
and	protein	expression	in	tissue	extracted	from	rats,	following	behavioural	paradigms.	
This	approach	is	accompanied	by	some	limitations.	Firstly,	it	restricts	expression	data	to	
specific	time	points	chosen	for	the	extraction	of	tissue.	Since	the	temporal	pattern	of	
regulated	gene	expression	can	vary	greatly,	any	conclusions	drawn	from	the	data	are	
relevant	only	to	those	times	observed.	In	order	to	increase	the	temporal	resolution	of	
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the	 expression	 data,	 it	 requires	 a	 multiplicative	 increase	 in	 the	 use	 of	 animals	 and	
demands	higher	stringency	in	statistical	testing.	Secondly,	linking	gene	expression	with	
a	particular	cognitive	process	preceding	 it	 relies	on	carefully	designed	control	groups	
with	which	to	make	quantitative	comparisons.	Completely	avoiding	the	observation	of	
gene	expression	changes	associated	with	non-specific	aspects	of	a	behavioural	paradigm	
is	often	 impossible,	particularly	with	gene	expression	arrays,	which	must	be	analysed	
with	an	awareness	of	a	proportion	of	 false	positives	and	 false	negatives.	Thirdly,	 the	
magnitude	of	detectable	differential	gene	or	protein	expression	is	limited	by	the	tools	
used.	The	method	 favours	 the	observation	of	 large	expression	changes,	but	makes	 it	
more	 difficult	 to	 conclusively	 demonstrate	 no	 change	 from	 control.	 This	 was	
compounded	by	 the	 lack	 of	 availability	 of	 short-form	 specific	Homer1	 antibodies	 for	
protein	quantification,	the	most	notable	being	the	absence	of	antibodies	against	Ania-
3.	
7.4 Future	directions	
7.4.1 Specific	future	investigations	
There	are	unresolved	research	questions	concerning	the	roles	of	short	Homer1	proteins,	
not	just	in	associative	learning,	but	also	in	further	synaptic	plasticity	processes	relevant	
to	 schizophrenia.	 I	 have	 discussed	 the	 opportunities	 for	 studying	 the	 function	 of	
Homer1a	 and	Ania-3	 in	 the	 consolidation	 and	extinction	of	 contextual	 fear	memory,	
through	the	use	of	alternative	knockdown	strategies.	Additional	studies	may	investigate	
Homer1	expression	in	models	of	schizophrenia	and	related	disorders.	Homer1	interacts	
with	a	number	of	proteins	strongly	implicated	in	schizophrenia	and/or	autism	spectrum	
disorders	through	large-scale	genomic	studies,	including	SHANK1-3,	CaV1.2	and	F-actin	
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(Sala	et	al.,	2003;	Inoue	et	al.,	2004;	Huang	et	al.,	2007;	Hayashi	et	al.,	2009;	Ripke	et	al.,	
2013,	2014;	Fromer	et	al.,	2014;	Purcell	et	al.,	2014;	Rees	et	al.,	2014a).	It	is	notable	that	
rats	 lacking	 the	 gene	 encoding	 CaV1.2,	 CACNA1C,	 exhibit	 impairments	 in	 inhibitory	
learning,	as	assessed	through	the	latent	inhibition	of	contextual	fear	conditioning	(Sykes	
et	 al.,	 2016,	 unpublished).	 Further	 synaptic	 complexes	 implicated	 in	 schizophrenia	
through	genetic	variants	functionally	overlap	with	Homer1,	such	as	FMRP	and	CYFIP1	
(Ronesi	et	al.,	2012;	Fromer	et	al.,	2014;	Szatkiewicz	et	al.,	2014b),	as	well	as	members	
of	the	MAGUK	protein	family,	PSD-95	and	PSD-93	(Sala	et	al.,	2003;	Kirov	et	al.,	2012;	
Fromer	et	al.,	2014;	Purcell	et	al.,	2014).	Through	expression	and	protein	 interaction	
studies	 in	model	organisms,	 the	role	of	Homer1	proteins	 in	 the	mechanisms	through	
which	these	genetic	variants	confer	risk	for	psychiatric	disease	may	be	explored.	
The	integration	of	human	genetic	studies	with	experimental	gene	expression	studies	in	
rodents,	presented	in	Chapter	3,	demonstrates	considerable	potential	for	this	approach	
in	the	investigation	of	biological	pathways	effected	by	genetic	variation.	In	comparison	
to	pathway	analyses	based	upon	gene	ontology	databases,	which	are	limited	by	the	prior	
functional	 annotation	 of	 genes,	 this	 method	 incorporates	 all	 genes	 in	 the	 analysis,	
regardless	of	prior	knowledge.	This	form	of	gene	set	enrichment	analysis	could	be	used	
to	 probe	 the	 impact	 of	 genetic	 variants	 associated	 with	 schizophrenia,	 and	 other	
disorders,	on	discrete	synaptic	plasticity	processes.	For	example,	this	approach	could	be	
used	to	investigate	the	enrichment	of	genes	associated	with	other	inhibitory	learning	
processes,	such	as	latent	inhibition,	in	schizophrenia-associated	variants.	Alternatively,	
it	may	be	used	to	explore	the	contribution	of	hebbian	and	non-hebbian	type	synaptic	
plasticity	processes	to	psychiatric	disease	(Turrigiano	and	Nelson,	2004;	Wondolowski	
General	Discussion	
	
194	
	
and	Dickman,	2013).	Furthermore,	by	analysing	genes	differentially	expressed	in	cells	or	
animals	 following	 the	 genetic	 alteration	 of	 psychiatric	 disease	 risk	 genes,	 or	 the	
exposure	 to	 environmental	 insult,	 this	 method	 may	 help	 to	 validate	 the	 disease	
relevance	of	model	organisms.	All	such	experiments	will	need	to	include	considerations	
of	the	relative	advantages	of	different	gene	expression	quantification	techniques.	With	
recent	advances	in	technology	and	the	reduction	in	cost	of	RNA	sequencing,	this	may	
now	be	a	favourable	technique	for	the	acquisition	of	high	quality	gene	expression	data,	
over	microarrays	(Ozsolak	and	Milos,	2011).		
7.4.2 General	future	directions	
Whilst	the	recent	years	have	seen	a	substantial	advance	in	our	understanding	of	both	
genetic	 variants	 and	 learning	 systems	 implicated	 in	 schizophrenia,	 the	 translation	 of	
these	 findings	 to	 disease	 pathogenesis	 and,	 ultimately,	 applications	 in	 the	 clinic	will	
require	extensive	further	research.		
It	is	likely	that	we	will	see	further	large-scale	genomic	studies	of	increasing	size,	in	order	
to	 identify	 additional	 rare	 and	 common	 variants	 associated	 with	 schizophrenia.	
However,	it	is	of	equal	importance	that	future	research	focuses	on	the	function	of	those	
genes	through	which	genetic	variants	confer	risk	to	the	disorder.	One	way	this	could	be	
explored	is	through	the	characterisation	and	partitioning	of	genes	sets	highly	enriched	
in	 case	 variants.	 This	 may	 include	 the	 investigation	 of	 regional	 and	 developmental	
expression	 patterns,	 or	 evolutionary	 origin.	 It	 is	 this	 type	 of	 information	 that	would	
substantially	 improve	 gene	 ontology	 databases	 used	 in	 pathway	 analyses.	 Another	
approach	is	the	generation	of	cell	and	animal	models	of	alleles	with	high	penetrance.	
This	is	facilitated	by	technological	advances	in	genome	engineering,	notably	the	advent	
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of	clustered	regularly	interspaced	short	palindromic	repeats	(CRISPR)	(Cong	et	al.,	2013).	
However,	whilst	 these	methods	are	useful	 for	 exploring	 the	effects	of	 individual	 risk	
variants,	 they	 may	 be	 less	 informative	 of	 the	 biological	 systems	 implicated	 in	
schizophrenia	pathogenesis.	This	is	where	environmental	models	may	be	advantageous;	
particularly	the	study	of	gene-environment	interactions	will	be	critical	to	understanding	
how	 at-risk	 individuals	 develop	 schizophrenia.	 Together	with	 studies	 into	 gene-gene	
epistatic	interactions,	this	research	will	contribute	to	exposing	the	“missing	heritability”	
associated	with	schizophrenia	and	other	psychiatric	disorders.		
7.5 Conclusions	
Genetic	 evidence	 increasingly	 suggests	 that	 genetic	 risk	 variants	 associated	 with	
schizophrenia	impact	on	specific	cognitive	processes.	One	of	these	cognitive	processes	
may	be	the	extinction	of	averse	associative	memories,	particularly	with	regards	to	rare	
CNVs.	The	association	between	extinction	and	schizophrenia	strengthens	the	existing	
link	 between	 inhibitory	 learning	 and	 schizophrenia	 and	 compliments	 recent	 findings	
implicating	 inhibitory	 circuits	 in	 the	 disorder.	 Imbalance	 between	 inhibitory	 and	
excitatory	systems	may	represent	a	key	abnormality	contributing	to	the	progression	of	
schizophrenia,	and	may	be	modelled	by	psychoactive	 compounds,	 such	as	ketamine,	
which	blocks	extinction	learning.	There	is	a	clear	role	for	synaptic	proteins,	particularly	
those	 of	 the	 postsynaptic	 density,	 in	 associative	 learning	 processes	 relevant	 to	
schizophrenia.	 Whilst	 further	 studies	 are	 required	 to	 delineate	 the	 contributions	 of	
individual	 schizophrenia-associated	 synaptic	 proteins	 in	 these	 processes,	 current	
evidence	 warrants	 the	 continued	 investigation	 of	 the	 Homer1	 family	 in	 this	 regard.	
Future	 research	 will	 also	 benefit	 from	 further	 use	 of	 bioinformatics	 to	 combine	
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experimental	 expression	 studies	 with	 human	 genomic	 data,	 with	 an	 aim	 to	 better	
characterise	specific	biological	pathways	underlying	psychiatric	disorders.	
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MD,	USA	(HHSN268200782096C,	"NIH	contract	High	throughput	genotyping	for	studying	the	
genetic	 contributions	 to	 human	 disease";	 HHSN268201100011I,	 "NIH	 contract	 High	
throughput	genotyping	for	studying	the	genetic	contributions	to	human	disease").	D)	Study	
of	 Melanoma	 Risk	 in	 Australia	 and	 the	 United	 Kingdom.	 dbGaP	 Study	 Accession:	
phs000519.v1.p1.	The	principal	investigator	was	Nicholas	Hayward	(Queensland	Institute	of	
Medical	Research,	Brisbane,	QLD,	Australia).	The	study	was	funded	by	the	National	Cancer	
Institute	of	the	National	Institutes	of	Health,	Bethesda,	MD,	USA	(R01CA088363).	Genotyping	
was	carried	out	at	the	Center	for	Inherited	Disease	Research	(CIDR),	Johns	Hopkins	University,	
Baltimore,	MD,	USA	 and	 funded	 by	 the	National	 Institutes	 of	Health,	 Bethesda,	MD,	USA	
(HHSN268201100011I).	E)	Genome-Wide	Association	of	Schizophrenia	Study,	(GAIN).	dbGaP	
accession	phs000021.v3.p2.	Funding	for	this	study	was	provided	by	the	National	Institute	of	
Mental	Health	(R01	MH67257,	R01	MH59588,	R01	MH59571,	R01	MH59565,	R01	MH59587,	
R01	MH60870,	R01	MH59566,	R01	MH59586,	R01	MH61675,	R01	MH60879,	R01	MH81800,	
U01	MH46276,	U01	MH46289	U01	MH46318,	U01	MH79469,	and	U01	MH79470)	and	the	
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genotyping	of	samples	was	provided	through	the	Genetic	Association	Information	Network.	
The	principle	investigator	was	Pablo	V.	Gejman,	Evanston	Northwestern	Healthcare	(ENH)	and	
Northwestern	University,	Evanston,	 IL,	USA.	F)	Genome-Wide	Association	of	Schizophrenia	
Study,	 (MGS_nonGAIN).	 dbGaP	 accession	 phs000167.v1.p1.	 Samples	 and	 associated	
phenotype	 data	 for	 the	MGS_nonGAIN	 study	 were	 collected	 under	 the	 following	 grants:	
NIMH	 Schizophrenia	 Genetics	 Initiative	 U01s:	 MH46276	 (CR	 Cloninger),	 MH46289	 (C	
Kaufmann),	and	MH46318	(MT	Tsuang);	and	MGS	Part	1	 (MGS1)	and	Part	2	 (MGS2)	R01s:	
MH67257	 (NG	Buccola),	MH59588	 (BJ	Mowry),	MH59571	 (PV	Gejman),	MH59565	 (Robert	
Freedman),	MH59587	(F	Amin),	MH60870	(WF	Byerley),	MH59566	(DW	Black),	MH59586	(JM	
Silverman),	MH61675	(DF	Levinson),	and	MH60879	(CR	Cloninger).	G)	Genetic	Architecture	of	
Smoking	 and	 Smoking	 Cessation	 dbGAP	 accession	 phs000404.v1.p1.	 Funding	 support	 for	
genotyping,	which	was	performed	at	the	Center	for	Inherited	Disease	Research	(CIDR),	was	
provided	by	1	X01	HG005274-01.	CIDR	 is	 fully	 funded	through	a	 federal	contract	 from	the	
National	Institutes	of	Health	to	The	Johns	Hopkins	University,	contract	number	HHSN2682007	
82096C.	Assistance	with	genotype	cleaning,	as	well	as	with	general	study	coordination,	was	
provided	by	the	Gene	Environment	Association	Studies	(GENEVA)	Coordinating	Center	(U01	
HG004446).	 Funding	 support	 for	 collection	 of	 datasets	 and	 samples	was	 provided	 by	 the	
Collaborative	 Genetic	 Study	 of	 Nicotine	 Dependence	 (COGEND;	 P01	 CA089392)	 and	 the	
University	of	Wisconsin	Transdisciplinary	Tobacco	Use	Research	Center	(P50	DA019706,	P50	
CA084724).	 H)	 High-	 Density	 SNP	 Association	 Analysis	 of	 Melanoma:	 Case–Control	 and	
Outcomes	Investigation.	dbGaP	accession	phs000187.v1.p1.	Research	support	to	collect	data	
and	 develop	 an	 application	 to	 support	 this	 project	 was	 provided	 by	 3P50CA093459,	
5P50CA097007,	 5R01ES011740	 and	 5R01CA133996.	 I)	 Genetic	 Epidemiology	 of	 Refractive	
Error	in	the	KORA	Study.	dbGaP	accession	phs000303.v1.p1.	Principal	investigators:	Dwight	
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Stambolian,	University	of	Pennsylvania,	Philadelphia,	PA,	USA;	H.	Erich	Wichmann,	 Institut	
fu¨r	 Humangenetik,	 Helmholtz-Zentrum	 Mu¨nchen,	 Germany,	 National	 Eye	 Institute,	
National	 Institutes	 of	 Health,	 Bethesda,	 MD,	 USA.	 Funded	 by	 R01	 EY020483,	 National	
Institutes	of	Health,	Bethesda,	MD,	USA.		
Samples	 from	 the	WTCCC2	 study	were	downloaded	 from	https://www.ebi.ac.uk/ega/	 and	
include	 samples	 from	 the	National	Blood	Donors	Cohort,	 EGAD00000000024	and	 samples	
from	 the	 1958	 British	 Birth	 Cohort,	 EGAD00000000022.	 Funding	 for	 these	 projects	 was	
provided	 by	 the	Wellcome	 Trust	 Case	 Control	 Consortium	 2	 project	 (085475/B/08/Z	 and	
085475/Z/	08/Z),	the	Wellcome	Trust	(072894/Z/03/Z,	090532/Z/09/Z	and	075491/Z/04/B)	
and	NIMH	grants	(MH	41953	and	MH08	3094).	For	the	CLOZUK	sample,	we	thank	Novartis	for	
their	guidance	and	co-operation.	We	also	thank	staff	at	The	Doctor’s	Laboratory,	in	particular	
Lisa	 Levett	 and	 Andrew	 Levett,	 for	 help	 and	 advice	 regarding	 sample	 acquisition.	 We	
acknowledge	Kiran	Mantripragada,	Lesley	Bates,	Catherine	Bresner	and	Lucinda	Hopkins	for	
laboratory	sample	management.	Finally,	we	thank	the	participants	and	clinicians	who	took	
part	in	the	Cardiff	COGS	study.	
	
